BioMedLib Search Engine
[ goto HOMEPAGE ]
Search the biomedical literature, for the most relevant articles.
Skip to content
Advanced Search
Search History
MeSH Query
Page Format
Query is expanded
Login
Skip to content
Export Citations
Search Results
RSS
Email
Articles' Details
Start new query
Reset All
Refine your query
(more in Advanced-Search):
Search all of MEDLINE
Focus on the recent 5 years
Focus on the current year
Focus on the last 30 days
More choices ...
Focus on articles with free fulltexts
More choices ...
Do simple 'keyword' search (no query expansion)
[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click
here to
RESET
all values
Click
here to
GO BACK
without resetting any value
Advanced Search
Submit one or more of the following items, and they will be searched along with your query in the search box above.
Any submit button will submit all of the items you have changed.
+
Publication-Date
Published in the last:
30 days
60 days
90 days
6 months
12 months
this year
2 years
3 years
5 years
10 years
Or published in the following date range: From (yyyy/mm/dd - month and day are optional)
to ('to' is optional)
+
Full Text
Retrieve articles with hyperlinks to:
full text (either free or subscription)
free full text
subscription full text
no full text link
+
Sort-Order
Sort the retrieved articles by:
relevance
publication date
+
Language
And with languages:
English
French
German
Italian
Japanese
Russian
Spanish
More languages:
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Bengali
Bosnian
Bulgarian
Catalan
Chinese
Czech
Danish
Dutch
Esperanto
Estonian
Finnish
Georgian
Scottish Gaelic
Greek, Modern
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Kinyarwanda
Korean
Latin
Latvian
Lithuanian
Macedonian
Malayalam
Maori
Malay
Multiple languages
Norwegian
Persian
Polish
Portuguese
Pushto
Romanian
Sanskrit
Serbian
Croatian
Slovak
Slovenian
Swedish
Thai
Turkish
Ukrainian
Undetermined
Urdu
Vietnamese
Welsh
+
Publication-Type
And with publication types:
Clinical Trial
Editorial
Letter
Meta-Analysis
Practice Guideline
Randomized Controlled Trial
Review
More publication types:
Addresses
Bibliography
Biography
Case Reports
Classical Article
Clinical Conference
Clinical Trial, Phase I
Clinical Trial, Phase II
Clinical Trial, Phase III
Clinical Trial, Phase IV
Comment
Comparative Study
Congresses
Consensus Development Conference
Consensus Development Conference, NIH
Controlled Clinical Trial
Corrected and Republished Article
Dictionary
Directory
Duplicate Publication
English Abstract
Evaluation Studies
Festschrift
Government Publications
Guideline
Historical Article
Interactive Tutorial
Interview
Introductory Journal Article
In Vitro
Journal Article
Lectures
Legal Cases
Legislation
Multicenter Study
News
Newspaper Article
Overall
Patient Education Handout
Periodical Index
Portraits
Published Erratum
Retracted Publication
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Retraction of Publication
Scientific Integrity Review
Technical Report
Twin Study
Validation Studies
+
Species
And for:
Humans
Animals
+
Gender
And for:
Male
Female
+
Age
And for these age groups:
Newborn: birth to 1 month
Infant: 1 to 23 months
Preschool child: 2 to 5 years
Child: 6 to 12 years
Adolescent: 13 to 18 years
Adult: 19 to 44 years
Middle aged: 45 to 64 years
Aged: 65+ years
80 and over: 80+ years
+
Title
And for this query matching the titles:
+
Transliterated-Title
And for this query matching the title in original language:
+
Abstract
And for this query matching the abstratcs:
+
Major-Mesh
And for this query matching the MeSH-Major terms:
+
Mesh
And for this query matching any MeSH terms:
+
Journal
And for one or more of these journal abbreviated names:
OR
OR
(see
title abbreviations
)
+
Volume
And with journal volume number:
+
Issue
And with journal issue number:
+
Page
And with page number:
+
ISSN
And with ISSN:
+
Publication-Place
And with journal's country of publication:
+
Author
And for...
all these author names:
AND
AND
(see
help
)
one or more of these author names:
OR
OR
but not having any of these unwanted author names:
NOT
NOT
+
Affiliation
And with affiliation to:
+
Has-Abstract
Find MEDLINE records with the abstract status:
has abstract
does not have abstract
include both record types
include both record types but rank higher the records having abstract (the default BML behavior)
+
PMID
Show me only articles for these PMIDs (PubMed IDs):
+
Semantic-Type
And with semantic types:
A. Entity
A1. Physical Object
A1.1. Organism
A1.1.1. Archaeon
A1.1.2. Bacterium
A1.1.3. Eukaryote
A1.1.3.1. Animal
A1.1.3.1.1. Vertebrate
A1.1.3.1.1.1. Amphibian
A1.1.3.1.1.2. Bird
A1.1.3.1.1.3. Fish
A1.1.3.1.1.4. Mammal
A1.1.3.1.1.4.1. Human
A1.1.3.1.1.5. Reptile
A1.1.3.2. Fungus
A1.1.3.3. Plant
A1.1.4. Virus
A1.2. Anatomical Structure
A1.2.1. Embryonic Structure
A1.2.2. Anatomical Abnormality
A1.2.2.1. Congenital Abnormality
A1.2.2.2. Acquired Abnormality
A1.2.3. Fully Formed Anatomical Structure
A1.2.3.1. Body Part, Organ, or Organ Component
A1.2.3.2. Tissue
A1.2.3.3. Cell
A1.2.3.4. Cell Component
A1.2.3.5. Gene or Genome
A1.3. Manufactured Object
A1.3.1. Medical Device
A1.3.1.1. Drug Delivery Device
A1.3.2. Research Device
A1.3.3. Clinical Drug
A1.4. Substance
A1.4.1. Chemical
A1.4.1.1. Chemical Viewed Functionally
A1.4.1.1.1. Pharmacologic Substance
A1.4.1.1.1.1. Antibiotic
A1.4.1.1.2. Biomedical or Dental Material
A1.4.1.1.3. Biologically Active Substance
A1.4.1.1.3.1. Neuroreactive Substance or Biogenic Amine
A1.4.1.1.3.2. Hormone
A1.4.1.1.3.3. Enzyme
A1.4.1.1.3.4. Vitamin
A1.4.1.1.3.5. Immunologic Factor
A1.4.1.1.3.6. Receptor
A1.4.1.1.4. Indicator, Reagent, or Diagnostic Aid
A1.4.1.1.5. Hazardous or Poisonous Substance
A1.4.1.2. Chemical Viewed Structurally
A1.4.1.2.1. Organic Chemical
A1.4.1.2.1.5. Nucleic Acid, Nucleoside, or Nucleotide
A1.4.1.2.1.6. Organophosphorus Compound
A1.4.1.2.1.7. Amino Acid, Peptide, or Protein
A1.4.1.2.1.8. Carbohydrate
A1.4.1.2.1.9. Lipid
A1.4.1.2.1.9.1. Steroid
A1.4.1.2.1.9.2. Eicosanoid
A1.4.1.2.2. Inorganic Chemical
A1.4.1.2.3. Element, Ion, or Isotope
A1.4.2. Body Substance
A1.4.3. Food
A2. Conceptual Entity
A2.1. Idea or Concept
A2.1.1. Temporal Concept
A2.1.2. Qualitative Concept
A2.1.3. Quantitative Concept
A2.1.4. Functional Concept
A2.1.4.1. Body System
A2.1.5. Spatial Concept
A2.1.5.1. Body Space or Junction
A2.1.5.2. Body Location or Region
A2.1.5.3. Molecular Sequence
A2.1.5.3.1. Nucleotide Sequence
A2.1.5.3.2. Amino Acid Sequence
A2.1.5.3.3. Carbohydrate Sequence
A2.1.5.4. Geographic Area
A2.2. Finding
A2.2.1. Laboratory or Test Result
A2.2.2. Sign or Symptom
A2.3. Organism Attribute
A2.3.1. Clinical Attribute
A2.4. Intellectual Product
A2.4.1. Classification
A2.4.2. Regulation or Law
A2.5. Language
A2.6. Occupation or Discipline
A2.6.1. Biomedical Occupation or Discipline
A2.7. Organization
A2.7.1. Health Care Related Organization
A2.7.2. Professional Society
A2.7.3. Self-help or Relief Organization
A2.8. Group Attribute
A2.9. Group
A2.9.1. Professional or Occupational Group
A2.9.2. Population Group
A2.9.3. Family Group
A2.9.4. Age Group
A2.9.5. Patient or Disabled Group
B. Event
B1. Activity
B1.1. Behavior
B1.1.1. Social Behavior
B1.1.2. Individual Behavior
B1.2. Daily or Recreational Activity
B1.3. Occupational Activity
B1.3.1. Health Care Activity
B1.3.1.1. Laboratory Procedure
B1.3.1.2. Diagnostic Procedure
B1.3.1.3. Therapeutic or Preventive Procedure
B1.3.2. Research Activity
B1.3.2.1. Molecular Biology Research Technique
B1.3.3. Governmental or Regulatory Activity
B1.3.4. Educational Activity
B1.4. Machine Activity
B2. Phenomenon or Process
B2.1. Human-caused Phenomenon or Process
B2.1.1. Environmental Effect of Humans
B2.2. Natural Phenomenon or Process
B2.2.1. Biologic Function
B2.2.1.1. Physiologic Function
B2.2.1.1.1. Organism Function
B2.2.1.1.1.1. Mental Process
B2.2.1.1.2. Organ or Tissue Function
B2.2.1.1.3. Cell Function
B2.2.1.1.4. Molecular Function
B2.2.1.1.4.1. Genetic Function
B2.2.1.2. Pathologic Function
B2.2.1.2.1. Disease or Syndrome
B2.2.1.2.1.1. Mental or Behavioral Dysfunction
B2.2.1.2.1.2. Neoplastic Process
B2.2.1.2.2. Cell or Molecular Dysfunction
B2.2.1.2.3. Experimental Model of Disease
B2.3. Injury or Poisoning
Page Format
Any submit button will submit all of the items you have changed.
[theme]
Use this page design theme:
original
twenty ten
[shown]
Results per page:
5
10
20
50
100
200
500
[expand/collapse]
show these sections expanded by default:
Advanced search
MeSH query
Search history
Page format
Query expansion
Articles details
Export citations
Email
[text size]
use this font size for text:
25%
50%
75%
100%
125%
150%
200%
or enter your choice of font size:
[page width]
use this page width (relative to the default initial value):
25%
50%
75%
100%
125%
150%
200%
or enter your choice of page width:
[highlight color]
use this color to highlight query words in the articles:
red
green
blue
black
purple
yellow
orange
navy
olive
maroon
none
[query history]
maximum number of queries shown in the history section:
[annotate]
Annotate these parts of each article:
title
abstract
both
none
Reset all values
Find best MeSH terms for
Search History
1
b cell small lymphocytic lymphoma nos 2005:2010[pubdate] *count=100
911 results
Searchbox
Export
PDF
RSS
Email
Delete
Email this search result to the following email address:
[X] Close
Expand the query
'
b cell small lymphocytic lymphoma nos
' expanded to all its synonyms;
details
Email the results to the following email address:
Export the checked citations in RIS format (RIS format is used by RefWorks, Endnote, among others).
Items 1 to 100 of about 911
1.
Esteghamati A, Khalilzadeh O, Ashraf H, Zandieh A, Morteza A, Rashidi A, Meysamie A, Nakhjavani M:
Physical activity is correlated with serum leptin independent of obesity: results of the national surveillance of risk factors of noncommunicable diseases in Iran (SuRFNCD-2007).
Metabolism
; 2010 Dec;59(12):1730-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Physical activity is correlated with
serum leptin
independent of obesity: results of the national surveillance of risk factors of noncommunicable diseases in Iran (SuRFNCD-2007).
Reports on the relationship between
leptin
and physical activity (PA) at the population
level
are scarce.
The present study examined the relationship between
serum leptin
concentrations and PA in a nationally representative sample of 3001 Iranian adults aged 25 to 64 years.
Serum leptin
was measured with an enzyme-linked immunosorbent assay.
After adjustment for age, area of residence, smoking, body mass index, and waist circumference, total PA (r = -0.129, P = .038 in men and r = -0.226, P = .006 in women), the duration of vigorous-intensity activity (r = -0.120, P = .044 in men and r = -0.154, P = .019 in women), the duration of moderate-intensity activity (r = -0.114, P = .047 in men and r = -0.160, P = .018 in women), and time spent on sedentary behaviors (r = 0.194, P = .014 in men and r = -0.204, P = .007 in women) were significantly correlated with
serum leptin
.
In both sexes, participants in higher categories of PA had significantly lower
serum leptin levels
.
In conclusion, our results demonstrated an inverse association between
leptin
concentrations and PA independent of age, sex, smoking, and body adiposity.
Our results point to the regulatory effects of PA on
serum leptin
.
[MeSH-major]
Exercise.
Leptin
/ blood. Obesity / physiopathology. Population Surveillance
Genetic Alliance.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Exercise and Physical Fitness
.
MedlinePlus Health Information.
consumer health - Obesity
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright © 2010 Elsevier Inc. All rights reserved.
(PMID = 20580780.001).
[ISSN]
1532-8600
[Journal-full-title]
Metabolism: clinical and experimental
[ISO-abbreviation]
Metab. Clin. Exp.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin
2.
Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, Del Monte G, Formica V, Laudisi A, Portarena I, Palmirotta R, Ferroni P:
Prognostic significance of serum adipokine levels in colorectal cancer patients.
Anticancer Res
; 2009 Aug;29(8):3321-7
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Prognostic significance of
serum
adipokine
levels
in colorectal cancer patients.
BACKGROUND: Adipokines may significantly influence the growth and proliferation of tumor stroma and
malignant
cells within.
Reduced adiponectin and increased
leptin serum levels
were found in colorectal cancer (CRC) patients.
Recently, it has been demonstrated that tumor necrosis factor-alpha (TNF-alpha) is able to induce dose-dependent changes in
serum
adipokine
levels
.
MATERIALS AND METHODS: Baseline
leptin
, adiponectin and TNF-alpha
levels
were analyzed in 90 patients with histologically diagnosed primary or newly diagnosed metastatic CRC treated at 'Tor Vergata' Clinical Center and followed up for a median period of 3 years.
RESULTS:
Serum leptin levels
were higher in CRC patients than in controls (p<0.0001).
Conversely,
serum
adiponectin
levels
were lower in CRC patients than in controls (p<0.0001).
Leptin
inversely correlated with adiponectin (p<0.005).
The
leptin
/adiponectin (L/A) ratio was eight-fold greater in CRC compared to controls (p<0.0001).
CONCLUSION:
Serum
adipokine
levels
might have a role in the biology of CRC and the combined measurement of
leptin
and adiponectin
levels
might provide useful prognostic information in the management of patients with CRC.
[MeSH-minor]
Adiponectin / blood. Adult. Aged. Case-Control Studies. Female. Follow-Up Studies. Humans.
Leptin
/ blood. Male. Middle Aged.
Neoplasm
Recurrence, Local / blood.
Neoplasm
Recurrence, Local / pathology.
Neoplasm
Recurrence, Local / surgery. Prognosis. Survival Rate. Treatment Outcome. Tumor Necrosis Factor-alpha / blood
Genetic Alliance.
consumer health - Colorectal Cancer
.
MedlinePlus Health Information.
consumer health - Colorectal Cancer
.
MedlinePlus Health Information.
consumer health - Liver Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19661351.001).
[ISSN]
1791-7530
[Journal-full-title]
Anticancer research
[ISO-abbreviation]
Anticancer Res.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Greece
[Chemical-registry-number]
0 / ADIPOQ protein, human; 0 / Adiponectin; 0 / Leptin; 0 / Tumor Necrosis Factor-alpha
3.
Bhat GK, Plant TM, Mann DR:
Relationship between serum concentrations of leptin, soluble leptin receptor, testosterone and IGF-I, and growth during the first year of postnatal life in the male rhesus monkey, Macaca mulatta.
Eur J Endocrinol
; 2005 Jul;153(1):153-8
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Relationship between
serum
concentrations of
leptin
, soluble
leptin
receptor, testosterone and IGF-I, and growth during the first year of postnatal life in the male rhesus monkey, Macaca mulatta.
OBJECTIVES: Subnormal
leptin levels
in low birth weight infants may allow for catch-up growth during infancy.
Scant data are available that relate growth with circulating
leptin
during normal infancy in primates.
The current study objective was to examine the association between
serum leptin
, its soluble receptor (sOB-R), testosterone and IGF-I concentrations, and body weight during infancy in male rhesus monkeys.
DESIGN: Hormone
levels
were assessed longitudinally in animals (n = 7) from birth until 1 year of age.
RESULTS: Body weight increased during the first 6 months of life and was strongly correlated with rising IGF-I
levels
and, as IGF-I plateaued and then declined during the second half of the year, body weight gain decelerated.
In contrast,
leptin levels
declined gradually with age during the first year of life in conjunction with increasing body weight.
There was no association between body weight gain and
serum leptin levels
or between
serum
testosterone and
leptin
values.
Since sOB-R
levels
also declined with
leptin
values, it does not appear that
levels
of bioavailable
leptin
changed during infancy.
CONCLUSIONS: The data do not support the contention that
leptin
regulates growth during infancy, but the close association between IGF-I
levels
and body weight suggested that this hormone may regulate growth in infant male monkeys.
The failure to observe an association between
serum
testosterone and
leptin
concentrations suggested that
leptin
is not involved in the activation of the hypothalamic-pituitary -testicular axis during this developmental period.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
TESTOSTERONE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15994757.001).
[ISSN]
0804-4643
[Journal-full-title]
European journal of endocrinology
[ISO-abbreviation]
Eur. J. Endocrinol.
[Language]
ENG
[Grant]
United States / NIGMS NIH HHS / GM / GM08248; United States / NICHD NIH HHS / HD / HD08610; United States / NICHD NIH HHS / HD / HD13254; United States / NICHD NIH HHS / HD / HD41749; United States / NCRR NIH HHS / RR / RR03024
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
[Publication-country]
England
[Chemical-registry-number]
0 / Leptin; 0 / Receptors, Cell Surface; 0 / Receptors, Leptin; 3XMK78S47O / Testosterone; 67763-96-6 / Insulin-Like Growth Factor I
Advertisement
4.
Krcmár J, Kotolová H, Veselá L, Csöllei J, Gonec T, Karpísek M, Bartosová L, Necas J:
[Study of a newly synthesized substance with a potential to stimulate beta3-adrenergic receptors].
Ceska Slov Farm
; 2006 May;55(3):120-3
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The effects of six-week oral administration of the newly synthesized substance B496 (methyl-4-[2-[2-hydroxy-3-(4-ethylcarbamoyl)phenoxyprophyl]amino]etyl)-phenoxyacetate hydrochloride) on
serum
glucose, triglycerides, total cholesterol, and
leptin levels
were studied in male Wistar rats fed with a high-fat diet.
The results indicated a significant reduction in
serum
glucose
levels
(-26 %, p<0,01), triacylglyceride
levels
(-21 %, p<0,05) and
leptin levels
(-43 %, p<0,01).
Further the effect of a single intraperitoneal dose (1 mg/kg) of B496 and BRL-37344 on
serum leptin levels
in the C57Bl/6J mouse was investigated.
Administration of BRL-37344 resulted in a significant decrease in
serum leptin levels
(-55 %, p<0,001).
[MeSH-major]
Adrenergic beta-Agonists / pharmacology.
Leptin
/ blood. Receptors, Adrenergic, beta-3 / drug effects
Hazardous Substances Data Bank.
CHOLESTEROL
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16838489.001).
[ISSN]
1210-7816
[Journal-full-title]
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti
[ISO-abbreviation]
Ceska Slov Farm
[Language]
cze
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Czech Republic
[Chemical-registry-number]
0 / Adrenergic beta-Agonists; 0 / B496 compound; 0 / Blood Glucose; 0 / Ethanolamines; 0 / Leptin; 0 / Phenoxyacetates; 0 / Receptors, Adrenergic, beta-3; 0 / Triglycerides; 114333-71-0 / BRL 37344; 97C5T2UQ7J / Cholesterol
5.
Jose VJ, Mariappan P, George PV, Selvakumar, Selvakumar D:
Serum leptin levels in acute myocardial infarction.
Indian Heart J
; 2005 Jan-Feb;57(1):39-43
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum leptin levels
in acute myocardial infarction.
BACKGROUND: Several studies have shown an association of
serum leptin levels
with cardiovascular diseases.
The present study was undertaken to assess
levels
of
serum leptin
in patients presenting with acute ST segment elevation myocardial infarction.
The
serum leptin levels
in patients with myocardial infarction was 6.51 +/- 6.76 ng/ml versus 2.86 +/- 2.22 ng/ml in controls.
In the multivariate analysis the odds ratio for
serum leptin
with myocardial infarction was 1.45 with a 95% confidence interval of 1.2 to 1.8.
CONCLUSIONS: Our results suggest that
serum leptin level
is elevated in patients with acute ST segment elevation myocardial infarction.
[MeSH-major]
Leptin
/ blood. Myocardial Infarction / blood
MedlinePlus Health Information.
consumer health - Heart Attack
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15852893.001).
[ISSN]
0019-4832
[Journal-full-title]
Indian heart journal
[ISO-abbreviation]
Indian Heart J
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
India
[Chemical-registry-number]
0 / Leptin
6.
Teixeira PF, Cabral MD, Silva NA, Soares DV, Braulio VB, Couto AP, Henriques JL, Costa AJ, Buescu A, Vaisman M:
Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition.
Thyroid
; 2009 May;19(5):443-50
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum leptin
in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition.
BACKGROUND: The relationship between thyroid status, including subclinical hypothyroidism (SH) and
serum leptin
is controversial or uncertain.
Therefore we evaluated
serum leptin
in SH and overt hypothyroidism (OH) and determined the effects of levothyroxine (LT(4)) replacement on
serum leptin
in these disorders.
METHODS:
Serum leptin
, thyrotropin (TSH), free thyroxine, insulin, glucose, and body composition parameters were compared in 55 SH, 20 OH, and 28 euthyroid (EU) pre- and postmenopausal women.
In addition, the effect of LT(4) treatment on
serum leptin
in SH and OH was assessed.
RESULTS: The mean +/- SD (median)
serum leptin
concentrations in the OH and SH groups were higher than in the EU group (35.1 +/- 27.2 [33.0] and 36.6 +/- 21.9 [30.6] ng/mL, respectively, vs. 23.2 +/- 19.3 [17.9] ng/mL, p = 0.011), but the difference was only significant in postmenopausal women.
In premenopausal women there was no correlation between
leptin
, BMI, or FMI and
serum
TSH
levels
(r(s) = 0.009, p = 0.474; r(s) = 0.043, p = 0.367; r(s) = 0.092, p = 0.232).
In the postmenopausal women, the partial correlation coefficient between TSH and
leptin
was present, even when controlling for BMI (r(s) = 0.297, p = 0.042) and FMI (r(s) = 0.275, p = 0.050).
LT(4) treatment was associated with a reduction of
serum leptin
concentrations in the OH group (p = 0.008).
In SH group there were no differences between LT(4) replacement or no treatment, since a fall in
serum leptin levels
was detected in both SH subgroups, despite a more pronounced fall with LT(4) use.
CONCLUSIONS:
Serum leptin
concentrations are elevated in postmenopausal women with SH or OH.
A relationship between thyroid status and
serum leptin
is further supported by the fact that LT(4) treatment, to restore the EU status, reduced
serum leptin levels
in OH in the absence of significant effects on BMI.
In women, hypothyroidism influences either
leptin
secretion or degradation and this effect is more pronounced in postmenopausal than in premenopausal women.
[MeSH-major]
Body Composition. Hormone Replacement Therapy. Hypothyroidism / drug therapy.
Leptin
/ blood. Postmenopause / blood. Premenopause / blood. Thyroxine / therapeutic use
MedlinePlus Health Information.
consumer health - Hormone Replacement Therapy
.
MedlinePlus Health Information.
consumer health - Hypothyroidism
.
Hazardous Substances Data Bank.
LEVOTHYROXINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19415994.001).
[ISSN]
1557-9077
[Journal-full-title]
Thyroid : official journal of the American Thyroid Association
[ISO-abbreviation]
Thyroid
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Blood Glucose; 0 / Insulin; 0 / Leptin; 9002-71-5 / Thyrotropin; Q51BO43MG4 / Thyroxine
7.
Gadzinowski J, Kowalska K, Vidyasagar D:
Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO.
J Perinatol
; 2008 Dec;28 Suppl 3:S56-66
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Treatment of MAS with PPHN using combined therapy:
SLL
, bolus surfactant and iNO.
In this study, thirteen infants with
diagnosis
of MAS and PPHN were first treated with conventional respiratory support.
Then between 2 and 22h of life they were randomized either to bolus surfactant treatment (n=6) or surfactant lung lavage (
SLL
, n=7) treatment.
The results showed that infants treated with
SLL
had significant improvements in oxygenation, decreases in MAP and A-a gradients.
In conclusion these data show no advantage of
SLL
therapy over bolus surfactant treatment in infants with MAS complicated by PPHN.
Hazardous Substances Data Bank.
NITRIC OXIDE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19057612.001).
[ISSN]
1476-5543
[Journal-full-title]
Journal of perinatology : official journal of the California Perinatal Association
[ISO-abbreviation]
J Perinatol
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Randomized Controlled Trial
[Publication-country]
United States
[Chemical-registry-number]
0 / Pulmonary Surfactants; 31C4KY9ESH / Nitric Oxide
8.
Aldoss IT, Blumel SM, Bierman PJ:
The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma.
Cancer Manag Res
; 2009;1:155-65
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The role of bendamustine in the treatment of indolent non-Hodgkin
lymphoma
.
There is no consensus on recommendations for the treatment of relapsed and refractory indolent non-Hodgkin
lymphoma
(NHL).
This agent has a high degree of activity against a variety of tumor
cell
lines.
Clinically, bendamustine has demonstrated activity against indolent NHL, chronic
lymphocytic lymphoma
, multiple myeloma and mantle
cell lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Clin Oncol. 2008 Sep 20;26(27):4473-9
[
18626004.001
]
[Cites]
Anticancer Drugs. 2005 Sep;16(8):871-7
[
16096436.001
]
[Cites]
J Clin Oncol. 2009 Feb 10;27(5):812-26
[
19103723.001
]
[Cites]
Ther Clin Risk Manag. 2008 Aug;4(4):727-32
[
19209254.001
]
[Cites]
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
[
19474385.001
]
[Cites]
Semin Hematol. 1988 Apr;25(2 Suppl 2):11-6
[
2456618.001
]
[Cites]
Biochim Biophys Acta. 1972 Dec 22;287(3):386-9
[
4629776.001
]
[Cites]
Semin Oncol. 2002 Aug;29(4 Suppl 13):12-4
[
12170426.001
]
[Cites]
N Engl J Med. 2005 Feb 3;352(5):441-9
[
15689582.001
]
[Cites]
J Clin Oncol. 2002 Aug 1;20(15):3262-9
[
12149300.001
]
[Cites]
Blood. 2005 Dec 1;106(12):3725-32
[
16123223.001
]
[Cites]
J Cancer Res Clin Oncol. 2006 Apr;132(4):205-12
[
16402269.001
]
[Cites]
J Clin Oncol. 2006 Sep 1;24(25):4143-9
[
16896003.001
]
[Cites]
Cancer Chemother Pharmacol. 2007 May;59(6):759-70
[
16957931.001
]
[Cites]
Anticancer Drugs. 2007 Jun;18(5):587-95
[
17414628.001
]
[Cites]
J Clin Oncol. 2007 May 20;25(15):1986-92
[
17420513.001
]
[Cites]
Leukemia. 2007 Nov;21(11):2316-23
[
17597807.001
]
[Cites]
Leuk Lymphoma. 2007 Jul;48(7):1299-306
[
17613757.001
]
[Cites]
J Cancer Res Clin Oncol. 2008 Feb;134(2):245-53
[
17653574.001
]
[Cites]
Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 1:S13-7
[
18282361.001
]
[Cites]
Blood. 2008 Jul 15;112(2):330-9
[
18451308.001
]
[Cites]
J Cancer Res Clin Oncol. 2009 Feb;135(2):227-34
[
18719942.001
]
[Cites]
Blood. 2008 Oct 1;112(7):2596-7
[
18809766.001
]
[Cites]
Anticancer Drugs. 1996 Jun;7(4):415-21
[
8826610.001
]
[Cites]
J Clin Oncol. 1997 Mar;15(3):1110-7
[
9060552.001
]
[Cites]
Pharmazie. 1985 Nov;40(11):782-4
[
4095129.001
]
[Cites]
J Cancer Res Clin Oncol. 2002 Nov;128(11):603-9
[
12458340.001
]
[Cites]
Semin Oncol. 2002 Aug;29(4 Suppl 13):4-11
[
12170425.001
]
[Cites]
Blood. 2005 Feb 15;105(4):1417-23
[
15494430.001
]
[Cites]
J Clin Oncol. 2005 May 20;23(15):3383-9
[
15908650.001
]
[Cites]
J Cancer Res Clin Oncol. 2006 Feb;132(2):105-12
[
16088404.001
]
[Cites]
J Clin Oncol. 2005 Oct 20;23(30):7565-73
[
16186600.001
]
[Cites]
J Clin Oncol. 2005 Nov 1;23(31):7985-93
[
16204016.001
]
[Cites]
J Cancer Res Clin Oncol. 2006 Feb;132(2):99-104
[
16292542.001
]
[Cites]
Br J Cancer. 2007 Jun 4;96(11):1692-8
[
17486132.001
]
[Cites]
J Clin Oncol. 2008 Jan 10;26(2):211-7
[
18056679.001
]
[Cites]
Clin Cancer Res. 2008 Jan 1;14(1):309-17
[
18172283.001
]
[Cites]
J Clin Oncol. 2008 Jan 10;26(2):204-10
[
18182663.001
]
[Cites]
Leukemia. 2002 Oct;16(10):2096-105
[
12357363.001
]
[Cites]
Lancet. 2003 Aug 16;362(9383):516-22
[
12932382.001
]
[Cites]
Leuk Lymphoma. 2004 Sep;45(9):1821-7
[
15223642.001
]
[Cites]
Leuk Lymphoma. 2004 May;45(5):911-3
[
15291348.001
]
[Cites]
Leuk Lymphoma. 2004 Dec;45(12):2445-9
[
15621757.001
]
[Cites]
Haematologica. 2001 May;86(5):485-93
[
11410411.001
]
[Cites]
Anticancer Drugs. 2001 Oct;12(9):725-9
[
11593053.001
]
[Cites]
Haematologica. 2002 Jan;87(1):33-43
[
11801463.001
]
[Cites]
Leuk Lymphoma. 2002 Feb;43(2):327-31
[
11999564.001
]
[Cites]
J Cancer Res Clin Oncol. 2002 May;128(5):271-8
[
12029443.001
]
[Cites]
Blood. 2008 Dec 15;112(13):4824-31
[
18799723.001
]
(PMID = 21188134.001).
[ISSN]
1179-1322
[Journal-full-title]
Cancer management and research
[ISO-abbreviation]
Cancer Manag Res
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
New Zealand
[Other-IDs]
NLM/ PMC3004665
[Keywords]
NOTNLM ; Treanda / alkylating agent / bendamustine / chronic lymphocytic lymphoma / indolent non-Hodgkin lymphoma
9.
Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen S, Cathomas R:
Primary manifestation of small lymphocytic lymphoma in the prostate.
Onkologie
; 2009 Oct;32(10):586-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary manifestation of
small lymphocytic lymphoma
in the prostate.
BACKGROUND: Infiltration of non-haematopoietic organs by
small lymphocytic lymphoma
/chronic
lymphocytic
leukaemia (
SLL
/CLL) is not unusual in late-stage disease and thus quite frequently encountered in post-mortem examinations.
However, primary manifestation of
SLL
/CLL in the prostate is rarely diagnosed.
PATIENTS AND METHODS: We report two cases of primary prostatic
SLL
/CLL, in one case in combination with prostate carcinoma, and discuss diagnostic pitfalls, pathophysiological mechanisms and therapeutic management, together with an overview of the literature.
CONCLUSIONS:
Lymphocytic
infiltration of the prostate associated with obstructive symptoms is rare but can already occur in very early disease.
Microscopically,
SLL
/CLL infiltration can be distinguished from chronic prostatitis by its pattern of infiltration and by immunohistochemistry.
As the incidence of both
SLL
/CLL and prostatic carcinoma increases with age, composite tumours might occur more often in the future.
[MeSH-major]
Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ pathology. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ therapy. Prostatic Neoplasms / pathology. Prostatic Neoplasms / therapy
MedlinePlus Health Information.
consumer health - Prostate Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2009 S. Karger AG, Basel.
[CommentIn]
Onkologie. 2009 Oct;32(10):550-1
[
19816069.001
]
(PMID = 19816076.001).
[ISSN]
1423-0240
[Journal-full-title]
Onkologie
[ISO-abbreviation]
Onkologie
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
Switzerland
[Number-of-references]
17
10.
Jahan S, Zinnat R, Hassan Z, Biswas KB, Habib SH:
Gender differences in serum leptin concentrations from umbilical cord blood of newborn infants born to nondiabetic, gestational diabetic and type-2 diabetic mothers.
Int J Diabetes Dev Ctries
; 2009 Oct;29(4):155-8
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Gender differences in
serum leptin
concentrations from umbilical cord blood of newborn infants born to nondiabetic, gestational diabetic and
type
-2 diabetic mothers.
To investigate gender differences, if any, in
leptin
concentrations from umbilical cord blood of new born infants of mothers with
type
2 diabetes mellitus (DM), gestational diabetes mellitus (GDM), and Non diabetic (ND) at delivery.
Serum leptin
concentrations were measured in 105 newborns (53 males and 52 females in the three groups).
Pearson correlation coefficient was used to explore the relationship between
serum leptin
concentrations and anthropometric measures of the fetus and their mother.
Both
Serum leptin level
and
serum C
-peptide was measured by chemiluminescence based ELISA.
The median range of
leptin
concentration in cord blood was ND group: Male [13.91 (3.22 - 47.63)], Female [16.88 (2 - 43.65)]; GDM group: Male [32 (7 - 76.00)], Female [36.73 (4.80 - 81.20)]; DM group: Male [20.90 (2 -76.00)], Female [32 {2.58 - 80.67)].
Cord
serum leptin levels
correlated with birth weight(r=0.587, p=0.0001), ponderal index (PI) (r=.319, p=0.024)of the babies and body mass index (BMI) (r=-0.299, p=0.035) of their mothers but did not correlate with gestational age, cord
serum C
-peptide concentration or placental weight at delivery.
Leptin
concentrations were higher in the female fetus in comparison to the male fetus.
We found that there are very strong associations between cord
leptin
concentrations at delivery and birth weight, ponderal index of the baby, body mass index of the mothers with
Type
2 DM.
We also found that high
leptin levels
could represent an important feedback modulator of substrate supply and subsequently for adipose tissue status during late gestation or adipose tissue is the major determinant of circulating
leptin levels
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Biochem Biophys Res Commun. 1995 Sep 25;214(3):1260-7
[
7575539.001
]
[Cites]
Eur J Endocrinol. 2001 Jul;145(1):53-8
[
11415852.001
]
[Cites]
Science. 1995 Jul 28;269(5223):546-9
[
7624778.001
]
[Cites]
Nature. 1994 Dec 1;372(6505):425-32
[
7984236.001
]
[Cites]
N Engl J Med. 1996 Feb 1;334(5):292-5
[
8532024.001
]
[Cites]
Pediatrics. 1996 Aug;98(2 Pt 1):201-3
[
8692618.001
]
[Cites]
Nat Med. 1996 Sep;2(9):949-50
[
8782440.001
]
[Cites]
J Clin Endocrinol Metab. 1996 Sep;81(9):3424-7
[
8784109.001
]
[Cites]
J Clin Endocrinol Metab. 1996 Nov;81(11):3909-13
[
8923837.001
]
[Cites]
J Clin Endocrinol Metab. 1997 Apr;82(4):1293-300
[
9100610.001
]
[Cites]
J Clin Endocrinol Metab. 1997 May;82(5):1642-4
[
9141565.001
]
[Cites]
J Clin Endocrinol Metab. 1997 Sep;82(9):2849-55
[
9284709.001
]
[Cites]
Eur J Endocrinol. 1997 Dec;137(6):655-8
[
9437232.001
]
[Cites]
Diabetes. 1998 May;47(5):847-50
[
9588462.001
]
[Cites]
Science. 1995 Jul 28;269(5223):540-3
[
7624776.001
]
(PMID = 20336197.001).
[ISSN]
1998-3832
[Journal-full-title]
International journal of diabetes in developing countries
[ISO-abbreviation]
Int J Diabetes Dev Ctries
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
India
[Other-IDs]
NLM/ PMC2839129
[Keywords]
NOTNLM ; Newborn infants / Serum leptin / Type 2 Diabetic / Umbilical cord blood / gestational diabetes mellitus / non diabetic
11.
McElroy C, Velilla R, Chaudhary H, Al-Abbadi MA:
Fine-needle aspiration diagnosis of squamous cell carcinoma in a lymph node involved with small lymphocytic lymphoma: case report and review of the literature.
Diagn Cytopathol
; 2009 Jan;37(1):48-50
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Fine-needle aspiration
diagnosis
of squamous
cell
carcinoma in
a lymph
node involved with
small lymphocytic lymphoma
: case report and review of the literature.
Diagnosis
of two distinct
malignant
entities existing concurrently and at the same location (synchronous malignancy) by fine- needle aspiration (FNA) is unusual but may occur.
Small lymphocytic lymphoma
/chronic
lymphocytic
leukemia (
SLL
/CLL) in particular is associated with an increased incidence of secondary tumor, likely due to associated immunodeficiency.
Co-occurrence of some carcinomas such as squamous
cell
carcinoma (SCC), may show especially aggressive behavior.
A 57-year-old Caucasian male presented with recurrent upper extremity lymphedema and
diffuse
lymphadenopathy of the axillary and cervical regions.
FNA of a large cervical
lymph
node was diagnostic for both atypical
lymphocytic
proliferation and SCC.
Flow cytometric analysis showed the atypical
lymphocytic
proliferation to be positive for CD5, CD23, CD19, CD20, HLA-DR, CD38, and the population was kappa light chain restricted.
These cells were negative for CD-10 and FMC-7 antigens, suggesting a phenotype of B-
cell
SLL
/CLL.
We report a rare occurrence of metastatic SCC to
a lymph
node infiltrated by
SLL
/CLL.
The
diagnosis
was achieved by a combination of cytomorphologic examination of FNA smears, immunohistochemical staining of
cell
block material, and flow cytometry on the sample obtained by FNA.
To the best of our knowledge, only three cases of SCC metastasis to
SLL
/CLL diagnosed by FNA have been reported in the English literature.
[MeSH-major]
Carcinoma, Squamous
Cell
/
diagnosis
. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/
diagnosis
.
Lymph
Nodes / pathology. Neoplasms, Multiple Primary /
diagnosis
. Oropharyngeal Neoplasms / pathology
Genetic Alliance.
consumer health - Carcinoma, Squamous Cell
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
(c) 2008 Wiley-Liss, Inc.
(PMID = 18973126.001).
[ISSN]
1097-0339
[Journal-full-title]
Diagnostic cytopathology
[ISO-abbreviation]
Diagn. Cytopathol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Biomarkers, Tumor
[Number-of-references]
16
12.
El-Ferzli GT, Philips JB 3rd, Bulger A, Ambalavanan N:
A pumpless lung assist device reduces mechanical ventilation-induced lung injury in juvenile piglets.
Pediatr Res
; 2009 Dec;66(6):671-6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The objective is to test the effect of the LAD on pulmonary histopathology in juvenile piglets with acute lung injury caused by saline lung lavage (
SLL
) followed by intermittent mandatory ventilation (IMV).
Three- to 4-wk-old piglets were randomized to no intervention (control group),
SLL
alone (
SLL
group),
SLL
+ IMV (IMV group), or
SLL
+ IMV + LAD (LAD group) (n = 6 per group).
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Chest. 1989 Oct;96(4):849-51
[
2676391.001
]
[Cites]
Early Hum Dev. 2008 Nov;84(11):709-16
[
18930613.001
]
[Cites]
J Thorac Cardiovasc Surg. 1993 May;105(5):823-32
[
7683735.001
]
[Cites]
J Thorac Cardiovasc Surg. 1994 Mar;107(3):838-48; discussion 848-9
[
8127113.001
]
[Cites]
J Pediatr. 1994 Jul;125(1):104-10
[
7517446.001
]
[Cites]
Perfusion. 1994;9(4):265-9
[
7981464.001
]
[Cites]
J Paediatr Child Health. 1995 Apr;31(2):105-11
[
7794609.001
]
[Cites]
Anesthesiology. 1995 Oct;83(4):710-20
[
7574050.001
]
[Cites]
J Pediatr. 1996 Jan;128(1):109-17
[
8551400.001
]
[Cites]
ASAIO J. 1994 Jul-Sep;40(3):M728-31
[
8555610.001
]
[Cites]
Lancet. 1996 Jul 13;348(9020):75-82
[
8676720.001
]
[Cites]
Pediatr Pulmonol. 1996 Oct;22(4):263-70
[
8905887.001
]
[Cites]
J Paediatr Child Health. 1997 Jun;33(3):202-8
[
9259293.001
]
[Cites]
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1058-65
[
9351603.001
]
[Cites]
ASAIO J. 1997 Sep-Oct;43(5):M821-4
[
9360161.001
]
[Cites]
Pediatr Pulmonol Suppl. 1997;16:51
[
9443195.001
]
[Cites]
Ann Thorac Surg. 2000 Feb;69(2):351-6
[
10735662.001
]
[Cites]
N Engl J Med. 2000 May 4;342(18):1301-8
[
10793162.001
]
[Cites]
Intensive Care Med. 2000 Sep;26(9):1334-42
[
11089761.001
]
[Cites]
J Thorac Cardiovasc Surg. 2001 Mar;121(3):542-51
[
11241090.001
]
[Cites]
Biol Neonate. 2001 Jul;80(1):74-80
[
11474154.001
]
[Cites]
Ann Thorac Surg. 2001 Sep;72(3):899-904
[
11570380.001
]
[Cites]
ASAIO J. 2001 Sep-Oct;47(5):486-91
[
11575823.001
]
[Cites]
J Pediatr. 2001 Oct;139(4):478-86
[
11598592.001
]
[Cites]
Am J Respir Crit Care Med. 2001 Oct 1;164(7):1154-60
[
11673202.001
]
[Cites]
Pediatr Res. 2002 Sep;52(3):387-92
[
12193673.001
]
[Cites]
Ann Thorac Surg. 2002 Oct;74(4):1011-6; discussion 1017-8
[
12400738.001
]
[Cites]
Pediatr Res. 2003 Feb;53(2):245-53
[
12538782.001
]
[Cites]
Crit Care Med. 2003 Mar;31(3):885-92
[
12627001.001
]
[Cites]
Eur Respir J Suppl. 2003 Aug;42:2s-9s
[
12945994.001
]
[Cites]
Respir Physiol Neurobiol. 2004 Jan 15;139(2):167-77
[
15123000.001
]
[Cites]
Anesthesiology. 2004 Sep;101(3):722-8
[
15329597.001
]
[Cites]
Minerva Pediatr. 2004 Aug;56(4):373-80
[
15457135.001
]
[Cites]
JAMA. 1986 Aug 15;256(7):881-6
[
3090285.001
]
[Cites]
Am J Respir Crit Care Med. 1998 Jan;157(1):294-323
[
9445314.001
]
[Cites]
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1332-47
[
9563759.001
]
[Cites]
J Pharmacol Toxicol Methods. 1998 Aug;40(2):101-7
[
10100499.001
]
[Cites]
Clin Chest Med. 2006 Dec;27(4):601-13; abstract viii
[
17085249.001
]
[Cites]
Clin Physiol Funct Imaging. 2007 Mar;27(2):67-90
[
17309528.001
]
[Cites]
J Pediatr. 2007 Jul;151(1):10-5
[
17586183.001
]
[Cites]
Neonatology. 2007;92(1):19-25
[
17596733.001
]
[Cites]
Intensive Care Med. 2007 Aug;33(8):1423-33
[
17563879.001
]
[Cites]
Am J Respir Crit Care Med. 2007 Sep 15;176(6):575-81
[
17641159.001
]
[Cites]
Crit Care Med. 2008 Jan;36(1):183-7
[
18090370.001
]
[Cites]
Int J Mol Med. 2008 Apr;21(4):513-9
[
18360698.001
]
[Cites]
J Perinatol. 2008 May;28 Suppl 1:S47-56
[
18446178.001
]
[Cites]
Ann Thorac Surg. 2008 Aug;86(2):410-7; discussion 417
[
18640306.001
]
[Cites]
BMC Pulm Med. 2008;8:10
[
18625067.001
]
[Cites]
J Pediatr Surg. 1992 Jan;27(1):40-3
[
1552442.001
]
(PMID = 19687779.001).
[ISSN]
1530-0447
[Journal-full-title]
Pediatric research
[ISO-abbreviation]
Pediatr. Res.
[Language]
ENG
[Grant]
United States / NICHD NIH HHS / HD / HD046513-02; United States / NICHD NIH HHS / HD / K08 HD046513; United States / NHLBI NIH HHS / HL / R01 HL092906; United States / NICHD NIH HHS / HD / K08 HD046513-02
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Other-IDs]
NLM/ NIHMS149422; NLM/ PMC2796292
13.
Wang YH, Huang TS, Liang HW, Su TC, Chen SY, Wang TD:
Fasting serum levels of adiponectin, ghrelin, and leptin in men with spinal cord injury.
Arch Phys Med Rehabil
; 2005 Oct;86(10):1964-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Fasting
serum levels
of adiponectin, ghrelin, and
leptin
in men with spinal cord injury.
OBJECTIVES: To measure
serum levels
of adiponectin, ghrelin, and
leptin
in men with spinal cord injury (SCI) and to investigate possible correlations between these
serum levels
and various factors, such as body mass index (BMI), age, injury
level
, and duration of injury.
MAIN OUTCOME MEASURES:
Serum levels
of adiponectin, ghrelin, and
leptin
and BMI.
RESULTS:
Serum leptin levels
in subjects with SCI (mean, 7.0+/-0.5 mg/mL) [corrected] were significantly higher than those in able-bodied controls (mean, 4.7+/-0.6 mg/mL) [corrected] (P<.01).
The group with tetraplegia had higher
serum leptin levels
than the group with paraplegia, but this did not reach a statistically significant
level
(8.2+/-1.1 ng/mL vs 6.4+/-0.5 mg/mL [corrected] P=.097).
There were significant differences in
serum leptin levels
among the 3 groups by 1-way analysis of variance (P=.008).
Serum
adiponectin
levels
in subjects with SCI (7.1+/-0.5 mg/mL) [corrected] were higher than those in able-bodied controls (5.6+/-0.5 mg/mL) [corrected] but this was not statistically significant (P=.08).
In contrast,
serum levels
of ghrelin in subjects with SCI (302.0+/-17.5 pg/mL) were similar to those in the controls (264.0+/-27.0 pg/mL) (P=.24).
Serum leptin levels
correlated positively with BMI (SCI, r=.698, P<.001; controls, r=.782, P<.001), whereas
serum
adiponectin (SCI, r=-.527, P<.001; controls, r=-.315, P=.057) and ghrelin (SCI, r=-.368, P<.001; controls, r=-.447, P=.006)
levels
correlated negatively with the BMI in both subjects with SCI and controls.
CONCLUSIONS: Men with SCI have significantly higher
serum leptin levels
than able-bodied controls, and
serum leptin levels
correlated with the degree of neurologic deficit.
Men with SCI had a tendency toward higher
serum
adiponectin
level
than able-bodied controls.
Serum levels
of ghrelin in men with SCI were similar to those of controls.
[MeSH-major]
Leptin
/ blood. Peptide Hormones / blood. Spinal Cord Injuries / blood
MedlinePlus Health Information.
consumer health - Spinal Cord Injuries
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[ErratumIn]
Arch Phys Med Rehabil. 2007 May;88(5):688
(PMID = 16213239.001).
[ISSN]
0003-9993
[Journal-full-title]
Archives of physical medicine and rehabilitation
[ISO-abbreviation]
Arch Phys Med Rehabil
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Ghrelin; 0 / Leptin; 0 / Peptide Hormones
14.
Sabattini E, Orduz R, Campidelli C, Zinzani PL, Callea V, Zupo S, Cutrona G, Morabito F, Ferrarini M, Pileri S:
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.
J Clin Pathol
; 2007 Jun;60(6):627-32
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
B cell
chronic
lymphocytic
leukaemia/
small lymphocytic lymphoma
: role of ZAP70 determination on bone marrow biopsy specimens.
BACKGROUND: The course of chronic
lymphocytic
leukaemia/
small lymphocytic lymphoma
(CLL/
SLL
) partly depends on the mutational status of the variable region of immunoglobulin heavy chain genes (IgV(H)), which defines two subgroups of tumours: mutated and unmutated.
METHODS: 26 patients with CLL/
SLL
detected on BMB and with known IgV(H) mutational status were selected.
ZAP70 was determined by immunohistochemistry (IHC) comparing three antibodies from different sources (Upstate,
Cell
Signaling, Santa Cruz, California, USA) and two different methods (APAAP and EnVision(+)).
RESULTS: ZAP70 determination on BMB specimens turned out to be easily feasible with routine procedures with reagents from Upstate and
Cell
Signaling.
CONCLUSIONS: The study confirms the role of ZAP70
as a
possible surrogate of mutational status and emphasises its application in routine diagnostics; it discloses a
small
subset of discordant cases (mutated/ZAP70 weakly positive) that clinically cluster with the more favourable forms.
[MeSH-major]
Biomarkers, Tumor / metabolism. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/
diagnosis
. ZAP-70 Protein-Tyrosine Kinase / metabolism
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Curr Opin Hematol. 2000 Jul;7(4):223-34
[
10882178.001
]
[Cites]
Am J Clin Pathol. 1996 Oct;106(4):457-61
[
8853032.001
]
[Cites]
Blood. 2001 Jul 1;98(1):181-6
[
11418478.001
]
[Cites]
Leuk Res. 2001 Nov;25(11):927-32
[
11597727.001
]
[Cites]
Blood. 2001 Nov 1;98(9):2633-9
[
11675331.001
]
[Cites]
J Exp Med. 2001 Dec 3;194(11):1625-38
[
11733577.001
]
[Cites]
J Exp Med. 2001 Dec 3;194(11):1639-47
[
11733578.001
]
[Cites]
Blood. 2002 Feb 1;99(3):1023-9
[
11807008.001
]
[Cites]
Br J Haematol. 2002 Jan;116(1):142-50
[
11841407.001
]
[Cites]
Blood. 2002 Mar 15;99(6):2262-4
[
11877310.001
]
[Cites]
Ann Hematol. 2002 Jun;81(6):299-303
[
12107557.001
]
[Cites]
Blood. 2002 Aug 15;100(4):1177-84
[
12149195.001
]
[Cites]
Blood. 2002 Aug 15;100(4):1410-6
[
12149225.001
]
[Cites]
Eur J Haematol. 2003 Jan;70(1):53-9
[
12631259.001
]
[Cites]
N Engl J Med. 2003 May 1;348(18):1764-75
[
12724482.001
]
[Cites]
Blood. 2003 Jun 15;101(12):4944-51
[
12595313.001
]
[Cites]
Hematology Am Soc Hematol Educ Program. 2003;:153-75
[
14633781.001
]
[Cites]
Lancet. 2004 Jan 10;363(9403):105-11
[
14726163.001
]
[Cites]
Leuk Lymphoma. 2004 Mar;45(3):455-62
[
15160906.001
]
[Cites]
Mod Pathol. 2004 Aug;17(8):954-61
[
15133473.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60
[
15284443.001
]
[Cites]
Cancer Genet Cytogenet. 2004 Aug;153(1):69-72
[
15325098.001
]
[Cites]
Hematol Oncol Clin North Am. 2004 Aug;18(4):795-805, vii
[
15325699.001
]
[Cites]
Hematol Oncol Clin North Am. 2004 Aug;18(4):807-26, viii
[
15325700.001
]
[Cites]
Hematol Oncol Clin North Am. 2004 Aug;18(4):827-48, viii
[
15325701.001
]
[Cites]
N Engl J Med. 2004 Aug 26;351(9):893-901
[
15329427.001
]
[Cites]
Leuk Lymphoma. 2004 Oct;45(10):2037-45
[
15370248.001
]
[Cites]
J Histochem Cytochem. 1984 Feb;32(2):219-29
[
6198355.001
]
[Cites]
J Clin Invest. 1998 Oct 15;102(8):1515-25
[
9788964.001
]
[Cites]
J Clin Pathol. 1998 Jul;51(7):506-11
[
9797726.001
]
[Cites]
Br J Haematol. 1999 May;105(2):394-401
[
10233410.001
]
[Cites]
Blood. 1999 Sep 15;94(6):1840-7
[
10477712.001
]
[Cites]
Blood. 1999 Sep 15;94(6):1848-54
[
10477713.001
]
[Cites]
J Pathol. 2005 Mar;205(4):507-13
[
15685592.001
]
[Cites]
J Clin Invest. 2005 Mar;115(3):755-64
[
15711642.001
]
[Cites]
Leukemia. 2005 May;19(5):750-8
[
15759031.001
]
[Cites]
Leukemia. 2005 Jun;19(6):1018-24
[
15800671.001
]
[Cites]
Cell. 1992 Nov 13;71(4):649-62
[
1423621.001
]
[Cites]
N Engl J Med. 1995 Oct 19;333(16):1052-7
[
7675049.001
]
[Cites]
N Engl J Med. 2000 Dec 28;343(26):1910-6
[
11136261.001
]
(PMID = 16916999.001).
[ISSN]
0021-9746
[Journal-full-title]
Journal of clinical pathology
[ISO-abbreviation]
J. Clin. Pathol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Biomarkers, Tumor; 0 / Immunoglobulin Heavy Chains; 0 / Immunoglobulin Variable Region; EC 2.7.10.2 / ZAP-70 Protein-Tyrosine Kinase
[Other-IDs]
NLM/ PMC1955054
15.
Alexander C, Cochran CJ, Gallicchio L, Miller SR, Flaws JA, Zacur H:
Serum leptin levels, hormone levels, and hot flashes in midlife women.
Fertil Steril
; 2010 Aug;94(3):1037-43
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum leptin levels
, hormone
levels
, and hot flashes in midlife women.
OBJECTIVE: To examine the associations between
serum leptin levels
, sex steroid hormone
levels
, and hot flashes in normal weight and obese midlife women.
MAIN OUTCOME MEASURE(S):
Serum leptin
and sex steroid hormone
levels
.
RESULT(S): Correlation and regression models were performed to examine associations between
leptin levels
, hormone
levels
, and hot flashes.
Leptin levels
were associated with BMI, with "ever experiencing hot flashes" (questionnaire), with hot flashes within the last 30 days, and with duration of hot flashes (>1 year, P=.03).
Leptin
was positively correlated with testosterone, free testosterone index, and free estrogen index and inversely associated with
levels
of sex hormone-binding globulin.
In women with a body mass index>or=30 kg/m2,
leptin levels
no longer correlated with testosterone
levels
.
CONCLUSION(S):
Serum leptin levels
are associated with the occurrence and duration of hot flashes in midlife women; however, no correlation was found between
leptin
and
serum
estradiol.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
[Cites]
J Clin Endocrinol Metab. 1995 Aug;80(8):2354-8
[
7629229.001
]
[Cites]
Am J Obstet Gynecol. 1993 Mar;168(3 Pt 1):772-80
[
8456878.001
]
[Cites]
N Engl J Med. 1996 Feb 1;334(5):292-5
[
8532024.001
]
[Cites]
Maturitas. 1996 Apr;23(3):301-5
[
8794424.001
]
[Cites]
J Clin Endocrinol Metab. 1997 Jan;82(1):318-21
[
8989281.001
]
[Cites]
Endocrinology. 1997 Feb;138(2):847-50
[
9003026.001
]
[Cites]
Br J Obstet Gynaecol. 1997 Aug;104(8):923-33
[
9255084.001
]
[Cites]
Endocrinology. 1998 Feb;139(2):551-8
[
9449624.001
]
[Cites]
J Clin Endocrinol Metab. 1998 Feb;83(2):453-9
[
9467557.001
]
[Cites]
Clin Exp Obstet Gynecol. 1997;24(3):163-6
[
9478308.001
]
[Cites]
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2541-6
[
9482922.001
]
[Cites]
Menopause. 1998 Spring;5(1):43-51
[
9689194.001
]
[Cites]
J Clin Endocrinol Metab. 1999 Feb;84(2):428-34
[
10022396.001
]
[Cites]
Ginekol Pol. 1999 Jan;70(1):1-7
[
10349800.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7047-52
[
10359836.001
]
[Cites]
Endocrine. 1999 Feb;10(1):19-23
[
10403567.001
]
[Cites]
Semin Reprod Med. 2005 May;23(2):117-25
[
15852197.001
]
[Cites]
Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E166-71
[
15741239.001
]
[Cites]
Am J Obstet Gynecol. 2005 Aug;193(2):347-51
[
16098853.001
]
[Cites]
Am J Obstet Gynecol. 2005 Oct;193(4):1353-60
[
16202725.001
]
[Cites]
Alcohol Alcohol. 2005 Nov-Dec;40(6):563-8
[
16087658.001
]
[Cites]
Maturitas. 2006 Jan 20;53(2):217-25
[
15913927.001
]
[Cites]
Maturitas. 2006 Jan 20;53(2):133-43
[
16368467.001
]
[Cites]
Obstet Gynecol. 1994 Jul;84(1):29-34
[
8008318.001
]
[Cites]
Maturitas. 2006 Jun 20;54(3):260-9
[
16423474.001
]
[Cites]
Clin Endocrinol (Oxf). 2006 Jul;65(1):125-31
[
16817831.001
]
[Cites]
Climacteric. 2007 Feb;10(1):27-37
[
17364602.001
]
[Cites]
Fertil Steril. 2007 Jun;87(6):1483-6
[
17276432.001
]
[Cites]
Obesity (Silver Spring). 2007 Sep;15(9):2217-24
[
17890489.001
]
[Cites]
Am J Epidemiol. 2008 Jan 1;167(1):78-85
[
17881385.001
]
[Cites]
Maturitas. 2008 Feb 20;59(2):149-57
[
18280066.001
]
[Cites]
Fertil Steril. 2008 Oct;90(4):1161-8
[
18304548.001
]
[Cites]
Int J Biometeorol. 1999 Nov;43(3):99-109
[
10639901.001
]
[Cites]
J Womens Health Gend Based Med. 2001 Jan-Feb;10(1):67-76
[
11224946.001
]
[Cites]
Am J Hum Biol. 2001 Jul-Aug;13(4):453-64
[
11400216.001
]
[Cites]
Obstet Gynecol. 2001 Sep;98(3):391-7
[
11530118.001
]
[Cites]
Maturitas. 2002 Jan 30;41(1):69-77
[
11809345.001
]
[Cites]
J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1417-29
[
11837495.001
]
[Cites]
Atherosclerosis. 2002 Apr;161(2):455-62
[
11888531.001
]
[Cites]
J Clin Endocrinol Metab. 2002 Oct;87(10):4522-7
[
12364429.001
]
[Cites]
Obstet Gynecol. 2003 Feb;101(2):264-72
[
12576249.001
]
[Cites]
Am J Epidemiol. 2004 Jun 15;159(12):1189-99
[
15191936.001
]
[Cites]
Endocrinology. 2004 Jul;145(7):3115-21
[
15059958.001
]
[Cites]
J Gen Intern Med. 2004 Jul;19(7):740-6
[
15209587.001
]
[Cites]
Clin Endocrinol (Oxf). 1985 Mar;22(3):293-312
[
3884189.001
]
[Cites]
Ann Clin Biochem. 1985 Sep;22 ( Pt 5):489-97
[
4062218.001
]
[Cites]
J Clin Endocrinol Metab. 1987 Apr;64(4):723-9
[
3818901.001
]
[Cites]
Int J Obes. 1989;13(1):1-9
[
2703288.001
]
[Cites]
Metabolism. 1991 Jan;40(1):101-4
[
1984562.001
]
[Cites]
Nat Med. 1995 Nov;1(11):1155-61
[
7584987.001
]
(PMID = 19476935.001).
[ISSN]
1556-5653
[Journal-full-title]
Fertility and sterility
[ISO-abbreviation]
Fertil. Steril.
[Language]
ENG
[Grant]
United States / NIA NIH HHS / AG / R01 AG018400-02; United States / NIA NIH HHS / AG / AG18400; United States / NIA NIH HHS / AG / R01 AG018400-03; United States / NIA NIH HHS / AG / R01 AG018400-05A2; United States / NIA NIH HHS / AG / R01 AG018400-01A1; United States / NIA NIH HHS / AG / R01 AG018400-06; United States / NIA NIH HHS / AG / R01 AG018400; United States / NIA NIH HHS / AG / R01 AG018400-04
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Gonadal Steroid Hormones; 0 / Leptin
[Other-IDs]
NLM/ NIHMS109122; NLM/ PMC3939020
16.
Kramer CK, von Mühlen D, Barrett-Connor E:
Does leptin predict incident hypertension in older adults?
Clin Endocrinol (Oxf)
; 2010 Aug;73(2):201-5
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Does
leptin
predict incident hypertension in older adults?
OBJECTIVE:
Leptin
is associated with blood pressure (BP) in experimental and cross-sectional studies, but only one previous prospective study of middle-aged men has reported the association between
leptin
and incident hypertension.
We examined the association of
leptin levels
with incident hypertension in a population-based study of older men and women.
POPULATION: Participants were 602 community-dwelling older adults with normal baseline BP
levels
who attended a research clinic visit between 1984 and 1987 and again 4.4 years later (mean age was 66.2 +/- 11.4; 60.6% were men; mean body mass index (BMI) 24.9 +/- 3.4 kg/m(2)).
Leptin
was measured by radioimmunoassay.
Baseline
serum leptin levels
were higher in participants who developed hypertension compared to persistent normotensives [median (25th-75th range)] [8.8(5-16) vs 7(4-11) ng/ml, P = 0.002].
In logistic regression models,
leptin
(log-transformed) predicted incident hypertension before and after adjustments for baseline age, BMI, systolic BP, total cholesterol, medications, and previous cardiovascular disease (OR 1.75 95% CI 1.17-2.61, P = 0.006).
CONCLUSION: Higher
leptin levels
were independently associated with increased odds of incident hypertension in older adults.
MedlinePlus Health Information.
consumer health - High Blood Pressure
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Hypertension. 2009 Mar;53(3):473-9
[
19204185.001
]
[Cites]
J Clin Endocrinol Metab. 2008 Oct;93(10):3922-6
[
18682500.001
]
[Cites]
J Clin Endocrinol Metab. 2009 Apr;94(4):1137-44
[
19174500.001
]
[Cites]
Am J Hypertens. 2009 May;22(5):577-80
[
19229195.001
]
[Cites]
Hypertension. 2009 Jun;53(6):965-72
[
19398660.001
]
[Cites]
J Vasc Res. 2009;46(6):609-17
[
19571581.001
]
[Cites]
Diabetes Care. 2000 Jan;23(1):57-63
[
10857969.001
]
[Cites]
Hypertens Res. 2000 Jul;23(4):303-10
[
10912765.001
]
[Cites]
Int J Obes Relat Metab Disord. 2001 Jan;25(1):121-5
[
11244467.001
]
[Cites]
Metabolism. 2001 Mar;50(3):325-9
[
11230786.001
]
[Cites]
Clin Exp Hypertens. 2001 May;23(4):357-68
[
11349826.001
]
[Cites]
J Neuroendocrinol. 2001 Oct;13(10):913-21
[
11679060.001
]
[Cites]
J Clin Invest. 2002 Oct;110(8):1093-103
[
12393845.001
]
[Cites]
Obes Res. 2003 Jan;11(1):160-6
[
12529499.001
]
[Cites]
JAMA. 2003 May 21;289(19):2560-72
[
12748199.001
]
[Cites]
J Clin Endocrinol Metab. 2003 Oct;88(10):4823-31
[
14557461.001
]
[Cites]
Nephron. 1976;16(1):31-41
[
1244564.001
]
[Cites]
Prev Med. 1976 Jun;5(2):207-15
[
935073.001
]
[Cites]
Am J Epidemiol. 1980 Jun;111(6):705-12
[
7386445.001
]
[Cites]
Hypertension. 1997 Sep;30(3 Pt 2):619-23
[
9322991.001
]
[Cites]
Hypertension. 1998 Jan;31(1 Pt 2):409-14
[
9453337.001
]
[Cites]
Eur J Pharmacol. 2005 Aug 22;518(2-3):175-81
[
16054621.001
]
[Cites]
J Hypertens. 2006 May;24(5):789-801
[
16612235.001
]
[Cites]
J Clin Endocrinol Metab. 2007 Feb;92(2):532-41
[
17118991.001
]
[Cites]
Am J Clin Nutr. 2009 Mar;89(3):991S-997S
[
19176740.001
]
(PMID = 20148909.001).
[ISSN]
1365-2265
[Journal-full-title]
Clinical endocrinology
[ISO-abbreviation]
Clin. Endocrinol. (Oxf)
[Language]
ENG
[Grant]
United States / NIA NIH HHS / AG / AG028507-03; United States / NIDDK NIH HHS / DK / R01 DK031801-15; United States / NIA NIH HHS / AG / R01 AG007181-12; United States / NIA NIH HHS / AG / R01 AG007181-13S1; United States / NIA NIH HHS / AG / AG007181-13S1; United States / NIA NIH HHS / AG / R01 AG028507-02; United States / NIA NIH HHS / AG / R01 AG007181; United States / NIA NIH HHS / AG / AG07181; United States / NIDDK NIH HHS / DK / R01 DK031801; United States / NIA NIH HHS / AG / AG007181-13; United States / NIA NIH HHS / AG / R01 AG007181-13; United States / NIDDK NIH HHS / DK / R01 DK031801-16; United States / NIDDK NIH HHS / DK / DK31801; United States / NIA NIH HHS / AG / R01 AG028507-03; United States / NIA NIH HHS / AG / AG028507-02; United States / NIA NIH HHS / AG / AG007181-12; United States / NIA NIH HHS / AG / R01 AG007181-14; United States / NIA NIH HHS / AG / R37 AG007181; United States / NIA NIH HHS / AG / R01 AG028507; United States / NIA NIH HHS / AG / AG028507
[Publication-type]
Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural
[Publication-country]
England
[Chemical-registry-number]
0 / Leptin
[Other-IDs]
NLM/ NIHMS175266; NLM/ PMC2891171
17.
Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, de Matias JM, Martin J, Dessein PH, Llorca J:
Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis.
Clin Exp Rheumatol
; 2009 Mar-Apr;27(2):222-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Anti-TNF-alpha therapy does not modulate
leptin
in patients with severe rheumatoid arthritis.
OBJECTIVE: The adipocytokine
leptin
regulates weight centrally and participates in the regulation of the immune and inflammatory responses.
In the present study we investigated whether inflammation, obesity or both of these characteristics are potential determinants of circulating
leptin
concentrations in a group of RA patients on periodical treatment with the TNF-alpha-blocker-infliximab due to severe disease.
We also assessed whether the infusion of infliximab may alter circulating
leptin
concentrations in patients with severe RA.
Serum leptin levels
were determined immediately prior to and after infliximab infusion.
RESULTS: There was a positive correlation between body mass index of RA patients and baseline
serum level
of
leptin
(rho=0.665, p<0.001).
Apart from a significant correlation with VCAM-1 (rho=0.349, p=0.04), no significant correlations between baseline
leptin levels
and the age at the time of the study or at the onset of the disease, disease duration, ESR and CRP
levels
, DAS28, lipids, insulin sensitivity, adhesion molecules, resistin, adiponectin, ghrelin or the cumulative prednisone dose at the time of the study were found.
Leptin levels
did not change upon infliximab infusion (p=0.48).
CONCLUSION: In RA patients on TNF-alpha blocker treatment, circulating
leptin levels
are unrelated to disease activity but constitute a manifestation of adiposity.
The beneficial effect of anti-TNF-alpha therapy on cardiovascular mortality in RA does not seem to be mediated by reduction in
serum levels
of
leptin
.
[MeSH-major]
Antibodies, Monoclonal / therapeutic use. Arthritis, Rheumatoid / blood. Arthritis, Rheumatoid / drug therapy.
Leptin
/ blood. Obesity / blood. Tumor Necrosis Factor-alpha / antagonists & inhibitors
Genetic Alliance.
consumer health - Arthritis
.
Genetic Alliance.
consumer health - Rheumatoid arthritis
.
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Rheumatoid Arthritis
.
Hazardous Substances Data Bank.
Infliximab
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19473561.001).
[ISSN]
0392-856X
[Journal-full-title]
Clinical and experimental rheumatology
[ISO-abbreviation]
Clin. Exp. Rheumatol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Italy
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Leptin; 0 / Tumor Necrosis Factor-alpha; 9007-41-4 / C-Reactive Protein; B72HH48FLU / Infliximab
18.
Bourdon C, Hojna S, Jordan M, Bérubé J, Kren V, Pravenec M, Liu P, Arab S, Pausová Z:
Genetic locus on rat chromosome 20 regulates diet-induced adipocyte hypertrophy: a microarray gene expression study.
Physiol Genomics
; 2009 Jun 10;38(1):63-72
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
In response to HFD, body weight, fat pad weights, adipocyte size, and
serum leptin levels
increased significantly more in SHR.1N than SHR.
Microarray gene expression profiles [Affymetrix, 15,923 genes and expressed sequence tags (ESTs)] showed that multiple genes of molecular pathways involved in lipogenesis were downregulated to a similar
level
in both strains, whereas genes involved in fatty acid oxidation and energy dissipation were upregulated less in SHR.1N than SHR.
MedlinePlus Health Information.
consumer health - Dietary Fats
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Hypertension. 2000 Jul;36(1):14-9
[
10904006.001
]
[Cites]
Nature. 2008 Aug 21;454(7207):961-7
[
18719582.001
]
[Cites]
Cell. 2001 Sep 7;106(5):563-73
[
11551504.001
]
[Cites]
JAMA. 2002 Jan 16;287(3):356-9
[
11790215.001
]
[Cites]
Diabetes. 2002 Jun;51(6):1876-83
[
12031976.001
]
[Cites]
Nucleic Acids Res. 2001 May 1;29(9):e45
[
11328886.001
]
[Cites]
JAMA. 2003 Jan 1;289(1):76-9
[
12503980.001
]
[Cites]
J Biol Chem. 2003 Apr 4;278(14):11888-96
[
12529376.001
]
[Cites]
Cell. 2003 Apr 18;113(2):159-70
[
12705865.001
]
[Cites]
Hypertension. 2003 May;41(5):1047-55
[
12654711.001
]
[Cites]
J Clin Invest. 2003 Dec;112(12):1796-808
[
14679176.001
]
[Cites]
Physiol Rev. 2004 Jan;84(1):277-359
[
14715917.001
]
[Cites]
Science. 2004 May 28;304(5675):1301-5
[
15166374.001
]
[Cites]
Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R112-9
[
15001430.001
]
[Cites]
Nature. 2004 Sep 9;431(7005):200-5
[
15306821.001
]
[Cites]
Cell. 1982 May;29(1):53-60
[
7105184.001
]
[Cites]
Biochem J. 1988 Feb 1;249(3):765-9
[
3355496.001
]
[Cites]
Mol Endocrinol. 1988 May;2(5):395-403
[
2901666.001
]
[Cites]
J Hypertens. 1989 Mar;7(3):217-21
[
2708818.001
]
[Cites]
Science. 1993 Jan 1;259(5091):87-91
[
7678183.001
]
[Cites]
J Clin Invest. 1995 Jul;96(1):158-62
[
7615786.001
]
[Cites]
J Clin Invest. 1995 Dec;96(6):2914-23
[
8675663.001
]
[Cites]
Diabetes. 1997 Sep;46(9):1468-72
[
9287048.001
]
[Cites]
Eur J Clin Invest. 1998 Jan;28(1):59-66
[
9502188.001
]
[Cites]
J Clin Invest. 1998 Jul 15;102(2):412-20
[
9664083.001
]
[Cites]
J Clin Invest. 2004 Dec;114(12):1752-61
[
15599400.001
]
[Cites]
J Biol Chem. 2005 Apr 22;280(16):15493-6
[
15746100.001
]
[Cites]
Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):31-4
[
15936931.001
]
[Cites]
Biol Cell. 2005 Jul;97(7):479-86
[
15966863.001
]
[Cites]
FASEB J. 2005 Sep;19(11):1567-9
[
16009704.001
]
[Cites]
Am J Hypertens. 2005 Oct;18(10):1271-5
[
16202847.001
]
[Cites]
Annu Rev Cell Dev Biol. 2005;21:247-69
[
16212495.001
]
[Cites]
Obes Res. 2005 Dec;13(12):2122-31
[
16421346.001
]
[Cites]
Curr Opin Nephrol Hypertens. 2006 Mar;15(2):173-8
[
16481885.001
]
[Cites]
Cell Metab. 2006 Mar;3(3):223-9
[
16517409.001
]
[Cites]
Exp Hematol. 2006 Aug;34(8):1106-14
[
16863918.001
]
[Cites]
Biochem J. 2006 Sep 1;398(2):153-68
[
16898874.001
]
[Cites]
Nature. 2006 Dec 14;444(7121):847-53
[
17167472.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4401-6
[
17360536.001
]
[Cites]
Int J Obes (Lond). 2007 Jun;31(6):1004-13
[
17130847.001
]
[Cites]
J Lipid Res. 2007 Dec;48(12):2751-61
[
17872589.001
]
[Cites]
FEBS Lett. 2008 Jan 9;582(1):117-31
[
18037376.001
]
[Cites]
Mol Endocrinol. 2008 May;22(5):1023-31
[
18202144.001
]
[Cites]
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E356-67
[
18492779.001
]
[Cites]
Curr Hypertens Rep. 1999 Feb-Mar;1(1):42-50
[
10981041.001
]
(PMID = 19383622.001).
[ISSN]
1531-2267
[Journal-full-title]
Physiological genomics
[ISO-abbreviation]
Physiol. Genomics
[Language]
ENG
[Grant]
United States / Howard Hughes Medical Institute / /
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Dietary Fats; 0 / Leptin
[Other-IDs]
NLM/ PMC2696153
19.
Okulicz JF, Lloyd BA, Krause JO, Conger NG:
Mycobacterium tuberculosis infection of a presumed Charcot joint.
South Med J
; 2005 Sep;98(9):924-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
A 65-year-old male with peripheral neuropathy and
small lymphocytic lymphoma
presented with erythema and edema of the left foot.
[MeSH-major]
Arthropathy, Neurogenic /
diagnosis
. Diagnostic Errors. Mycobacterium tuberculosis / isolation & purification. Tuberculosis, Osteoarticular /
diagnosis
. Tuberculosis, Osteoarticular / microbiology
[MeSH-minor]
Aged. Antitubercular Agents / therapeutic use. Drug Therapy, Combination. Foot Ulcer / drug therapy. Foot Ulcer / microbiology. Humans. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ complications. Male. Peripheral Nervous System Diseases / complications. Synovial Fluid / microbiology
Genetic Alliance.
consumer health - Tuberculosis
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16217986.001).
[ISSN]
0038-4348
[Journal-full-title]
Southern medical journal
[ISO-abbreviation]
South. Med. J.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antitubercular Agents
20.
Horoz M, Aslan M, Koylu AO, Bolukbas C, Bolukbas FF, Selek S, Erel O:
The relationship between leptin level and oxidative status parameters in hemodialysis patients.
Artif Organs
; 2009 Jan;33(1):81-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The relationship between
leptin level
and oxidative status parameters in hemodialysis patients.
Both
serum leptin level
and oxidative stress are increased in hemodialysis (HD) patients.
In the present study, we aimed to investigate whether there is association between oxidative status and
leptin level
in HD patients.
Serum leptin level
, total peroxide (TP)
level
, total antioxidant capacity (TAC), and oxidative stress index (OSI) were determined.
Serum leptin level
, TP
level
, and OSI were significantly higher in HD patients than controls (all P < 0.001) while TAC was lower (P < 0.001).
In HD patients,
serum leptin level
was significantly correlated with TP
level
and OSI (r = 0.372, P < 0.001 and r = 0.409, P < 0.001, respectively).
The correlation of
serum leptin level
with TP
level
and OSI remained statistically significant after adjusting for age, gender, and body-fat percentage (r = 0.446, P < 0.001 and r = 0.463, P < 0.001, respectively).
Hyperleptinemia seems to be associated with increased oxidative stress in HD patients, and this association may provide better understanding about the disorders related to either elevated
serum leptin levels
and/or increased oxidative stress in HD patients.
[MeSH-major]
Leptin
/ blood. Oxidative Stress. Renal Dialysis
MedlinePlus Health Information.
consumer health - Dialysis
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19178446.001).
[ISSN]
1525-1594
[Journal-full-title]
Artificial organs
[ISO-abbreviation]
Artif Organs
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antioxidants; 0 / Leptin; 0 / Peroxides
21.
Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y:
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ai Zheng
; 2007 Apr;26(4):418-22
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Bone marrow immunophenotypes of 112 cases of lymphoid system
malignant
diseases].
BACKGROUND & OBJECTIVE:
Diagnosis
of
lymphocytic
leukemia and non-Hodgkin's
lymphoma
(NHL) is based on bone marrow morphology.
Immunophenotyping will make
diagnosis
more precise through analyzing the origin and differentiation status of tumor, which is necessary for treatment and prognosis prediction.
This study was to analyze the immunophenotypic characteristics of
lymphocytic
leukemia and NHL with bone marrow involvement using flow cytometry (FCM).
METHODS: Bone marrow specimens from 112 patients with
lymphocytic
leukemia or NHL with bone marrow involvement were detected by FCM using antibodies of T, B and myeloid
cell
series.
RESULTS: In 45 cases of precursor B lymphoblastic leukemia/
lymphoma
(B-ALL/LBL), the antigens were mainly CD19, CD10, TdT, CD34, HLA-DR, and CD20.
In 32 cases of precursor T lymphoblastic leukemia/
lymphoma
(T-ALL/LBL), the antigens were mainly CD7, CD5, cytoplasmic (Cy)CD3, TdT, CD34, surface CD3 (sCD3), and HLA-DR.
Among the 35 cases of mature B-
cell
malignancies, 17 cases of chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
(CLL/
SLL
) mainly expressed CD19, CD20, CD5, HLA-DR, with coexpression of CD19 and CD5; 4 cases of
diffuse
large B-
cell lymphoma
(DLBCL) mainly expressed CD19, CD20, CD10, and HLA-DR; 3 cases of Burkitt's
lymphoma
(BL) mainly expressed CD19, CD10, CD20, and sIgM; 1 case of mantle
cell lymphoma
(MCL) expressed CD5, CD19, CD20, and HLA-DR.
Among the 10 mature T-
cell
malignancies, 5 cases of unspecialied peripheral T-
cell lymphoma
(PTCL) mainly expressed sCD3, CD5 and CD7, CD4 or CD8; 1 case of anaplastic large
cell lymphoma
(ALCL) expressed sCD3 and HLA-DR; 4 cases of NK/T-
cell
malignancies expressed CD56 and HLA-DR, CD4 or CD8 or CD7.
CONCLUSION: Multiparameter FCM can not only provide data of
cell
lineage and differentiation status but also detect phenotypic aberrancies, which is helpful for minimal residual disease detecting.
[MeSH-major]
Antigens, CD / analysis. Bone Marrow / immunology. Immunophenotyping. Leukemia, Lymphoid / immunology.
Lymphoma
, Non-Hodgkin / immunology
MedlinePlus Health Information.
consumer health - Acute Lymphocytic Leukemia
.
MedlinePlus Health Information.
consumer health - Chronic Lymphocytic Leukemia
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17430665.001).
[Journal-full-title]
Ai zheng = Aizheng = Chinese journal of cancer
[ISO-abbreviation]
Ai Zheng
[Language]
chi
[Publication-type]
English Abstract; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Antigens, CD; 0 / HLA-DR Antigens
22.
Shabat S, Nyska M, Eintacht S, Lis M, Bogomolni A, Berner Y, Kestanbaum-Shainkin R:
Serum leptin level in geriatric patients with hip fractures: possible correlation to biochemical parameters of bone remodeling.
Arch Gerontol Geriatr
; 2009 Mar-Apr;48(2):250-3
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum leptin level
in geriatric patients with hip fractures: possible correlation to biochemical parameters of bone remodeling.
Since
leptin
was suggested to be involved in bone remodeling, its possible involvement in fracture formation/prevention was evaluated, by determination of
serum leptin level
in geriatric population with hip fracture, and evaluation the relationships with biochemical parameters of bone remodeling.
Serum leptin level
of this total population distributed between 1 and 134ng/ml.
40% of patients were in the normal range of our laboratory (10-40ng/ml), 40% had decreased
leptin level
(<10ng/ml) and 20% had higher
leptin level
(>40ng/ml).
No correlation was detected between
serum leptin level
and vitamin D-25(OH)D3, which was under normal range in 60% of the patients.
Leptin
also did not correlate to ICTP
level
, which was high in 80% of the patients, suggesting an extensive bone resorption in this population.
Evaluation of
leptin level
in female versus male suggests that
leptin level
is higher in females than males also in this age (28.4ng/ml vs. 14.4ng/ml, p<0.001).
The higher
leptin levels
in women was accompanied by higher
serum levels
of glucose, albumin, Ca, cholesterol, Na and FT4.
Comparison of 50 patients with the lowest
leptin levels
(mean of 3.4ng/ml) to 50 patients with highest
leptin levels
(mean of 34ng/ml), did not indicate differences in both 25(OH)D3 and ICTP between these two populations in spite of the highly significant difference in
leptin levels
.
The high range of
serum leptin
concentration in these geriatric patients with hip fracture of both sexes, and the absence of any correlation between
leptin
and the tested parameters of bone resorption and Ca metabolism, teleopeptide
type
I collagen (ICTP) and 25(OH)D3, does not support a direct massive involvement of
serum leptin
in hip fracture of the very old population.
[MeSH-major]
Bone Remodeling / physiology. Hip Fractures / blood.
Leptin
/ blood
[MeSH-minor]
Aged. Aged, 80 and over. Biomarkers / blood. Calcifediol / blood. Case-Control Studies. Cohort Studies. Collagen
Type
I. Dihydroxycholecalciferols / blood. Female. Humans. Male. Peptide Fragments / blood. Peptides. Procollagen / blood. Sex Distribution
MedlinePlus Health Information.
consumer health - Hip Injuries and Disorders
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18359113.001).
[ISSN]
1872-6976
[Journal-full-title]
Archives of gerontology and geriatrics
[ISO-abbreviation]
Arch Gerontol Geriatr
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Biomarkers; 0 / Collagen Type I; 0 / Dihydroxycholecalciferols; 0 / Leptin; 0 / Peptide Fragments; 0 / Peptides; 0 / Procollagen; 0 / collagen type I trimeric cross-linked peptide; P6YZ13C99Q / Calcifediol
23.
Thway K, Freeman A, Woodhouse CR, Fisher C:
Epithelial-stromal tumor of seminal vesicle in a patient with chromophobe renal cell carcinoma and small lymphocytic lymphoma.
Ann Diagn Pathol
; 2008 Dec;12(6):433-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Epithelial-stromal tumor of seminal vesicle in a patient with chromophobe renal
cell
carcinoma and
small lymphocytic lymphoma
.
In addition, this was associated with 2 synchronous
malignant
neoplasms, chromophobe renal
cell
carcinoma and
small lymphocytic lymphoma
, both of which were detected incidentally after clinical presentation because of the seminal vesicle mass.
[MeSH-major]
Carcinoma /
diagnosis
. Carcinoma, Renal
Cell
/
diagnosis
. Genital Neoplasms, Male /
diagnosis
. Kidney Neoplasms /
diagnosis
. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/
diagnosis
. Neoplasms, Multiple Primary /
diagnosis
. Seminal Vesicles
Genetic Alliance.
consumer health - Chromophobe Renal Cell Carcinoma
.
Genetic Alliance.
consumer health - Renal cell carcinoma
.
MedlinePlus Health Information.
consumer health - Kidney Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18995209.001).
[ISSN]
1532-8198
[Journal-full-title]
Annals of diagnostic pathology
[ISO-abbreviation]
Ann Diagn Pathol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
28
24.
Mao J, Yang T, Gu Z, Heird WC, Finegold MJ, Lee B, Wakil SJ:
aP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes growth retardation and reduced lipid accumulation in adipose tissues.
Proc Natl Acad Sci U S A
; 2009 Oct 13;106(41):17576-81
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
FACC1KO mice showed prenatal growth retardation; after weaning, however, their weight gain was comparable to that of wild-
type
(WT) mice on a normal diet.
In addition, there was about a 30% decrease in
serum
insulin-like growth factor I (IGF1), and while the
serum leptin level
was decreased by about 50%, it did not counteract the osteopenic effects of IGF1 on the bone.
Fatty acid analyses of mutant bone lipids revealed relatively higher
levels
of C18:2n-6 and C18:3n-3 and lower
levels
of their elongation C20 homologs than that of WT cohorts, leading to lower
levels
of C20 homologs and bone development.
MedlinePlus Health Information.
consumer health - Growth Disorders
.
COS Scholar Universe.
author profiles
.
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Biol Chem. 1964 Feb;239:375-80
[
14169133.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7088-92
[
10359843.001
]
[Cites]
Expert Opin Ther Targets. 2005 Apr;9(2):267-81
[
15934915.001
]
[Cites]
Cell Metab. 2005 Feb;1(2):107-19
[
16054052.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12011-6
[
16103361.001
]
[Cites]
Cell Mol Life Sci. 2005 Aug;62(16):1784-803
[
15968460.001
]
[Cites]
Mol Cell Biol. 2006 Feb;26(3):1063-76
[
16428458.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8552-7
[
16717184.001
]
[Cites]
J Bone Miner Res. 2006 Sep;21(9):1350-8
[
16939393.001
]
[Cites]
Transgenic Res. 2006 Oct;15(5):647-53
[
16952017.001
]
[Cites]
Endocrinology. 2006 Oct;147(10):4753-61
[
16857753.001
]
[Cites]
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1803-7
[
17234407.001
]
[Cites]
Gastroenterology. 2007 May;132(6):2103-15
[
17498506.001
]
[Cites]
Cell. 2007 Aug 10;130(3):456-69
[
17693256.001
]
[Cites]
Nat Med. 2008 Mar;14(3):299-305
[
18297084.001
]
[Cites]
Cell. 2000 Jan 21;100(2):197-207
[
10660043.001
]
[Cites]
Annu Rev Physiol. 2000;62:413-37
[
10845097.001
]
[Cites]
Endocr Rev. 2000 Aug;21(4):393-411
[
10950158.001
]
[Cites]
Endocrinology. 2000 Dec;141(12):4436-41
[
11108252.001
]
[Cites]
Dev Biol. 2001 Jan 1;229(1):141-62
[
11133160.001
]
[Cites]
Prog Lipid Res. 2001 Jan-Mar;40(1-2):125-48
[
11137570.001
]
[Cites]
Trends Endocrinol Metab. 2000 Oct;11(8):327-32
[
10996528.001
]
[Cites]
Science. 2001 Mar 30;291(5513):2613-6
[
11283375.001
]
[Cites]
Biochem J. 2001 Aug 15;358(Pt 1):127-35
[
11485560.001
]
[Cites]
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):138-43
[
11756679.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7515-20
[
12810950.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15712-7
[
14660788.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3258-63
[
14978271.001
]
[Cites]
Methods Enzymol. 1975;35:59-65
[
235706.001
]
[Cites]
J Biol Chem. 1983 Sep 25;258(18):11074-81
[
6136512.001
]
[Cites]
Annu Rev Biochem. 1983;52:537-79
[
6137188.001
]
[Cites]
J Biol Chem. 1985 May 25;260(10):6318-23
[
2860106.001
]
[Cites]
J Biol Chem. 1988 May 5;263(13):6447-53
[
2896193.001
]
[Cites]
Cell. 1993 Oct 8;75(1):73-82
[
8402902.001
]
[Cites]
Genes Dev. 1993 Dec;7(12B):2609-17
[
8276243.001
]
[Cites]
Nature. 1994 Dec 1;372(6505):425-32
[
7984236.001
]
[Cites]
Gene. 1995 Mar 10;154(2):271-5
[
7890176.001
]
[Cites]
Brain Res Dev Brain Res. 1997 Feb 20;98(2):197-203
[
9051261.001
]
[Cites]
Annu Rev Nutr. 1997;17:77-99
[
9240920.001
]
[Cites]
Nature. 1998 Oct 22;395(6704):763-70
[
9796811.001
]
[Cites]
Genes Dev. 1999 Apr 15;13(8):1025-36
[
10215629.001
]
[Cites]
J Nutr Biochem. 2004 Nov;15(11):651-6
[
15590268.001
]
(PMID = 19805143.001).
[ISSN]
1091-6490
[Journal-full-title]
Proceedings of the National Academy of Sciences of the United States of America
[ISO-abbreviation]
Proc. Natl. Acad. Sci. U.S.A.
[Language]
ENG
[Grant]
United States / NIGMS NIH HHS / GM / R01 GM063115; United States / NIGMS NIH HHS / GM / GM-63115
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural
[Publication-country]
United States
[Chemical-registry-number]
0 / DNA Primers; EC 2.3.1.- / Acetyltransferases; EC 2.3.1.- / aminoglycoside N1-acetyltransferase; EC 6.4.1.2 / Acetyl-CoA Carboxylase
[Other-IDs]
NLM/ PMC2762677
25.
Gogas H, Trakatelli M, Dessypris N, Terzidis A, Katsambas A, Chrousos GP, Petridou ET:
Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study.
Ann Oncol
; 2008 Feb;19(2):384-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Melanoma risk in association with
serum leptin levels
and lifestyle parameters: a case-control study.
BACKGROUND: Solar radiation has been identified
as a
principal factor for the causation of melanoma, whereas changing lifestyle patterns associated with obesity and diabetes might also contribute to the increasing incidence of the malignancy.
No study has investigated the role of
leptin
, a hormone whose
levels
increase in obesity and which has also been related to cancer.
Anthropometrical measures were also recorded and blood samples were obtained for determination of
serum leptin levels
.
RESULTS: An excess melanoma risk was observed for sun sensitive individuals and those with high circulating
levels
of
leptin
(OR: 1.56, 95% confidence interval 1.07-2.28, P = 0.02), after controlling for obesity indices, diabetes mellitus and education.
CONCLUSIONS: Melanoma risk was found to be positively associated with
serum leptin levels
and inversely with healthy lifestyle factors.
MedlinePlus Health Information.
consumer health - Melanoma
.
MedlinePlus Health Information.
consumer health - Skin Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17925285.001).
[ISSN]
1569-8041
[Journal-full-title]
Annals of oncology : official journal of the European Society for Medical Oncology
[ISO-abbreviation]
Ann. Oncol.
[Language]
ENG
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Biomarkers, Tumor; 0 / Leptin
26.
Rao SN, Gurumurthy GP, Gururajan P, Arumugam SB, Saibabu, Kirthivasan V, Cherian KM:
Clinical and biochemical parameters in relation to serum leptin levels in South Indian children and adolescents.
Indian J Pediatr
; 2010 May;77(5):555-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Clinical and biochemical parameters in relation to
serum leptin levels
in South Indian children and adolescents.
OBJECTIVE: To investigate the relationship between
serum leptin
and lipid profile in South Indian School children and adolescents, and to evaluate the role of
serum leptin
in obese, overweight and congenital heart diseased children and adolescents; in South Indian population and its correlation with anthropometric and biochemical parameters.
Anthropometric variables, lipid profile, fasting
serum
glucose were analyzed by autoanalyser and
serum leptin
by ELISA.
RESULTS:
Serum leptin levels
were significantly elevated in obese and overweight children than in control children (36.88+/-18.60ng/mL, 20.64+/-11.18ng/mL vs 7.97+/-2.79ng/mL; p value <0.001), and decreased in congenital heart diseased children than in control children (6.20+/-4.23 ng/mL vs 7.97+/-2.79ng/mL; p value <0.005).
CONCLUSIONS: This study provides a good relationship between
serum leptin levels
and anthropometric and biochemical parameters, such as total cholesterol, triglycerides and LDL-cholesterol.
We observed negative correlation between
serum leptin
and fasting glucose
levels
and HDL-cholesterol
levels
were found to be non-significant among the groups.
Further studies with large sample size are needed to ascertain the relationship between
serum leptin
and lipid profile in different groups of children and adolescents.
[MeSH-major]
Heart Defects, Congenital / blood.
Leptin
/ blood. Lipids / blood. Obesity / blood. Overweight / blood
MedlinePlus Health Information.
consumer health - Congenital Heart Defects
.
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity in Children
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Clin Invest. 1997 Aug 15;100(4):808-13
[
9259579.001
]
[Cites]
J Clin Invest. 2000 May;105(9):1243-52
[
10791999.001
]
[Cites]
Obes Res. 2003 Apr;11(4):532-40
[
12690082.001
]
[Cites]
Eur J Clin Nutr. 2007 Jun;61(6):719-26
[
17164827.001
]
[Cites]
Ann Intern Med. 1997 Jan 1;126(1):26-31
[
8992920.001
]
[Cites]
Int J Cardiol. 2003 Nov;92(1):93-7
[
14602223.001
]
[Cites]
Eur J Epidemiol. 2001;17(10):911-6
[
12188009.001
]
[Cites]
J Clin Endocrinol Metab. 1996 Nov;81(11):3909-13
[
8923837.001
]
[Cites]
J Intern Med. 1999 Oct;246(4):409-18
[
10583712.001
]
[Cites]
Obes Res. 2005 Aug;13(8):1476-84
[
16129731.001
]
[Cites]
J Clin Endocrinol Metab. 1997 Jul;82(7):2148-52
[
9215286.001
]
[Cites]
Indian Pediatr. 2007 Apr;44(4):257-62
[
17468520.001
]
[Cites]
Pediatrics. 2005 Apr;115(4):e500-3
[
15741351.001
]
[Cites]
Indian J Pediatr. 2006 Jul;73(7):593-6
[
16877853.001
]
[Cites]
Pediatrics. 1996 Aug;98(2 Pt 1):201-3
[
8692618.001
]
(PMID = 20401706.001).
[ISSN]
0973-7693
[Journal-full-title]
Indian journal of pediatrics
[ISO-abbreviation]
Indian J Pediatr
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
India
[Chemical-registry-number]
0 / Biomarkers; 0 / Leptin; 0 / Lipids
27.
Dedeoğlu EN, Erenus M, Yörük P:
Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Fertil Steril
; 2009 Feb;91(2):425-31
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Effects of hormone therapy and tibolone on body composition and
serum leptin levels
in postmenopausal women.
OBJECTIVE: To compare the changes in body composition and in
leptin levels
in postmenopausal women receiving hormone therapy (HT) or tibolone.
MAIN OUTCOME MEASURE(S): Anthropometric indices,
leptin levels
, tissue fat percentage, total fat, and lean mass measurements were performed at baseline and after 6 months.
RESULT(S): The
serum leptin levels
were in strong correlation with the total fat percentage and total fat mass at baseline.
Untreated women had weight gain and a gradual decrease in
leptin levels
.
Women receiving HT had significantly increased
leptin levels
.
Women in the tibolone group, however, had a significant decrease in
leptin levels
accompanied by decreased total fat mass, fat percentage, and increased total lean mass.
The changes in
leptin levels
were more pronounced in lean women.
CONCLUSION(S): Postmenopausal women tend to gain weight accompanied with a reduction in
leptin
concentrations.
Hormone therapy administration increases
leptin levels
while maintaining body weight and body fat distribution, whereas tibolone use decreases
leptin levels
, total fat percentage, and total fat mass.
[MeSH-major]
Adiposity / drug effects. Estrogen Replacement Therapy. Estrogens, Conjugated (USP) / therapeutic use.
Leptin
/ blood. Medroxyprogesterone Acetate / therapeutic use. Norpregnenes / therapeutic use. Postmenopause. Weight Gain / drug effects
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18249383.001).
[ISSN]
1556-5653
[Journal-full-title]
Fertility and sterility
[ISO-abbreviation]
Fertil. Steril.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Randomized Controlled Trial
[Publication-country]
United States
[Chemical-registry-number]
0 / Estrogens, Conjugated (USP); 0 / Leptin; 0 / Norpregnenes; C2QI4IOI2G / Medroxyprogesterone Acetate; FF9X0205V2 / tibolone
28.
Li L, Gao Y, Zhang LL, He DL:
Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells.
Cancer Biol Ther
; 2008 Nov;7(11):1787-92
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in
leptin
-mediated proliferation of renal
cell
carcinoma Caki-2 cells.
Serum leptin levels
are often elevated in obese people.
Leptin
has been reported to act
as a
mitogenic agent and promote renal cancer
cell
proliferation, whereas the detailed mechanisms still remain to be elucidated.
The purpose of this study is to investigate the proliferation and mobility effects in
leptin
-treated Caki-2 renal
cell
carcinoma and analyze the alterations of
leptin
-inducible STAT3 pathways and mitogenic signaling ERK pathways.
Our results indicate the constitutive expression of
leptin
receptor could not be upregulated upon the stimulation of
leptin
in Caki-2 cells.
Leptin
increases the proliferation and mobility capabilities of Caki-2 cells via upregulating the expression of both phosphor-ERK and phosphor-STAT3 and these two pathways could be partially abolished by inhibition of the activation of JAK-STAT3 and completely abrogated by inhibition of ERK1/2 pathways.
Our results also suggest that mitogenic actions of
leptin
are not the consequence of altered its receptor expression; whereas the cellular proliferation appears to be working through the cross-talking of JAK-STAT3 and ERK1/2 pathways in renal
cell
carcinoma caki-2 cells.
[MeSH-major]
Carcinoma, Renal
Cell
/ metabolism. Extracellular Signal-Regulated MAP Kinases / metabolism. Gene Expression Regulation. Janus Kinase 1 / metabolism.
Leptin
/ metabolism. STAT3 Transcription Factor / metabolism
[MeSH-minor]
Cell
Line, Tumor.
Cell
Proliferation. Flow Cytometry. Humans. Kidney Neoplasms / metabolism. MAP Kinase Signaling System. Obesity / metabolism. Protein Kinase C / metabolism. Signal Transduction
Genetic Alliance.
consumer health - Renal cell carcinoma
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18787400.001).
[ISSN]
1555-8576
[Journal-full-title]
Cancer biology & therapy
[ISO-abbreviation]
Cancer Biol. Ther.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin; 0 / STAT3 Transcription Factor; EC 2.7.10.2 / Janus Kinase 1; EC 2.7.11.13 / Protein Kinase C; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases
29.
Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dattani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, Lessan N, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S:
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor.
N Engl J Med
; 2007 Jan 18;356(3):237-47
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Clinical and molecular genetic spectrum of congenital deficiency of the
leptin
receptor.
BACKGROUND: A single family has been described in which obesity results from a mutation in the
leptin
-receptor gene (LEPR), but the prevalence of such mutations in severe, early-onset obesity has not been systematically examined.
Serum leptin levels
were within the range predicted by the elevated fat mass in these subjects.
Their clinical features were less severe than those of subjects with congenital
leptin
deficiency.
Circulating
levels
of
leptin
were not disproportionately elevated, suggesting that
serum leptin
cannot be used
as a
marker for
leptin
-receptor deficiency.
Congenital
leptin
-receptor deficiency should be considered in the differential
diagnosis
in any child with hyperphagia and severe obesity in the absence of developmental delay or dysmorphism.
[MeSH-major]
Metabolism, Inborn Errors /
diagnosis
. Metabolism, Inborn Errors / genetics. Obesity / genetics. Receptors,
Cell
Surface / deficiency. Receptors,
Cell
Surface / genetics
[MeSH-minor]
Adult. Age of Onset. Basal Metabolism. Body Composition. Child.
Diagnosis
, Differential. Female. Genotype. Humans. Hyperphagia / blood. Hyperphagia / complications. Hyperphagia / genetics. Hypogonadism / blood. Hypogonadism / complications. Hypogonadism / genetics. Immunologic Deficiency Syndromes / blood. Immunologic Deficiency Syndromes / complications. Immunologic Deficiency Syndromes / genetics.
Leptin
/ blood.
Lymphocyte
Count. Male. Mutation. Pedigree. Phenotype. Receptors,
Leptin
Genetic Alliance.
consumer health - Leptin receptor deficiency
.
Genetics Home Reference.
consumer health - leptin receptor deficiency
.
Genetics Home Reference.
consumer health - LEPR gene
.
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity in Children
.
COS Scholar Universe.
author profiles
.
Faculty of 1000.
commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine.
(subscription/membership/fee required).
SciCrunch.
OMIM: Data: Gene Annotation
.
SciCrunch.
Clinical Genomic Database: Data: Gene Annotation
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2007 Massachusetts Medical Society.
[Cites]
Diabetes. 2000 Aug;49(8):1347-52
[
10923636.001
]
[Cites]
Clin Endocrinol (Oxf). 2006 Jun;64(6):667-71
[
16712669.001
]
[Cites]
Int J Obes Relat Metab Disord. 2002 May;26(5):640-6
[
12032747.001
]
[Cites]
Obes Rev. 2001 Feb;2(1):29-36
[
12119634.001
]
[Cites]
J Clin Invest. 2002 Oct;110(8):1093-103
[
12393845.001
]
[Cites]
N Engl J Med. 2003 Mar 20;348(12):1085-95
[
12646665.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4531-6
[
15070752.001
]
[Cites]
J Clin Endocrinol Metab. 2004 Oct;89(10):4821-6
[
15472169.001
]
[Cites]
Am J Clin Nutr. 1979 Mar;32(3):607-29
[
420153.001
]
[Cites]
Am J Clin Nutr. 1982 May;35(5 Suppl):1169-75
[
7081099.001
]
[Cites]
Am J Clin Nutr. 1991 Dec;54(6):963-9
[
1957828.001
]
[Cites]
Eur J Clin Nutr. 1993 Oct;47(10):724-34
[
8269887.001
]
[Cites]
Diabet Med. 1995 Jan;12(1):30-5
[
7712700.001
]
[Cites]
Arch Dis Child. 1995 Jul;73(1):25-9
[
7639544.001
]
[Cites]
J Pediatr. 1995 Oct;127(4):571-7
[
7562278.001
]
[Cites]
Biochem Biophys Res Commun. 1997 Apr 7;233(1):248-52
[
9144432.001
]
[Cites]
Nature. 1997 Jun 26;387(6636):903-8
[
9202122.001
]
[Cites]
Nat Genet. 1997 Jul;16(3):303-6
[
9207799.001
]
[Cites]
Nat Genet. 1998 Mar;18(3):213-5
[
9500540.001
]
[Cites]
Nature. 1998 Mar 26;392(6674):398-401
[
9537324.001
]
[Cites]
Am J Physiol. 1998 Apr;274(4 Pt 2):R985-90
[
9575960.001
]
[Cites]
Nat Genet. 1998 Jun;19(2):155-7
[
9620771.001
]
[Cites]
Nature. 1998 Aug 27;394(6696):897-901
[
9732873.001
]
[Cites]
Baillieres Clin Endocrinol Metab. 1998 Jul;12(2):297-314
[
10083898.001
]
[Cites]
N Engl J Med. 1999 Sep 16;341(12):879-84
[
10486419.001
]
[Cites]
J Clin Endocrinol Metab. 1999 Oct;84(10):3686-95
[
10523015.001
]
[Cites]
Annu Rev Med. 2005;56:443-58
[
15660521.001
]
[Cites]
J Clin Endocrinol Metab. 2005 Mar;90(3):1849-55
[
15598687.001
]
[Cites]
J Clin Endocrinol Metab. 2005 Mar;90(3):1871-87
[
15598688.001
]
[Cites]
Nature. 2001 Nov 1;414(6859):34-5
[
11689931.001
]
(PMID = 17229951.001).
[ISSN]
1533-4406
[Journal-full-title]
The New England journal of medicine
[ISO-abbreviation]
N. Engl. J. Med.
[Language]
eng
[Grant]
Italy / Telethon / / GJT04008; United Kingdom / Wellcome Trust / / 077016; United Kingdom / Wellcome Trust / / 068086; United Kingdom / Medical Research Council / / G0502115; United Kingdom / Wellcome Trust / / 067457; United Kingdom / Wellcome Trust / /
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin; 0 / Receptors, Cell Surface; 0 / Receptors, Leptin; 0 / leptin receptor, human
[Other-IDs]
NLM/ PMC2670197; NLM/ UKMS4351
30.
Matheny M, Zhang Y, Shapiro A, Tümer N, Scarpace PJ:
Central overexpression of leptin antagonist reduces wheel running and underscores importance of endogenous leptin receptor activity in energy homeostasis.
Am J Physiol Regul Integr Comp Physiol
; 2009 Nov;297(5):R1254-61
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Central overexpression of
leptin
antagonist reduces wheel running and underscores importance of endogenous
leptin
receptor activity in energy homeostasis.
We used recombinant adeno-associated virus (rAAV)-mediated gene delivery to overexpress a mutant of rat
leptin
yielding a protein that acts
as a
neutral
leptin
receptor antagonist.
Leptin
antagonist overexpression was confirmed by examination of mRNA
levels
in the hypothalamus.
The degree of antagonist overexpression was sufficient to partially block signal transducer and activator of transcription 3 (STAT3) phosphorylation due to administration of an acute submaximal dose of
leptin
.
In contrast, when
leptin
was overexpressed in the hypothalamus, WR activity was increased by greater than twofold.
At death, adiposity and
serum leptin levels
were greater in the antagonist group.
These data indicate that submaximal central
leptin
receptor blockade promotes obesity and diminishes WR activity.
These findings underscore the critical role of unrestrained
leptin
receptor activity in long-term energy homeostasis and suggest that even minor disruption of
leptin
receptor function can promote obesity.
COS Scholar Universe.
author profiles
.
Gene Ontology.
gene/protein/disease-specific - Gene Ontology annotations from this paper
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Nature. 2000 Apr 6;404(6778):661-71
[
10766253.001
]
[Cites]
J Clin Invest. 1995 Sep;96(3):1658-63
[
7657836.001
]
[Cites]
J Clin Invest. 2000 Jun;105(12):1827-32
[
10862798.001
]
[Cites]
Regul Pept. 2001 Jun 15;99(2-3):69-77
[
11384767.001
]
[Cites]
Neuroscience. 2001;104(4):1111-7
[
11457594.001
]
[Cites]
Neuropharmacology. 2002 Mar;42(4):548-61
[
11955525.001
]
[Cites]
Obes Rev. 2000 Oct;1(2):87-94
[
12119990.001
]
[Cites]
Endocrinology. 2002 Aug;143(8):3026-35
[
12130569.001
]
[Cites]
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8878-83
[
9238071.001
]
[Cites]
Am J Physiol. 1997 Jul;273(1 Pt 1):E226-30
[
9252501.001
]
[Cites]
Diabetes. 1997 Nov;46(11):1782-5
[
9356026.001
]
[Cites]
Nat Genet. 1998 Mar;18(3):213-5
[
9500540.001
]
[Cites]
Endocrinology. 1998 Sep;139(9):3681-90
[
9724018.001
]
[Cites]
Nature. 1998 Oct 22;395(6704):763-70
[
9796811.001
]
[Cites]
J Biol Chem. 1999 Jun 18;274(25):17541-4
[
10364187.001
]
[Cites]
Nat Biotechnol. 2004 Dec;22(12):1583-7
[
15568020.001
]
[Cites]
Diabetologia. 2005 Jun;48(6):1075-83
[
15864530.001
]
[Cites]
J Virol. 2006 Feb;80(4):1874-85
[
16439543.001
]
[Cites]
J Pharmacol Exp Ther. 2007 Feb;320(2):706-12
[
17082312.001
]
[Cites]
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R868-74
[
17023670.001
]
[Cites]
Front Biosci. 2007;12:3531-44
[
17485319.001
]
[Cites]
Behav Brain Res. 2008 Mar 17;188(1):100-8
[
18063139.001
]
[Cites]
Diabetes. 2008 Mar;57(3):614-22
[
18086903.001
]
[Cites]
Endocrinology. 2008 Jun;149(6):3009-15
[
18308842.001
]
[Cites]
Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1370-5
[
18703413.001
]
[Cites]
Exp Biol Med (Maywood). 2002 Sep;227(8):587-600
[
12192100.001
]
[Cites]
Methods. 2002 Oct;28(2):158-67
[
12413414.001
]
[Cites]
Expert Opin Investig Drugs. 2003 Mar;12(3):373-8
[
12605561.001
]
[Cites]
Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1011-20
[
14557234.001
]
[Cites]
Obes Res. 2004 Jan;12(1):150-60
[
14742854.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4531-6
[
15070752.001
]
[Cites]
Metabolism. 1977 Apr;26(4):371-80
[
846405.001
]
[Cites]
Q J Exp Physiol. 1987 Oct;72(4):549-59
[
3423201.001
]
[Cites]
Science. 1995 Jul 28;269(5223):543-6
[
7624777.001
]
[Cites]
Science. 1995 Jul 28;269(5223):546-9
[
7624778.001
]
[Cites]
Annu Rev Physiol. 2000;62:413-37
[
10845097.001
]
(PMID = 19726711.001).
[ISSN]
1522-1490
[Journal-full-title]
American journal of physiology. Regulatory, integrative and comparative physiology
[ISO-abbreviation]
Am. J. Physiol. Regul. Integr. Comp. Physiol.
[Language]
ENG
[Grant]
United States / NIA NIH HHS / AG / AG-26159; United States / NIA NIH HHS / AG / P30-AG-028740,
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / Ion Channels; 0 / Leptin; 0 / Mitochondrial Proteins; 0 / RNA, Messenger; 0 / Receptors, Leptin; 0 / STAT3 Transcription Factor; 0 / Stat3 protein, rat; 0 / mitochondrial uncoupling protein
[Other-IDs]
NLM/ PMC2777784
31.
Benetti-Pinto CL, Castro N, Grassiotto Oda R, Garmes HM:
Leptin and adiponectin blood levels in women with premature ovarian failure and age- and weight-matched women with normal menstrual cycles.
Menopause
; 2010 Jan-Feb;17(1):174-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Leptin
and adiponectin blood
levels
in women with premature ovarian failure and age- and weight-matched women with normal menstrual cycles.
OBJECTIVE: The aim of this study was to evaluate
leptin
and adiponectin blood
levels
in women with premature ovarian failure (POF) and women with a normal menstrual cycle.
Serum leptin levels
were significantly lower in G1 compared with G2 (8.8 +/- 12.2 and 12.2 +/- 9.7 ng/mL; P < 0.05).
Serum
adiponectin
levels
were similar in both groups.
Leptin levels
were positively correlated to weight (r = 0.38; P = 0.03) but were not correlated to BMI and age in women with POF (G1); in G2, they were positively correlated to BMI (r = 0.59; P = 0.0006), weight (r = 0.63; P = 0.0006), and age (r = 0.40; P = 0.02).
Adiponectin
levels
did not correlate to weight, BMI, or age in both groups.
CONCLUSIONS: These results suggest that gonadal function loss may decrease
leptin
circulating
levels
, independently from age and BMI.
[MeSH-major]
Adiponectin / blood.
Leptin
/ blood. Primary Ovarian Insufficiency / blood
Genetic Alliance.
consumer health - premature ovarian failure
.
MedlinePlus Health Information.
consumer health - Premature Ovarian Failure
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19609224.001).
[ISSN]
1530-0374
[Journal-full-title]
Menopause (New York, N.Y.)
[ISO-abbreviation]
Menopause
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Adiponectin; 0 / Leptin
32.
Ruhlen RL, Howdeshell KL, Mao J, Taylor JA, Bronson FH, Newbold RR, Welshons WV, vom Saal FS:
Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice.
Environ Health Perspect
; 2008 Mar;116(3):322-8
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Low phytoestrogen
levels
in feed increase fetal
serum
estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice.
RESULTS: In fetuses whose mothers consumed the low-phytoestrogen PMI 5K96 feed, we found a paradoxical significant elevation in endogenous
serum
estradiol, which was associated postnatally with adverse reproductive outcomes referred to as the "fetal estrogenization syndrome (FES)".
The low-phytoestrogen-fed males and females were lighter at birth, but, between weaning and adulthood, they became obese and developed abnormally high
serum leptin levels
; these males, but not females, showed impaired glucose regulation.
Genetic Alliance.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
ESTRADIOL
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2056-61
[
9050904.001
]
[Cites]
Environ Health Perspect. 2003 Jun;111(8):994-1006
[
12826473.001
]
[Cites]
Toxicol Ind Health. 1998 Jan-Apr;14(1-2):239-60
[
9460178.001
]
[Cites]
Environ Health Perspect. 1998 Jul;106(7):369-73
[
9637793.001
]
[Cites]
Epidemiol Rev. 1998;20(2):157-72
[
9919436.001
]
[Cites]
Exp Biol Med (Maywood). 2004 Dec;229(11):1127-35
[
15564439.001
]
[Cites]
J Nutr. 2005 May;135(5):1331-5
[
15867335.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 May 10;102(19):7014-9
[
15867144.001
]
[Cites]
Birth Defects Res A Clin Mol Teratol. 2005 Jul;73(7):478-80
[
15959888.001
]
[Cites]
Environ Res. 2006 Jan;100(1):50-76
[
16256977.001
]
[Cites]
Reprod Toxicol. 2006 Apr;21(3):307-12
[
16257506.001
]
[Cites]
Endocrinology. 2006 Jun;147(6 Suppl):S56-69
[
16690810.001
]
[Cites]
Lab Anim. 2007 Jan;41(1):1-18
[
17234046.001
]
[Cites]
Environ Health Perspect. 2007 Jun;115(6):902-8
[
17589598.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13056-61
[
17670942.001
]
[Cites]
Environ Health Perspect. 2007 Oct;115(10):1467-73
[
17938737.001
]
[Cites]
Environ Health Perspect. 2008 Mar;116(3):389-93
[
18335108.001
]
[Cites]
Nature. 1999 Oct 21;401(6755):763-4
[
10548101.001
]
[Cites]
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12729-34
[
11070086.001
]
[Cites]
J Nutr. 2001 Feb;131(2):354S-60S
[
11160560.001
]
[Cites]
Cancer Res. 2001 Jun 1;61(11):4325-8
[
11389053.001
]
[Cites]
Exp Biol Med (Maywood). 2001 Dec;226(11):978-81
[
11743132.001
]
[Cites]
Comp Med. 2003 Dec;53(6):607-15
[
14727808.001
]
[Cites]
Reprod Toxicol. 2004 May;18(3):399-406
[
15082075.001
]
[Cites]
J Anim Sci. 1989 Jul;67(7):1824-40
[
2670873.001
]
[Cites]
Biol Reprod. 1990 Nov;43(5):751-61
[
2291911.001
]
[Cites]
J Vet Diagn Invest. 1990 Oct;2(4):268-73
[
2151311.001
]
[Cites]
Endocrinology. 1992 Jun;130(6):3184-90
[
1375894.001
]
[Cites]
Biol Reprod. 1992 Nov;47(5):723-9
[
1477199.001
]
[Cites]
J Steroid Biochem Mol Biol. 1993 Feb;44(2):147-53
[
8382517.001
]
[Cites]
Biol Reprod. 1995 Nov;53(5):1198-207
[
8527526.001
]
[Cites]
Environ Health Perspect. 1995 Oct;103 Suppl 7:83-7
[
8593881.001
]
[Cites]
Clin Chem. 1996 Jun;42(6 Pt 1):955-64
[
8665689.001
]
[Cites]
Med Sci Monit. 2002 Dec;8(12):RA282-92
[
12503048.001
]
[Cites]
Clin Chem. 1997 May;43(5):850; author reply 852
[
9166244.001
]
(PMID = 18335098.001).
[ISSN]
0091-6765
[Journal-full-title]
Environmental health perspectives
[ISO-abbreviation]
Environ. Health Perspect.
[Language]
ENG
[Grant]
United States / NIEHS NIH HHS / ES / R01 ES011283; United States / NIGMS NIH HHS / GM / T32 GM008396; United States / NIEHS NIH HHS / ES / ES11283
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin; 0 / Phytoestrogens; 4TI98Z838E / Estradiol
[Other-IDs]
NLM/ PMC2265041
[Keywords]
NOTNLM ; casein / estradiol / fat / glucose tolerance / leptin / metabolic syndrome / obesity / puberty / reproductive organs / soy
33.
Bhattacharya A, Rahman MM, McCarter R, O'Shea M, Fernandes G:
Conjugated linoleic acid and chromium lower body weight and visceral fat mass in high-fat-diet-fed mice.
Lipids
; 2006 May;41(5):437-44
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
This effect was accompanied by decreased
serum leptin levels
in CLA-fed and CLA + Cr-fed mice, and by higher energy expenditure (EE) and oxygen consumption (OC) in CLA + Cr-fed mice.
Serum levels
of glucose, insulin, the pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6),
as well
as insulin resistance index (IRI), decreased with CLA, whereas CLA and Cr in combination had significant effects on insulin and IL-6 concentrations and IRI.
In summary, CLA + Cr decreased body weight and fat mass in high-fat-diet-fed mice, which may be associated with decreased
leptin levels
and higher EE and OC.
[MeSH-minor]
Adiponectin / blood. Analysis of Variance. Animals. Dietary Fats / administration & dosage. Dietary Fats / pharmacology. Energy Metabolism / drug effects.
Leptin
/ blood. Male. Mice. Mice, Inbred BALB C
MedlinePlus Health Information.
consumer health - Body Weight
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
CHROMIUM, ELEMENTAL
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Obes Rev. 2005 Aug;6(3):247-58
[
16045640.001
]
[Cites]
Biochem Biophys Res Commun. 2004 Oct 15;323(2):679-84
[
15369804.001
]
[Cites]
Diabetes. 2000 Sep;49(9):1534-42
[
10969838.001
]
[Cites]
Am J Clin Nutr. 2004 Oct;80(4):887-95
[
15447895.001
]
[Cites]
Diabetes Res Clin Pract. 1996 Mar;31(1-3):27-35
[
8792099.001
]
[Cites]
Lipids Health Dis. 2005 Jan 10;4:3
[
15642120.001
]
[Cites]
Am J Clin Nutr. 2004 Jun;79(6 Suppl):1199S-1206S
[
15159257.001
]
[Cites]
Biosci Biotechnol Biochem. 2002 Apr;66(4):916-20
[
12036077.001
]
[Cites]
JAMA. 2004 Jun 16;291(23):2847-50
[
15199035.001
]
[Cites]
Int J Obes Relat Metab Disord. 2003 Apr;27(4):522-9
[
12664086.001
]
[Cites]
J Nutr Biochem. 2004 Nov;15(11):680-7
[
15590272.001
]
[Cites]
Wei Sheng Yan Jiu. 2000 Nov;29(6):370-1
[
12520958.001
]
[Cites]
J Biomed Mater Res. 1996 Dec;32(4):655-61
[
8953156.001
]
[Cites]
Biochim Biophys Acta. 2002 Apr 15;1581(3):89-99
[
12020636.001
]
[Cites]
J Lipid Res. 2002 Sep;43(9):1400-9
[
12235171.001
]
[Cites]
J Endocrinol. 1998 Oct;159(1):165-72
[
9795354.001
]
[Cites]
Am J Clin Nutr. 2004 Jun;79(6):1118-25
[
15159244.001
]
[Cites]
Aging (Milano). 1997 Feb-Apr;9(1-2):73-9
[
9177588.001
]
[Cites]
Nutr Rev. 1998 Sep;56(9):266-70
[
9763876.001
]
[Cites]
J Nutr. 2005 May;135(5):1124-30
[
15867292.001
]
[Cites]
Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):67-79
[
15772897.001
]
[Cites]
Metabolism. 1998 Apr;47(4):396-400
[
9550535.001
]
[Cites]
Diabetologia. 2004 Jun;47(6):1016-9
[
15168020.001
]
[Cites]
Am J Physiol. 1998 Sep;275(3 Pt 2):R667-72
[
9728060.001
]
[Cites]
Am J Clin Nutr. 2004 Jun;79(6 Suppl):1153S-1158S
[
15159250.001
]
[Cites]
Diabetes Care. 2002 Sep;25(9):1516-21
[
12196420.001
]
[Cites]
J Nutr Sci Vitaminol (Tokyo). 2004 Dec;50(6):416-21
[
15895517.001
]
[Cites]
Am J Clin Nutr. 2004 Jun;79(6 Suppl):1169S-1174S
[
15159253.001
]
[Cites]
Am J Clin Nutr. 2004 Jun;79(6 Suppl):1164S-1168S
[
15159252.001
]
[Cites]
Lipids. 2002 Jul;37(7):725-8
[
12216844.001
]
[Cites]
Diabetes. 2002 Jul;51(7):2037-44
[
12086931.001
]
[Cites]
Annu Rev Nutr. 2002;22:505-31
[
12055356.001
]
[Cites]
J Bone Miner Res. 2003 Jul;18(7):1206-16
[
12854830.001
]
[Cites]
J Dairy Sci. 1995 Nov;78(11):2358-65
[
8747326.001
]
[Cites]
Nat Med. 1995 Nov;1(11):1155-61
[
7584987.001
]
[Cites]
Diabetes Obes Metab. 2001 Aug;3 Suppl 1:S11-9
[
11685824.001
]
[Cites]
Biochem Biophys Res Commun. 2003 Apr 11;303(3):795-9
[
12670481.001
]
[Cites]
Lipids. 1997 Aug;32(8):853-8
[
9270977.001
]
[Cites]
Prog Lipid Res. 2004 Nov;43(6):553-87
[
15522764.001
]
[Cites]
J Am Coll Nutr. 2005 Jun;24(3):200-9
[
15930486.001
]
[Cites]
Public Health Nutr. 2004 Feb;7(1A):123-46
[
14972057.001
]
[Cites]
Lipids. 2001 Jul;36(7):669-74
[
11521964.001
]
[Cites]
Nutrition. 1999 Sep;15(9):720-2
[
10467621.001
]
[Cites]
J Biol Chem. 2005 Nov 18;280(46):38445-56
[
16155293.001
]
[Cites]
JAMA. 1999 Oct 27;282(16):1519-22
[
10546690.001
]
[Cites]
Nature. 2000 Apr 6;404(6778):635-43
[
10766250.001
]
[Cites]
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E527-33
[
12736161.001
]
[Cites]
J Nutr. 2003 Jun;133(6):1793-9
[
12771319.001
]
[Cites]
Diabetes Res Clin Pract. 1995 Jun;28(3):179-84
[
8529496.001
]
[Cites]
J Clin Endocrinol Metab. 2004 Jun;89(6):2665-71
[
15181039.001
]
[Cites]
J Nutr. 2000 Oct;130(10 ):2471-7
[
11015475.001
]
[Cites]
Am J Clin Nutr. 2004 Jun;79(6 Suppl):1132S-1136S
[
15159246.001
]
[Cites]
Am J Physiol Regul Integr Comp Physiol. 2000 Dec;279(6):R2057-65
[
11080069.001
]
[Cites]
Am J Clin Nutr. 1985 May;41(5 Suppl):1132-45
[
3993620.001
]
[Cites]
J Nutr. 2002 Oct;132(10):2995-8
[
12368384.001
]
[Cites]
Nature. 1999 Dec 23-30;402(6764):860-1
[
10622250.001
]
[Cites]
Diabetes. 2001 May;50(5):1149-57
[
11334420.001
]
[Cites]
Nutrition. 2003 Jan;19(1):30-5
[
12507636.001
]
[Cites]
Am J Physiol Endocrinol Metab. 2000 Mar;278(3):E563-9
[
10710512.001
]
[Cites]
Am J Clin Nutr. 1981 Dec;34(12):2670-8
[
7032273.001
]
[Cites]
Biochem Biophys Res Commun. 2003 Oct 17;310(2):562-6
[
14521947.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6207-12
[
15833818.001
]
[Cites]
Am J Vet Res. 1997 Jun;58(6):594-600
[
9185964.001
]
[Cites]
Int J Obes. 1991 Sep;15 Suppl 2:109-15
[
1794931.001
]
[Cites]
Obes Res. 2003 Mar;11(3):368-72
[
12634431.001
]
[Cites]
J Nutr. 2005 Apr;135(4):778-84
[
15795434.001
]
[Cites]
Metabolism. 1992 Jul;41(7):768-71
[
1619996.001
]
[Cites]
Diabetes Care. 1994 Dec;17(12):1449-52
[
7882815.001
]
[Cites]
Diabet Med. 2000 Sep;17(9):684-5
[
11051290.001
]
[Cites]
Nutrition. 2004 Nov-Dec;20(11-12):1008-17
[
15561492.001
]
[Cites]
Biochem Biophys Res Commun. 1998 Mar 27;244(3):678-82
[
9535724.001
]
[Cites]
Diabetologia. 1985 Jul;28(7):412-9
[
3899825.001
]
[Cites]
Lipids. 1999 Mar;34(3):235-41
[
10230716.001
]
(PMID = 16933788.001).
[ISSN]
0024-4201
[Journal-full-title]
Lipids
[ISO-abbreviation]
Lipids
[Language]
eng
[Grant]
United States / NIA NIH HHS / AG / AG023648; United States / NIA NIH HHS / AG / AG027562
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
Germany
[Chemical-registry-number]
0 / Adiponectin; 0 / Dietary Fats; 0 / Leptin; 0 / Linoleic Acids, Conjugated; 0R0008Q3JB / Chromium
34.
Al Maskari MY, Alnaqdy AA:
Correlation between Serum Leptin Levels, Body Mass Index and Obesity in Omanis.
Sultan Qaboos Univ Med J
; 2006 Dec;6(2):27-31
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Correlation between
Serum Leptin Levels
, Body Mass Index and Obesity in Omanis.
OBJECTIVE: To ascertain the relationship between
serum leptin levels
and related variables (weight, Body Mass Index (BMI) and fat percentage) in a group of Omani obese and non-obese healthy subjects.
METHODS:
Leptin levels
were assessed in
serum
samples from 35 obese Omanis and 20 non-obese healthy subjects.
RESULTS: There was a significant difference (p< 0.001) in
serum leptin
between the obese group (34.78 + 13.96 ng/ml) and the control non-obese subjects (10.6 ± 4.2 ng/ml).
Leptin levels
were higher in females compared to males.
There was a significantly positive correlation between
leptin levels
in obese subjects with weight (p=0.002), body fat percentage (p=0.0001) and BMI (p=0.001).
CONCLUSIONS: We concluded that
serum leptin levels
are higher in the Omani obese group and correlate positively with body fatness and obesity.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Clin Endocrinol Metab. 1996 Sep;81(9):3424-7
[
8784109.001
]
[Cites]
J Clin Endocrinol Metab. 1997 May;82(5):1632-4
[
9141562.001
]
[Cites]
J Clin Invest. 1997 May 15;99(10):2398-404
[
9153282.001
]
[Cites]
J Clin Endocrinol Metab. 1997 Dec;82(12):4144-8
[
9398729.001
]
[Cites]
J Clin Endocrinol Metab. 1998 Jun;83(6):2149-55
[
9626154.001
]
[Cites]
Kidney Int. 1998 Oct;54(4):1267-75
[
9767543.001
]
[Cites]
Horm Res. 1998;50(6):297-302
[
9973668.001
]
[Cites]
Adv Physiol Educ. 2003 Dec;27(1-4):70-7
[
12760843.001
]
[Cites]
Diabet Med. 2002 Nov;19(11):954-7
[
12421434.001
]
[Cites]
J Clin Endocrinol Metab. 1996 Sep;81(9):3419-23
[
8784108.001
]
[Cites]
Ann Saudi Med. 2000 Mar;20(2):113-8
[
17322705.001
]
[Cites]
Diabetes. 2002 Jun;51(6):1980-5
[
12031989.001
]
[Cites]
Physiol Res. 2001;50(5):443-59
[
11702849.001
]
[Cites]
Atherosclerosis. 2001 Aug;157(2):495-503
[
11472752.001
]
[Cites]
Cesk Fysiol. 2001 Feb;50(1):25-30
[
11268559.001
]
[Cites]
East Mediterr Health J. 1999 Jan;5(1):14-20
[
10793776.001
]
[Cites]
Nutrition. 1999 Nov-Dec;15(11-12):829-33
[
10575656.001
]
[Cites]
J Mol Endocrinol. 1999 Apr;22(2):173-84
[
10194520.001
]
[Cites]
Int J Obes Relat Metab Disord. 1999 Feb;23 Suppl 1:22-8
[
10193858.001
]
[Cites]
Nat Med. 1995 Nov;1(11):1155-61
[
7584987.001
]
[Cites]
Nature. 1994 Dec 1;372(6505):425-32
[
7984236.001
]
[Cites]
N Engl J Med. 1996 Feb 1;334(5):292-5
[
8532024.001
]
[Cites]
Diabet Med. 1995 Dec;12(12):1122-5
[
8750224.001
]
(PMID = 21748132.001).
[ISSN]
2075-051X
[Journal-full-title]
Sultan Qaboos University medical journal
[ISO-abbreviation]
Sultan Qaboos Univ Med J
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Oman
[Other-IDs]
NLM/ PMC3074914
[Keywords]
NOTNLM ; Body Mass Index / Body weight / Leptin / Obesity / Oman
35.
Di Carlo C, Tommaselli GA, Gargano V, Sammartino A, Bifulco G, Tauchmanova L, Colao A, Nappi C:
Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women.
Menopause
; 2007 Jan-Feb;14(1):38-44
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Effects of estrogen-progestin therapy on
serum levels
of RANKL, osteoprotegerin, osteocalcin,
leptin
, and ghrelin in postmenopausal women.
OBJECTIVE: The aim of this study was to evaluate the effects of estrogen-progestin therapy on
serum levels
of receptor-activating nuclear factor kappabeta ligand (RANKL), osteoprotegerin, osteocalcin,
leptin
, and ghrelin in a cross-sectional study of 99 healthy postmenopausal women conducted at the Menopause Clinic of our department.
Serum leptin levels
were significantly lower in group B than in group A, whereas ghrelin was significantly higher in group B than in group A.
Similarly, although several reports suggest that
leptin
and ghrelin are involved in bone metabolism, we could not detect any important correlation of these two hormones with bone metabolism or bone status in treated and untreated postmenopausal women.
[MeSH-minor]
Administration, Cutaneous. Bone Density / drug effects. Cross-Sectional Studies. Female. Finger Phalanges / ultrasonography. Ghrelin. Humans.
Leptin
/ blood. Middle Aged. Osteocalcin / blood. Osteoporosis / prevention & control. Peptide Hormones / blood. Receptors,
Leptin
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Menopause. 2007 Jan-Feb;14(1):7-9
[
17194959.001
]
(PMID = 17075432.001).
[ISSN]
1072-3714
[Journal-full-title]
Menopause (New York, N.Y.)
[ISO-abbreviation]
Menopause
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Estrogens; 0 / Ghrelin; 0 / Leptin; 0 / Osteoprotegerin; 0 / Peptide Hormones; 0 / Progestins; 0 / RANK Ligand; 0 / Receptors, Leptin; 0 / leptin receptor, human; 104982-03-8 / Osteocalcin
36.
Argentou M, Tiniakos DG, Karanikolas M, Melachrinou M, Makri MG, Kittas C, Kalfarentzos F:
Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
Obes Surg
; 2009 Sep;19(9):1313-23
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Adipokine
serum levels
are related to liver histology in severely obese patients undergoing bariatric surgery.
BACKGROUND:
Leptin
, adiponectin, and resistin are adipokines linked to the development of insulin resistance, which plays a central role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).
We aimed to define adipokine
serum levels
in severely obese patients undergoing bariatric surgery and to correlate these with anthropometric and metabolic variables, liver function tests, and histopathological parameters of NAFLD and nonalcoholic steatohepatitis (NASH).
Serum leptin
, adiponectin, and resistin
levels
were measured, and histology was assessed using Brunt's and Kleiner's scoring systems.
RESULTS: Waist/hip ratio was significantly higher in men (p = 0.0001), and
leptin
(p = 0.036) and adiponectin (p = 0.0001)
serum levels
were higher in women.
In NAFLD patients,
serum
adiponectin was negatively correlated with activity grade and fibrosis stage, resistin was negatively correlated with steatosis grade (p = 0.033), while
leptin
was not related to histology.
Leptin
/adiponectin ratio showed positive association with stage (p = 0.044).
In the subgroup of NASH patients, adiponectin was negatively correlated only with stage (p = 0.01), while there was no correlation between
leptin
, resistin, or
leptin
/adiponectin and histology.
CONCLUSIONS:
Serum
adiponectin and resistin
levels
are related to liver histology in bariatric patients and may be indicative of the histological severity of NAFLD and the extent of hepatic steatosis, respectively.
Serum leptin levels
are not informative of underlying liver histology in severely obese patients.
MedlinePlus Health Information.
consumer health - Hepatitis
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Clin Chem. 1972 Jun;18(6):499-502
[
4337382.001
]
[Cites]
Am J Gastroenterol. 1999 Sep;94(9):2467-74
[
10484010.001
]
[Cites]
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S15-21
[
17331160.001
]
[Cites]
Hepatology. 2003 Apr;37(4):917-23
[
12668987.001
]
[Cites]
Hepatology. 2004 Jul;40(1):46-54
[
15239085.001
]
[Cites]
Am J Gastroenterol. 2006 Nov;101(11):2629-40
[
16952281.001
]
[Cites]
J Clin Endocrinol Metab. 2006 Dec;91(12):5122-5
[
16968796.001
]
[Cites]
Dig Dis Sci. 2008 Apr;53(4):1088-92
[
17934820.001
]
[Cites]
Nutr Rev. 2007 Jun;65(6 Pt 2):S57-63
[
17605315.001
]
[Cites]
Hepatology. 2008 Feb;47(2):484-92
[
18220286.001
]
[Cites]
Curr Opin Clin Nutr Metab Care. 2008 May;11(3):267-74
[
18403923.001
]
[Cites]
Expert Rev Mol Diagn. 2007 Mar;7(2):195-205
[
17331066.001
]
[Cites]
Surg Endosc. 2007 Sep;21(9):1593-9
[
17294310.001
]
[Cites]
Hepatology. 2002 Aug;36(2):403-9
[
12143049.001
]
[Cites]
Clin Endocrinol (Oxf). 2006 Jun;64(6):679-83
[
16712671.001
]
[Cites]
Curr Opin Lipidol. 2006 Apr;17(2):170-5
[
16531754.001
]
[Cites]
Gastroenterology. 2006 Sep;131(3):934-45
[
16952562.001
]
[Cites]
Hepatology. 2005 Jun;41(6):1313-21
[
15915461.001
]
[Cites]
Obes Surg. 2005 Feb;15(2):228-37
[
15802066.001
]
[Cites]
Gastroenterology. 2006 May;130(6):1848-52
[
16697746.001
]
[Cites]
Obes Surg. 2008 Nov;18(11):1430-7
[
18500507.001
]
[Cites]
Am J Gastroenterol. 2003 Dec;98(12):2771-6
[
14687831.001
]
[Cites]
Liver Int. 2006 Mar;26(2):151-6
[
16448452.001
]
[Cites]
Obes Surg. 2005 Mar;15(3):310-5
[
15826462.001
]
[Cites]
J Hepatol. 2006 Oct;45(4):600-6
[
16899321.001
]
[Cites]
Mediators Inflamm. 2006;2006(6):34295
[
17392582.001
]
[Cites]
JAMA. 2001 May 16;285(19):2486-97
[
11368702.001
]
[Cites]
J Hepatol. 2008;48 Suppl 1:S104-12
[
18304679.001
]
[Cites]
Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21
[
18081738.001
]
[Cites]
Hepatology. 2005 Aug;42(2):490-2
[
15977205.001
]
[Cites]
Clin Liver Dis. 2007 Feb;11(1):191-207, x-xi
[
17544979.001
]
[Cites]
Obes Surg. 2006 Oct;16(10):1351-8
[
17059746.001
]
[Cites]
J Hepatol. 2004 Dec;41(6):943-9
[
15582127.001
]
[Cites]
J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504
[
15797948.001
]
[Cites]
Obes Surg. 2006 Dec;16(12):1584-93
[
17217634.001
]
[Cites]
Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
[
16447287.001
]
[Cites]
Scand J Gastroenterol. 2008;43(9):1128-36
[
18609175.001
]
[Cites]
Hepatogastroenterology. 2007 Jul-Aug;54(77):1512-6
[
17708287.001
]
[Cites]
Hepatology. 2003 May;37(5):1202-19
[
12717402.001
]
[Cites]
Hepatology. 2007 Aug;46(2):582-9
[
17661414.001
]
[Cites]
Hepatology. 2007 Sep;46(3):716-22
[
17659597.001
]
[Cites]
Gut. 2005 Jan;54(1):117-21
[
15591515.001
]
[Cites]
J Clin Endocrinol Metab. 2004 Apr;89(4):1844-8
[
15070954.001
]
[Cites]
Am J Gastroenterol. 2007 Feb;102(2):399-408
[
17311652.001
]
[Cites]
Obes Surg. 2000 Aug;10(4):378-9
[
11202981.001
]
[Cites]
Gastroenterology. 2008 May;134(6):1682-98
[
18471547.001
]
[Cites]
Med Clin North Am. 2007 Nov;91(6):1125-49, ix
[
17964913.001
]
[Cites]
J Appl Physiol (1985). 1988 Feb;64(2):529-34
[
3372410.001
]
[Cites]
J Clin Endocrinol Metab. 2006 Mar;91(3):1081-6
[
16394091.001
]
[Cites]
J Hepatol. 2008 May;48(5):829-34
[
18321606.001
]
[Cites]
Scand J Gastroenterol. 2006 May;41(5):566-72
[
16638699.001
]
[Cites]
Am J Gastroenterol. 2007 Sep;102(9):1931-8
[
17511754.001
]
[Cites]
J Pediatr Endocrinol Metab. 2004 Aug;17(8):1069-75
[
15379417.001
]
[Cites]
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8
[
17268250.001
]
[Cites]
Hepatology. 2005 Nov;42(5):1175-83
[
16231364.001
]
[Cites]
Eur J Endocrinol. 2005 Jan;152(1):113-8
[
15762194.001
]
[Cites]
Am J Clin Pathol. 2007 Nov;128(5):837-47
[
17951208.001
]
[Cites]
Diabetologia. 1985 Jul;28(7):412-9
[
3899825.001
]
(PMID = 19693638.001).
[ISSN]
0960-8923
[Journal-full-title]
Obesity surgery
[ISO-abbreviation]
Obes Surg
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Adipokines
37.
Srivastava RK, Krishna A:
Adiposity associated rise in leptin impairs ovarian activity during winter dormancy in Vespertilionid bat, Scotophilus heathi.
Reproduction
; 2007 Jan;133(1):165-76
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Adiposity associated rise in
leptin
impairs ovarian activity during winter dormancy in Vespertilionid bat, Scotophilus heathi.
The aim of the study was to evaluate the seasonal variation in
serum leptin levels
in a natural population of the female bat, Scotophilus heathi and their relationship to the changes in the body mass,
serum
insulin
level
, and ovarian activity.
Circulating
leptin level
varied significantly over the season and correlated positively with the changes in body mass, and circulating insulin and androstenedione (A4)
levels
.
Circulating
leptin
concentrations showed two peaks; one coincides with the maximum fat accumulation prior to winter dormancy, whereas the second shorter peak coincides with late pregnancy.
The in vivo study in S. heathi showed that the increased circulating
leptin level
during winter dormancy coincides with the decreased expression of ovarian steroidogenic acute regulatory (StAR) protein, and low circulating estradiol (E2)
level
.
At the same time, increased circulating
leptin level
coincides with increased expression of ovarian insulin receptor and high circulating A4
level
.
The low circulating
leptin level
during preovulatory period coincides with the increase in StAR protein but decrease in insulin receptor protein.
The in vitro study confirmed the in vivo observations of inhibitory effect of
leptin
on LH induced StAR expression and E2 production, whereas the stimulatory effect of
leptin
(high dose) on LH induced expression of insulin receptor protein and A4 production.
However, pharmacological dose of
leptin
produced inhibitory effect on the expression of insulin receptor protein.
The results of the present study thus suggest that high circulating
leptin level
during winter dormancy promotes adiposity and impairs ovarian activity by suppressing StAR-mediated E2 production
as well
as by enhancing insulin receptor-mediated A4 synthesis thereby contributing anovulatory condition of delayed ovulation in S. heathi.
[MeSH-major]
Adiposity / physiology. Chiroptera / metabolism. Hibernation / physiology.
Leptin
/ blood. Ovary / metabolism
Hazardous Substances Data Bank.
ESTRADIOL
.
Hazardous Substances Data Bank.
PROGESTERONE
.
Hazardous Substances Data Bank.
ANDROSTENEDIONE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17244743.001).
[ISSN]
1470-1626
[Journal-full-title]
Reproduction (Cambridge, England)
[ISO-abbreviation]
Reproduction
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Insulin; 0 / Leptin; 0 / Phosphoproteins; 0 / steroidogenic acute regulatory protein; 409J2J96VR / Androstenedione; 4G7DS2Q64Y / Progesterone; 4TI98Z838E / Estradiol; 9002-67-9 / Luteinizing Hormone; EC 2.7.10.1 / Receptor, Insulin
38.
Zemanová M, Petruzelka L, Pazdrová G, Haluzík M, Novák F, Svobodník A:
[Changes in leptin, leptin receptor and fatty acids levels during chemoradiotherapy for oesophageal cancer].
Cas Lek Cesk
; 2005;144(12):811-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Changes in
leptin
,
leptin
receptor and fatty acids
levels
during chemoradiotherapy for oesophageal cancer].
Leptin
, a protein produced by adipocytes, is an important signalling molecule in energy regulation, metabolism of fatty acids and it can also augment tumour growth of various cancer
cell
lines.
METHODS AND RESULTS: In this study we examined the nutritional status (pre-treatment weight-loss, actual weight, body mass index),
serum levels
of
leptin
, soluble
leptin
receptor, TNF-alpha, IGF-1 and plasma phosphatidyl-cholin fatty acids before the beginning of treatment, after the onset of treatment and shortly before its completion.
Concomitant chemoradiation led to transient elevation of
serum leptin level
despite the weight loss during chemoradiotherapy.
[MeSH-major]
Esophageal Neoplasms / blood. Fatty Acids / blood.
Leptin
/ blood. Receptors,
Cell
Surface / blood
[MeSH-minor]
Adult. Aged. Combined Modality Therapy. Female. Humans. Insulin-Like Growth Factor I / analysis. Male. Middle Aged. Phosphatidylcholines / chemistry. Receptors,
Leptin
. Tumor Necrosis Factor-alpha / analysis. Weight Loss
MedlinePlus Health Information.
consumer health - Esophageal Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16389753.001).
[ISSN]
0008-7335
[Journal-full-title]
Casopís lékar̆ů c̆eských
[ISO-abbreviation]
Cas. Lek. Cesk.
[Language]
cze
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Czech Republic
[Chemical-registry-number]
0 / Fatty Acids; 0 / Leptin; 0 / Phosphatidylcholines; 0 / Receptors, Cell Surface; 0 / Receptors, Leptin; 0 / Tumor Necrosis Factor-alpha; 0 / leptin receptor, human; 67763-96-6 / Insulin-Like Growth Factor I
39.
Korotkova M, Gabrielsson BG, Holmäng A, Larsson BM, Hanson LA, Strandvik B:
Gender-related long-term effects in adult rats by perinatal dietary ratio of n-6/n-3 fatty acids.
Am J Physiol Regul Integr Comp Physiol
; 2005 Mar;288(3):R575-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We have previously shown that the ratio of n-6 to n-3 polyunsaturated fatty acids (PUFA) in the maternal diet affects
serum leptin levels
and growth of the suckling pups.
The aim of the present study was to investigate the long-term effects of various ratios of the dietary n-6 and n-3 PUFA during the perinatal period on
serum leptin
, insulin, and triacylglycerol,
as well
as body growth in the adult offspring.
At 3 wk of age, the n-6/n-3 PUFA ratios in the
serum
phospholipids of the offspring were 2.5, 8.3, and 17.5, respectively.
At the 28th postnatal wk, mean body weight and fasting insulin
levels
were significantly increased in the rats fed the n-6/n-3 diet perinatally compared with the other groups.
The systolic blood pressure and
serum
triacylglycerol
levels
were only increased in adult male rats of the same group.
MedlinePlus Health Information.
consumer health - Seniors' Health
.
Hazardous Substances Data Bank.
CHOLESTEROL
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[ErratumIn]
Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1564
(PMID = 15699360.001).
[ISSN]
0363-6119
[Journal-full-title]
American journal of physiology. Regulatory, integrative and comparative physiology
[ISO-abbreviation]
Am. J. Physiol. Regul. Integr. Comp. Physiol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Fatty Acids; 0 / Fatty Acids, Omega-3; 0 / Fatty Acids, Omega-6; 0 / Insulin; 0 / Phospholipids; 0 / Triglycerides; 97C5T2UQ7J / Cholesterol
40.
Pauwels NS, Bracke KR, Maes T, Pilette C, Joos GF, Brusselle GG:
The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease.
Exp Lung Res
; 2010 Oct;36(8):469-83
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Increased
levels
of interleukin-6 (IL-6) have been demonstrated in sputum and
serum
of COPD patients.
Wild-
type
(WT) and IL-6 knockout (KO) mice were exposed subacutely (4 weeks) and chronically (24 weeks) to air or cigarette smoke (CS).
Subacute and chronic CS exposure significantly increased pulmonary IL-6 mRNA expression in lung tissue and IL-6 protein
levels
in bronchoalveolar lavage fluid of WT mice.
Remarkably, air-exposed IL-6 KO mice have lower body weight,
serum leptin levels
, and adipose tissue mass compared to air-exposed WT mice.
[MeSH-minor]
Adipose Tissue, White / drug effects. Adipose Tissue, White / metabolism. Animals. Bronchoalveolar Lavage Fluid / cytology.
Cell
Count. Cytokines / genetics. Cytokines / metabolism. Disease Models, Animal. Gene Expression / drug effects.
Leptin
/ genetics.
Leptin
/ metabolism.
Lymphocytes
/ drug effects.
Lymphocytes
/ metabolism.
Lymphocytes
/ pathology. Male. Mice. Mice, Knockout. RNA, Messenger / metabolism. Smoking / adverse effects. Tobacco Smoke Pollution / adverse effects
MedlinePlus Health Information.
consumer health - COPD
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20939756.001).
[ISSN]
1521-0499
[Journal-full-title]
Experimental lung research
[ISO-abbreviation]
Exp. Lung Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Cytokines; 0 / Interleukin-6; 0 / Leptin; 0 / RNA, Messenger; 0 / Tobacco Smoke Pollution
41.
Aurangzeb B, Leach ST, Lemberg DA, Day AS:
Nutritional status of children with coeliac disease.
Acta Paediatr
; 2010 Jul;99(7):1020-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
METHODS: The nutritional status of newly diagnosed CD was assessed by anthropometry, Bioelectrical Impedance and
serum leptin levels
, and contrasted to age and gender matched controls.
Mean height and weight for age, other nutritional parameters and
serum leptin
did not differ between the groups.
Serum leptin
correlated with BMI in both groups.
Variations in nutrition (under to overnutrition) may be seen at
diagnosis
, without relationship to the presence of symptoms.
Leptin levels
were not altered specifically in the setting of CD.
[MeSH-minor]
Adolescent. Anthropometry. Case-Control Studies. Child. Child, Preschool. Electric Impedance. Female. Humans. Infant.
Leptin
/ blood. Male. Nutrition Assessment
MedlinePlus Health Information.
consumer health - Celiac Disease
.
MedlinePlus Health Information.
consumer health - Child Nutrition
.
MedlinePlus Health Information.
consumer health - Toddler Nutrition
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20178518.001).
[ISSN]
1651-2227
[Journal-full-title]
Acta paediatrica (Oslo, Norway : 1992)
[ISO-abbreviation]
Acta Paediatr.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Norway
[Chemical-registry-number]
0 / Leptin
42.
Akinci M, Kosova F, Cetin B, Aslan S, Ari Z, Cetin A:
Leptin levels in thyroid cancer.
Asian J Surg
; 2009 Oct;32(4):216-23
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Leptin levels
in thyroid cancer.
BACKGROUND:
Leptin
has physiological roles in multiple systems, and has possible effects on several carcinogenesis steps.
The aim of this study was to investigate the
leptin levels
in thyroid papillary carcinoma (TPC) patients.
TPC patients had a bilateral total thyroidectomy operation and their
leptin levels
were measured before and 20 days after the operation.
RESULTS:
Serum leptin levels
of TPC patients were higher than in control group subjects (21.15 +/- 14.12 ng/mL vs. 9.89 +/- 0.21 ng/mL, p < 0.05).
The
leptin levels
decreased after total thyroidectomy (13.92 +/- 10.55 ng/mL) compared to prethyroidectomy
levels
(22.94 +/- 14.67 ng/mL) in 34 patients who came to the follow-up visit (p < 0.05).
However, the decreased post-thyroidectomy
levels
of
leptin
were still statistically significantly higher than the control group
levels
.
Multivariate regression analysis showed that the
leptin levels
in TPC patients were not related to age, menopausal status or pathologic occult status but were directly related to the cancer group.
CONCLUSION:
Leptin levels
were elevated in thyroid cancer, decreased after total thyroidectomy, and might be associated with thyroid papillary carcinogenesis.
Genetic Alliance.
consumer health - Thyroid Cancer
.
MedlinePlus Health Information.
consumer health - Thyroid Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19892624.001).
[ISSN]
0219-3108
[Journal-full-title]
Asian journal of surgery
[ISO-abbreviation]
Asian J Surg
[Language]
ENG
[Publication-type]
Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Leptin
43.
Jaleel F, Jaleel A, Aftab J, Rahman MA:
Leptin and blood lipid levels in postmenopausal diabetic women with and without complication of ischemic heart disease.
Med Sci Monit
; 2006 Sep;12(9):CR382-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Leptin
and blood lipid
levels
in postmenopausal diabetic women with and without complication of ischemic heart disease.
BACKGROUND: Recent studies have provided evidence that
leptin
has significant effects on vascular development and repair.
The aim was to determine the
levels
of
leptin
and lipid profile in diabetic postmenopausal women with and without the complication of ischemic heart disease and to develop correlation between them.
Moreover, the relationship between
leptin levels
and extent of ischemic changes were determined.
The first group comprised normal healthy controls, the second diabetic
type
2 patients with no history of ischemic heart disease (I1ID), and the third diabetic patients with IHD.
Serum leptin levels
were determined by a Kit obtained from DRG and samples were analyzed on ELISA.
RESULTS: The results show that
leptin
and
serum
lipid
levels
increased significantly in diabetic patients with IHD compared with diabetic patients without IHD
as well
as normal subjects.
Moreover; the sertum
leptin level
increased significantly in the diabetic patients with IHD who had positive findings in myocardial perfusion scan compared with those having negative findings.
CONCLUSIONS: Hyperleptinemia in diabetic patients shows that
leptin
contributes to the development of cardiovascular disease in diabetic patients.
[MeSH-major]
Diabetes Mellitus,
Type
2 / blood. Hyperlipidemias / complications.
Leptin
/ blood. Myocardial Ischemia / etiology. Postmenopause / blood
Genetic Alliance.
consumer health - Heart Disease
.
MedlinePlus Health Information.
consumer health - Diabetes Type 2
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16940932.001).
[ISSN]
1234-1010
[Journal-full-title]
Medical science monitor : international medical journal of experimental and clinical research
[ISO-abbreviation]
Med. Sci. Monit.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Poland
[Chemical-registry-number]
0 / Leptin; 0 / Lipids
44.
Tsukamoto N, Kojima M, Hasegawa M, Oriuchi N, Matsushima T, Yokohama A, Saitoh T, Handa H, Endo K, Murakami H:
The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
Cancer
; 2007 Aug 1;110(3):652-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of
lymphoma
: relation to histologic subtypes based on the World Health Organization
classification
.
BACKGROUND: Although studies comparing conventional imaging modalities with (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) for the detection of
lymphoma
and although the relations between (18)F-FDG-PET and histologic types were reported previously, most studies were not systematic and involved relatively
small
numbers of patients.
METHODS: Two hundred fifty-five patients with
lymphoma
had their disease staged using (18)F-FDG-PET, and 191 of those patients also were assessed using gallium-67 scintigraphy ((67)Ga).
The results of these conventional imaging modalities were compared with the results from (8)F-FDG-PET and (67)Ga, and correlations between the imaging results and pathologic diagnoses were evaluated by using the World Health Organization
classification
system.
RESULTS: Of 913 disease sites in 255 patients, (18)F-FDG-PET identified >97% of disease sites of Hodgkin
lymphoma
(HL) and aggressive and highly aggressive non-Hodgkin
lymphoma
.
For indolent
lymphoma
, the detection rate of (18)F-FDG-PET was 91% for follicular
lymphoma
(FL); 82% for extranodal marginal zone B-
cell lymphoma
of mucosa-associated lymphoid tissue, irrespective of plasmacytic differentiation; and approximately 50% for
small lymphocytic lymphoma
(
SLL
) and splenic marginal zone
lymphoma
(SMZL).
However, the sensitivity of (67)Ga was unexpectedly poor for FL, for mantle
cell lymphoma
(MCL), and for the nasal
type
of natural killer/T-
cell lymphoma
(NK/T-nasal), ranging from 30% to 38%.
CONCLUSIONS: (18)F-FDG-PET was useful for all histologic subtypes of
lymphoma
other than
SLL
and SMZL.
[MeSH-major]
Fluorodeoxyglucose F18. Gallium Radioisotopes. Hodgkin Disease / radionuclide imaging.
Lymphoma
, Non-Hodgkin / radionuclide imaging. Radiopharmaceuticals. Tomography, Emission-Computed / methods
[MeSH-minor]
Diagnosis
, Differential. Humans.
Neoplasm
Staging / methods. Sensitivity and Specificity. World Health Organization
MedlinePlus Health Information.
consumer health - Hodgkin Disease
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
(c) 2007 American Cancer Society.
(PMID = 17582800.001).
[ISSN]
0008-543X
[Journal-full-title]
Cancer
[ISO-abbreviation]
Cancer
[Language]
eng
[Publication-type]
Comparative Study; Evaluation Studies; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Gallium Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
45.
Levitt MJ, Gharibo M, Strair R, Schaar D, Rubin A, Bertino JR:
Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
J Chemother
; 2009 Aug;21(4):434-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Accelerated R-COP: a pilot study for the treatment of advanced low grade
lymphomas
that has a high complete response rate.
This pilot study tested the hypothesis that dose intensity/dose density treatment may improve the response rate and remission duration in patients with advanced low grade
lymphomas
. ten patients with low grade
lymphomas
: follicular
lymphoma
grades I and II, marginal zone
lymphoma
, and
small cell lymphocytic lymphoma
with progressive disease were studied.
This program is
well
tolerated with a high CR rate, and may serve
as a
basis for future trials.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ drug therapy.
Lymphoma
, B-
Cell
, Marginal Zone / drug therapy.
Lymphoma
, Follicular / drug therapy.
Lymphoma
, Non-Hodgkin / drug therapy
[MeSH-minor]
Adult. Aged. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Murine-Derived. Cyclophosphamide / administration & dosage. Female. Granulocyte Colony-Stimulating Factor / administration & dosage. Humans. Male. Middle Aged.
Neoplasm
Staging. Pilot Projects. Prednisone / administration & dosage. Prognosis. Rituximab. Treatment Outcome. Vincristine / administration & dosage
Hazardous Substances Data Bank.
RITUXIMAB
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
Hazardous Substances Data Bank.
PREDNISONE
.
Hazardous Substances Data Bank.
VINCRISTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19622463.001).
[ISSN]
1973-9478
[Journal-full-title]
Journal of chemotherapy (Florence, Italy)
[ISO-abbreviation]
J Chemother
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / CA 5-P30-CA 072720-13
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural
[Publication-country]
Italy
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 143011-72-7 / Granulocyte Colony-Stimulating Factor; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone
46.
Jalil A, Amir S, Majeed R, Jalil F:
Circulating leptin levels in elderly subjects with and without cerebrovasular disease.
J Coll Physicians Surg Pak
; 2010 May;20(5):350-1
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Circulating
leptin levels
in elderly subjects with and without cerebrovasular disease.
Serum
concentrations of
leptin
was investigated in 40 patients with ischemic stroke, in context of the size of the lesion and also in 40 non-diseased controls, matched according to age, gender and waist hip ratio.
Serum leptin
concentrations were determined in ng/ml with ELISA and computer tomography (CT) scan was performed in patients to estimate lesion size in cms.
Serum leptin
concentrations were found to be significantly higher (p < 0.001) in stroke patients (51.61+1.39), compared with controls (37.76+1.207).
Moreover, positive correlation (r=0.93) existed between
serum leptin level
and infarction size in patients with stroke.
[MeSH-major]
Cerebrovascular Disorders / blood.
Leptin
/ blood
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20642935.001).
[ISSN]
1022-386X
[Journal-full-title]
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
[ISO-abbreviation]
J Coll Physicians Surg Pak
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Pakistan
[Chemical-registry-number]
0 / Blood Glucose; 0 / Leptin
47.
O'Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, MacGregor-Cortelli B, Curly T, Moskowitz C, Portlock C, Horwitz S, Zelenetz AD, Frankel S, Richon V, Marks P, Kelly WK:
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.
J Clin Oncol
; 2006 Jan 1;24(1):166-73
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The spectrum of diseases included patients with
diffuse
large B-
cell lymphoma
(n = 12), Hodgkin's disease (HD; n = 12), multiple myeloma (n = 2), T-
cell lymphoma
(n = 3), mantle
cell lymphoma
(n = 2),
small lymphocytic lymphoma
(n = 2), and myeloid leukemia (n = 2).
One patient with transformed
small lymphocytic lymphoma
met criteria for complete response, whereas another met the criteria for partial response (PR).
CONCLUSION: These results suggest that SAHA has activity in hematologic malignancies including HD and select subtypes of non-Hodgkin's
lymphoma
.
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
COS Scholar Universe.
author profiles
.
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
Faculty of 1000.
commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine.
(subscription/membership/fee required).
Hazardous Substances Data Bank.
Vorinostat
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16330674.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / P30-CA-08748
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Antineoplastic Agents; 0 / Enzyme Inhibitors; 0 / Histone Deacetylase Inhibitors; 0 / Hydroxamic Acids; 58IFB293JI / vorinostat
48.
Ioannou GN, Weiss NS, Kearney DJ:
Is Helicobacter pylori seropositivity related to body mass index in the United States?
Aliment Pharmacol Ther
; 2005 Mar 15;21(6):765-72
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BACKGROUND: Helicobacter pylori infection may decrease
serum
ghrelin and increase gastric
leptin levels
, which may, in turn, decrease body mass index.
METHODS:
Serum
H. pylori and cytotoxin-associated gene product A (CagA) antibody
levels
were measured on 6724 adult participants of the third National Health and Nutrition Examination Survey (1988-91).
We also investigated whether H. pylori/cytotoxin-associated gene product A antibody status was associated with fasting
serum leptin levels
.
RESULTS: H. pylori/CagA antibody status was not associated with obesity (body mass index > or = 30 kg/m(2)) [adjusted odds ratio (OR) 1.2, 95% CI: 0.9-1.6 comparing (+/+) to (-/-) and adjusted OR 1.1, 95% CI: 0.8-1.5 comparing (+/-) to (-/-)], overweight (body mass index 25 to <30 kg/m(2)) [adjusted OR 1.0, 95% CI: 0.7-1.2 comparing (+/+) to (-/-) and adjusted OR 1.0, 95% CI: 0.8-1.3 comparing (+/-) to (-/-)], or fasting
serum leptin level
in the USA population.
CONCLUSIONS: H. pylori seropositivity and CagA antibody status are not associated with body mass index or fasting
serum leptin level
.
[MeSH-minor]
Adult. Aged. Antigens, Bacterial / blood. Bacterial Proteins / blood. Enzyme-Linked Immunosorbent Assay. Epidemiologic Methods. Female. Humans.
Leptin
/ blood. Male. Middle Aged. Obesity / blood. Obesity / epidemiology. Obesity / ethnology. United States / epidemiology
MedlinePlus Health Information.
consumer health - Helicobacter Pylori Infections
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15771763.001).
[ISSN]
0269-2813
[Journal-full-title]
Alimentary pharmacology & therapeutics
[ISO-abbreviation]
Aliment. Pharmacol. Ther.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Antigens, Bacterial; 0 / Bacterial Proteins; 0 / Leptin; 0 / cagA protein, Helicobacter pylori
49.
Axelsson J, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P, Bárány P:
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
Am J Kidney Dis
; 2005 Oct;46(4):628-34
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Body fat mass and
serum leptin levels
influence epoetin sensitivity in patients with ESRD.
Furthermore, the adipokine
leptin
stimulates human erythroid development in vitro.
In the present study, we investigate the impact of fat mass and
leptin level
on epoetin sensitivity in patients with ESRD.
Body composition was analyzed by dual-energy X-ray absorptiometry and correlated with
serum
markers of inflammation and
leptin
(analyzed by enzyme-linked immunosorbent assays),
as well
as with epoetin dose, in international units administered per week (IU/wk).
To correct for differences in body mass and hemoglobin (Hb)
levels
, epoetin sensitivity was approximated as epoetin/Hb ratio, ie, epoetin dose per unit of Hb (IU/wk/g/dL) and epoetin/Hb/kg ratio, ie, epoetin dose per unit of Hb and kilogram of patient body weight (IU/wk/Hb/kg).
The 3 groups had significantly different
serum levels
of high-sensitivity C-reactive protein (hsCRP; median, 8.6 versus 3.1 and 8.0 mg/L, respectively; P < 0.05), neopterin (median, 112.4 versus 94.3 and 96.1 ng/L, respectively; P < 0.05), and IL-6 (median, 6.8 versus 4.1 and 6.5 ng/mL, respectively; P < 0.05).
Significant between-group differences also were found in fat mass and
leptin levels
(median, 14.8 versus 10.5 and 7.9 ng/mL, respectively; P = 0.02).
In univariate analyses, significant relationships between epoetin sensitivity indices,
leptin levels
, and
levels
of the inflammatory markers hsCRP and IL-6 were found.
In a multivariate stepwise regression model, log ferritin, parathyroid hormone, log
leptin
, log IL-6, and polycystic kidney disease were significantly associated with the epoetin/Hb ratio.
CONCLUSION: The present study shows that
leptin level
may be a predictor of epoetin sensitivity.
Although truncal fat is associated with secretion of proinflammatory cytokines, this secretion appears not to have inhibitory effects on epoetin sensitivity in the presence of high
leptin levels
.
[MeSH-major]
Adipose Tissue / pathology. Anemia / drug therapy. Body Composition. Erythropoiesis / drug effects. Erythropoietin / analogs & derivatives. Kidney Failure, Chronic / complications.
Leptin
/ blood
MedlinePlus Health Information.
consumer health - Anemia
.
MedlinePlus Health Information.
consumer health - Kidney Failure
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
DARBEPOETIN ALFA
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Am J Kidney Dis. 2006 Feb;47(2):371; author reply 372
[
16431269.001
]
(PMID = 16183417.001).
[ISSN]
1523-6838
[Journal-full-title]
American journal of kidney diseases : the official journal of the National Kidney Foundation
[ISO-abbreviation]
Am. J. Kidney Dis.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Hemoglobins; 0 / Interleukin-6; 0 / Leptin; 11096-26-7 / Erythropoietin; 15UQ94PT4P / Darbepoetin alfa; 9007-41-4 / C-Reactive Protein; 9007-73-2 / Ferritins
50.
Hirosawa M, Minata M, Harada KH, Hitomi T, Krust A, Koizumi A:
Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin.
Biochem Biophys Res Commun
; 2008 Jun 27;371(2):320-3
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by
leptin
and insulin.
Ovariectomized diabetic (AFO) and nondiabetic (B6FO) mice had significantly lower food intake and elevated
serum leptin levels
.
ERaKOAkt and ERaKO mice also increased
serum leptin
concentrations, while hypoinsulinemia was observed in ERaKOAkt and hyperinsulinemia in ERaKO mice.
RT-PCR showed a significant attenuation of POMC expression in both ERaKOAkt and ERaKO mice, irrespective of the elevated
leptin serum levels
or hyperinsulinemia, while elevated
serum leptin levels
in AFO and B6FO mice upregulated POMC gene expression.
These results indicate that ERalpha plays an essential role in
leptin
- and insulin-stimulated upregulation of the POMC gene.
[MeSH-major]
Estrogen Receptor alpha / physiology. Gene Expression Regulation. Hyperphagia / genetics. Insulin / metabolism.
Leptin
/ metabolism. Pro-Opiomelanocortin / genetics
MedlinePlus Health Information.
consumer health - Diabetes Medicines
.
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18439911.001).
[ISSN]
1090-2104
[Journal-full-title]
Biochemical and biophysical research communications
[ISO-abbreviation]
Biochem. Biophys. Res. Commun.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Estrogen Receptor alpha; 0 / Insulin; 0 / Leptin; 66796-54-1 / Pro-Opiomelanocortin
51.
Wang HC, Yang YK, Chen PS, Lee IH, Yeh TL, Lu RB:
Increased plasma leptin in antipsychotic-naïve females with schizophrenia, but not in males.
Neuropsychobiology
; 2007;56(4):213-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Increased plasma
leptin
in antipsychotic-naïve females with schizophrenia, but not in males.
BACKGROUND: Metabolic abnormalities, including insulin resistance and increased
leptin levels
, were noted in patients with schizophrenia who had received antipsychotics.
In this study, we examined the
leptin levels
of antipsychotic-naïve schizophrenic patients.
Serum leptin levels
of the healthy controls and antipsychotic-naïve patients were compared.
The relationships between
leptin level
and gender, Positive and Negative Syndrome Scale score, and duration of illness were analyzed by Spearman's correlation.
RESULTS: Compared with sex-, age- and BMI-matched subjects, the female schizophrenic patients had elevated
serum leptin levels
.
In the male patients, the results of this preliminary study also revealed a positive correlation between
leptin levels
and the Aggression Risk Profile subscale of the PANSS.
CONCLUSION: This preliminary study suggests possible gender-specific
leptin
dysregulation in antipsychotic-naïve schizophrenic patients.
[MeSH-major]
Leptin
/ blood. Schizophrenia / blood. Sex Characteristics
Genetic Alliance.
consumer health - Schizophrenia
.
MedlinePlus Health Information.
consumer health - Schizophrenia
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2008 S. Karger AG, Basel.
(PMID = 18382119.001).
[ISSN]
1423-0224
[Journal-full-title]
Neuropsychobiology
[ISO-abbreviation]
Neuropsychobiology
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
Switzerland
[Chemical-registry-number]
0 / Leptin
52.
Zent CS, Kay NE:
Autoimmune complications in chronic lymphocytic leukaemia (CLL).
Best Pract Res Clin Haematol
; 2010 Mar;23(1):47-59
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Autoimmune complications in chronic
lymphocytic
leukaemia (CLL).
Patients with B-chronic
lymphocytic
leukaemia /
small lymphocytic lymphoma
(CLL) have a 5-10% risk of developing autoimmune complications, which primarily cause cytopaenia.
The most common autoimmune complication is autoimmune haemolytic anaemia with a lower frequency of immune thrombocytopaenia and pure red blood
cell
aplasia and only rarely, autoimmune granulocytopaenia (AIG).
Autoimmune cytopaenia should always be considered in the differential
diagnosis
of cytopaenia in patients with CLL.
Optimal therapy will depend on a timely and accurate
diagnosis
of autoimmune cytopaenia and should be individualised according to the severity of the cytopaenia and the presence or absence of concomitant progressive CLL requiring therapy.
MedlinePlus Health Information.
consumer health - Autoimmune Diseases
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2010 Elsevier Ltd. All rights reserved.
[Cites]
Am J Hematol. 1999 Jun;61(2):98-102
[
10367787.001
]
[Cites]
Br J Haematol. 1999 Jul;106(1):261-2
[
10444204.001
]
[Cites]
Br J Haematol. 1999 Sep;106(3):836-7
[
10469479.001
]
[Cites]
Am J Med. 1955 Jun;18(6):961-89
[
14376415.001
]
[Cites]
Blood. 1956 Jul;11(7):648-64
[
13328945.001
]
[Cites]
Am J Hematol. 2004 Dec;77(4):413-5
[
15551407.001
]
[Cites]
Blood. 2000 May 1;95(9):2786-92
[
10779422.001
]
[Cites]
Clin Cancer Res. 2001 Apr;7(4):791-4
[
11309323.001
]
[Cites]
Cancer. 2001 Sep 1;92(5):1325-30
[
11571749.001
]
[Cites]
Cancer. 2001 Oct 15;92(8):2016-22
[
11596014.001
]
[Cites]
Blood. 2002 Feb 1;99(3):1092-4
[
11807020.001
]
[Cites]
Am J Hematol. 2002 Apr;69(4):258-71
[
11921020.001
]
[Cites]
Blood. 2002 Jul 15;100(2):635-9
[
12091358.001
]
[Cites]
Leukemia. 2002 Oct;16(10):2092-5
[
12357362.001
]
[Cites]
Hematol J. 2002;3(6):299-301
[
12522452.001
]
[Cites]
Eur J Haematol. 2003 May;70(5):319-21
[
12694169.001
]
[Cites]
Blood. 2007 Jan 15;109(2):405-11
[
17008537.001
]
[Cites]
Leukemia. 2007 Mar;21(3):511-4
[
17215854.001
]
[Cites]
J Clin Oncol. 2007 Mar 1;25(7):793-8
[
17283364.001
]
[Cites]
Br J Haematol. 2007 Mar;136(6):800-5
[
17341265.001
]
[Cites]
Leuk Lymphoma. 2007 Dec;48(12):2412-7
[
18067017.001
]
[Cites]
Haematologica. 2008 Jan;93(1):151-2
[
18166805.001
]
[Cites]
Blood. 2008 Jan 15;111(2):680-7
[
17761830.001
]
[Cites]
Blood. 2008 Feb 1;111(3):1110-6
[
17986663.001
]
[Cites]
Blood. 2008 Feb 15;111(4):1820-6
[
18055869.001
]
[Cites]
Blood Rev. 2008 Jan;22(1):17-31
[
17904259.001
]
[Cites]
Br J Haematol. 2008 May;141(5):615-21
[
18373706.001
]
[Cites]
Blood. 2008 Jun 15;111(12):5446-56
[
18216293.001
]
[Cites]
Blood. 2008 Aug 15;112(4):1325-8
[
18420827.001
]
[Cites]
J Immunol. 2008 Sep 1;181(5):3674-83
[
18714043.001
]
[Cites]
Br J Haematol. 2008 Oct;143(1):16-26
[
18573111.001
]
[Cites]
Leuk Res. 2009 Mar;33(3):366-7
[
18930543.001
]
[Cites]
Blood. 2009 Apr 2;113(14):3154-60
[
19096013.001
]
[Cites]
Leuk Lymphoma. 2009 Jun;50(6):892-9
[
19391041.001
]
[Cites]
Leuk Lymphoma. 2009 Jun;50(6):863-4
[
19455465.001
]
[Cites]
Am J Hematol. 2003 Sep;74(1):1-8
[
12949883.001
]
[Cites]
Br J Haematol. 2003 Oct;123(2):278-81
[
14531909.001
]
[Cites]
Mayo Clin Proc. 2003 Nov;78(11):1340-6
[
14601692.001
]
[Cites]
Leuk Lymphoma. 2003 Nov;44(11):1951-5
[
14738149.001
]
[Cites]
Clin Exp Immunol. 1966 Jan;1(1):3-11
[
5953036.001
]
[Cites]
Blood. 1967 Apr;29(4):Suppl:566-84
[
6022294.001
]
[Cites]
Blood. 1975 Aug;46(2):219-34
[
1139039.001
]
[Cites]
J Exp Med. 1980 Dec 1;152(6):1484-96
[
6969771.001
]
[Cites]
Cancer. 1981 Jul 1;48(1):198-206
[
7237385.001
]
[Cites]
Cancer. 1983 Mar 1;51(5):844-50
[
6821851.001
]
[Cites]
J Clin Pathol. 1986 Jul;39(7):713-6
[
3488334.001
]
[Cites]
J Autoimmun. 1988 Oct;1(5):469-81
[
2473761.001
]
[Cites]
Am J Hematol. 1992 Sep;41(1):5-12
[
1503099.001
]
[Cites]
Am J Med. 1992 Oct;93(4):435-40
[
1415307.001
]
[Cites]
J Clin Invest. 1993 Apr;91(4):1672-80
[
8473510.001
]
[Cites]
Leuk Lymphoma. 1993 Jan;9(1-2):149-51
[
8477195.001
]
[Cites]
Blood. 1993 May 15;81(10):2475-87
[
8490163.001
]
[Cites]
Lancet. 1993 Aug 28;342(8870):555
[
8102691.001
]
[Cites]
N Engl J Med. 1994 Jun 2;330(22):1560-4
[
8177245.001
]
[Cites]
Clin Exp Immunol. 1994 May;96(2):297-302
[
8187337.001
]
[Cites]
Am J Hematol. 1994 Aug;46(4):375-6
[
8037200.001
]
[Cites]
Blood. 1994 Aug 15;84(4):1216-9
[
8049436.001
]
[Cites]
Leuk Lymphoma. 1994 Sep;15(1-2):187-8
[
7858499.001
]
[Cites]
Ann Oncol. 1995 Mar;6(3):300-1
[
7612497.001
]
[Cites]
Br J Haematol. 1995 Oct;91(2):341-4
[
8547072.001
]
[Cites]
Blood. 1996 May 1;87(9):3869-76
[
8611714.001
]
[Cites]
Eur J Haematol. 1997 Feb;58(2):109-13
[
9111592.001
]
[Cites]
Hematol J. 2004;5(6):546-7
[
15570303.001
]
[Cites]
J Thromb Haemost. 2005 Jan;3(1):74-8
[
15634268.001
]
[Cites]
Blood. 2005 Feb 15;105(4):1417-23
[
15494430.001
]
[Cites]
Blood. 2005 Mar 1;105(5):2007-15
[
15284121.001
]
[Cites]
Autoimmun Rev. 2005 Jun;4(5):264-9
[
15990072.001
]
[Cites]
Blood. 2005 Sep 15;106(6):2018-25
[
15914560.001
]
[Cites]
Curr Opin Immunol. 2005 Dec;17(6):638-42
[
16209918.001
]
[Cites]
Leuk Res. 2006 Jan;30(1):109-14
[
16043218.001
]
[Cites]
Blood. 2006 Jan 1;107(1):265-76
[
16150940.001
]
[Cites]
Blood. 2006 Feb 1;107(3):885-91
[
16219797.001
]
[Cites]
Semin Oncol. 2006 Apr;33(2):230-9
[
16616070.001
]
[Cites]
Blood. 2006 Jul 1;108(1):292-6
[
16527887.001
]
[Cites]
Am J Hematol. 2006 Aug;81(8):598-602
[
16823816.001
]
[Cites]
Haematologica. 2006 Dec;91(12):1689-92
[
17145607.001
]
[Cites]
Cancer Res. 2009 Jul 1;69(13):5424-32
[
19549911.001
]
[Cites]
Leuk Res. 2009 Nov;33(11):1452-3
[
19632721.001
]
[Cites]
Leuk Lymphoma. 2009 Aug;50(8):1261-8
[
19811329.001
]
[Cites]
Blood. 1997 Oct 1;90(7):2701-15
[
9326237.001
]
[Cites]
Semin Oncol. 1998 Feb;25(1):80-97
[
9482530.001
]
[Cites]
J Clin Oncol. 1998 May;16(5):1885-9
[
9586905.001
]
[Cites]
Br J Haematol. 1999 Mar;104(3):442-7
[
10086776.001
]
(PMID = 20620970.001).
[ISSN]
1532-1924
[Journal-full-title]
Best practice & research. Clinical haematology
[ISO-abbreviation]
Best Pract Res Clin Haematol
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / CA097274-01; United States / NCI NIH HHS / CA / P50 CA097274; United States / NCI NIH HHS / CA / CA97274; United States / NCI NIH HHS / CA / P50 CA097274-01
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Review
[Publication-country]
Netherlands
[Number-of-references]
84
[Other-IDs]
NLM/ NIHMS174960; NLM/ PMC2909690
53.
Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, Hayakawa M:
Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.
J Urol
; 2006 Oct;176(4 Pt 1):1631-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Increased
serum leptin levels
and over expression of
leptin
receptors are associated with the invasion and progression of renal
cell
carcinoma.
PURPOSE:
Leptin
, an adipocyte derived cytokine that is closely associated with obesity, was recently shown to be involved in carcinogenesis and cancer progression.
Because obesity is a significant risk factor for renal
cell
carcinoma, we investigated the link between
leptin
and the development of renal
cell
carcinoma.
MATERIALS AND METHODS: Associations between preoperative
serum leptin levels
and
leptin
receptor expression in tumor specimens and various clinicopathological parameters were analyzed in 57 patients with renal
cell
carcinoma.
RESULTS:
Serum leptin levels
were 1.2 to 16.2 ng/ml (mean 4.5).
Of 57 tumors 22 (38.6%) demonstrated high
leptin
receptor expression.
Serum leptin levels
were significantly higher in patients with vs without tumor specimen venous invasion (p = 0.030) and higher in patients with high vs low
leptin
receptor expression (p = 0.019).
There were significant associations between high
leptin
receptor expression and the presence of venous invasion (p = 0.013), histological
type
(p = 0.0076) and regional
lymph
node metastasis (p = 0.047).
Of 42 patients with N0M0 disease those with
serum leptin
5.0 ng/ml or more had significantly shorter progression-free survival than patients with lower
levels
(p = 0.0043).
Multivariate Cox proportional hazards model analysis demonstrated that higher
serum leptin
was an independent predictor of progression-free survival (p = 0.0406).
CONCLUSIONS:
Leptin
and
leptin
receptor could have a key role in the invasion of renal
cell
carcinoma and they could be valuable predictors of progression.
[MeSH-major]
Carcinoma, Renal
Cell
/ metabolism. Carcinoma, Renal
Cell
/ pathology. Kidney Neoplasms / metabolism. Kidney Neoplasms / pathology.
Leptin
/ blood. Receptors,
Cell
Surface / metabolism
[MeSH-minor]
Adult. Aged. Body Mass Index. Disease-Free Survival. Female. Humans. Male. Middle Aged.
Neoplasm
Invasiveness. Receptors,
Leptin
. Treatment Outcome
Genetic Alliance.
consumer health - Renal cell carcinoma
.
MedlinePlus Health Information.
consumer health - Kidney Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16952705.001).
[ISSN]
0022-5347
[Journal-full-title]
The Journal of urology
[ISO-abbreviation]
J. Urol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin; 0 / Receptors, Cell Surface; 0 / Receptors, Leptin; 0 / leptin receptor, human
54.
Gharote HP, Mody RN:
Estimation of serum leptin in oral squamous cell carcinoma.
J Oral Pathol Med
; 2010 Jan;39(1):69-73
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Estimation of
serum leptin
in oral squamous
cell
carcinoma.
Leptin
, a homologous protein of cytokine family, is found to be decreased in
serum
with cachexia.
The purpose of this study was to compare
serum leptin levels
of oral squamous
cell
carcinoma patients with that of control group and correlate it with body mass index.
METHOD:
Serum
samples of 31 oral squamous
cell
carcinoma patients and that of 28 healthy individuals were subjected to evaluation of
serum leptin levels
(ng/ml) using enzyme-linked immunosorbent assay.
RESULTS: A significant reduction in
leptin level
of oral squamous
cell
carcinoma patients was observed.
Definite correlation between body mass index and
serum leptin
and also between
serum leptin levels
of various histopathological variants of oral squamous
cell
carcinoma was observed.
CONCLUSION: The results of this study suggest that evaluation of
serum leptin level
can provide status of cachexia in oral squamous
cell
carcinoma patients.
[MeSH-major]
Carcinoma, Squamous
Cell
/ blood.
Leptin
/ blood. Mouth Neoplasms / blood
[MeSH-minor]
Adult. Age Factors. Aged. Area Under Curve. Biomarkers / blood. Body Mass Index. Cachexia / blood. Female. Humans. Male. Middle Aged.
Neoplasm
Staging. ROC Curve. Sensitivity and Specificity. Sex Factors. Young Adult
Genetic Alliance.
consumer health - Carcinoma, Squamous Cell
.
Genetic Alliance.
consumer health - Oral squamous cell carcinoma
.
MedlinePlus Health Information.
consumer health - Oral Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19817969.001).
[ISSN]
1600-0714
[Journal-full-title]
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
[ISO-abbreviation]
J. Oral Pathol. Med.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
Denmark
[Chemical-registry-number]
0 / Biomarkers; 0 / Leptin
55.
Mendoza-Núñez VM, Correa-Muñoz E, Garfias-Cruz EA, Sánchez-Rodriguez MA, Galván-Duarte RE, Retana-Ugalde R:
Hyperleptinemia as a risk factor for high blood pressure in the elderly.
Arch Pathol Lab Med
; 2006 Feb;130(2):170-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Hyperleptinemia
as a
risk factor for high blood pressure in the elderly.
CONTEXT: Studies have demonstrated that high
serum leptin levels
are associated with aging.
We measured
serum leptin levels
through the radioimmunoassay method.
RESULTS: The elderly subjects with HBP had significantly higher
leptin levels
than the healthy elderly subjects (P = .02).
Furthermore, in female elderly subjects we observed a statistically significant correlation between systolic blood pressure and
leptin
(r = 0.37, P = .003),
as well
as systolic blood pressure and age (r = 0.29, P = .02), but not with diastolic blood pressure.
In male elderly subjects, there was no correlation between
leptin
and systolic blood pressure or
leptin
and diastolic blood pressure.
[MeSH-major]
Hypertension / blood.
Leptin
/ blood
MedlinePlus Health Information.
consumer health - High Blood Pressure
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16454556.001).
[ISSN]
1543-2165
[Journal-full-title]
Archives of pathology & laboratory medicine
[ISO-abbreviation]
Arch. Pathol. Lab. Med.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin
56.
Ly M, Belli E, Leobon B, Kortas C, Grollmüss OE, Piot D, Planché C, Serraf A:
Results of the double switch operation for congenitally corrected transposition of the great arteries.
Eur J Cardiothorac Surg
; 2009 May;35(5):879-83; discussion 883-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Segmental anatomy was {
SLL
} in all patients, dextrocardia in two patients, mesocardia in two patients.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19346135.001).
[ISSN]
1873-734X
[Journal-full-title]
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
[ISO-abbreviation]
Eur J Cardiothorac Surg
[Language]
eng
[Publication-type]
Evaluation Studies; Journal Article
[Publication-country]
Germany
57.
Brito N, Fonseca M, Dinis I, Mirante A:
Metabolic factors in obesity.
J Pediatr Endocrinol Metab
; 2010 Jan-Feb;23(1-2):97-100
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Leptin
is an important hormone involved in the pathogenesis of obesity and has been under investigation
as a
risk marker for future complications. AIMS: 1.
To evaluate the relation between
serum leptin levels
and body mass index (BMI) and height.
2. To compare
leptin levels
in obese and non-obese children.
3. To evaluate the relation between
leptin levels
and insulin resistance index.
In the obese group we assessed sex, age, BMI SDS and height SDS for age and sex, and
serum levels
of glucose, insulin and
leptin
.
In the control group were obtained BMI SDS and height SDS for age and sex and
leptin levels
.
Leptin levels
showed a positive correlation with BMI SDS (r = 0.69; p < 0.001) and height SDS (r = 0.31; p < 0.001).
When comparing
leptin levels
between obese and non-obese groups, we found a significant difference in boys (50.7 +/- 27.3 versus 7.0 +/- 6.8 ng/ml; p < 0.001) and in girls (57.6 +/- 25.5 versus 16.5 +/- 10.3 ng/ml; p < 0.001).
In the nonobese group,
leptin levels
were lower in boys.
Leptin
showed a positive correlation with insulin resistance index in boys (r = 0.45, p = 0.05), but not in girls.
CONCLUSIONS: This study has confirmed a positive correlation between
leptin levels
and BMI SDS.
In obese children elevated
leptin
is associated with central resistance to its action.
The positive correlation of
leptin
with insulin resistance index may suggest a major role of
leptin
in insulin resistance.
[MeSH-major]
Blood Glucose / metabolism. Insulin Resistance.
Leptin
/ blood. Obesity / epidemiology. Obesity / metabolism
Genetic Alliance.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Blood Sugar
.
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity in Children
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20432812.001).
[ISSN]
0334-018X
[Journal-full-title]
Journal of pediatric endocrinology & metabolism : JPEM
[ISO-abbreviation]
J. Pediatr. Endocrinol. Metab.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
0 / Blood Glucose; 0 / Insulin; 0 / Leptin
58.
Chang HH, Gean PW, Chou CH, Yang YK, Tsai HC, Lu RB, Chen PS:
C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients.
J Clin Psychopharmacol
; 2010 Oct;30(5):512-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar
disorder
patients.
BACKGROUND: Valproate (VPA) is a mood stabilizer for treating patients with bipolar
disorder
(BD).
RESULTS: The variation of GNB3 C825T showed an association with higher plasma total cholesterol (P = 0.037), triglyceride (P = 0.014), and
leptin
(P < 0.001)
levels
in BD patients treated with VPA.
After adjusting for age, sex, types of BDs, and
serum
concentration of VPA, the variation of GNB3 C825T remained significantly associated with the
levels
of
serum leptin
and body mass index (BMI; P < 0.001 and P = 0.030, respectively).
In addition, the GNB3 C825T showed significant drug-single-nucleotide polymorphism interactions with insulin
levels
(P = 0.033), triglyceride
levels
(P = 0.013),
leptin levels
(P = 0.013), and BMI (P = 0.018).
These results indicated that the T allele may be associated with lower
serum leptin levels
and BMI in BD patients treated with VPA.
[MeSH-major]
Alleles. Bipolar
Disorder
/ genetics. Bipolar
Disorder
/ metabolism. Heterotrimeric GTP-Binding Proteins / genetics. Polymorphism, Single Nucleotide / genetics. Protein Subunits / genetics. Valproic Acid / adverse effects
[MeSH-minor]
Adult. Body Mass Index. Female. Heterozygote Detection. Humans.
Leptin
/ blood. Male. Middle Aged. Young Adult
Genetic Alliance.
consumer health - Bipolar Disorder
.
MedlinePlus Health Information.
consumer health - Bipolar Disorder
.
Hazardous Substances Data Bank.
VALPROIC ACID
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20814328.001).
[ISSN]
1533-712X
[Journal-full-title]
Journal of clinical psychopharmacology
[ISO-abbreviation]
J Clin Psychopharmacol
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / G-protein beta3 subunit; 0 / Leptin; 0 / Protein Subunits; 614OI1Z5WI / Valproic Acid; EC 3.6.5.1 / Heterotrimeric GTP-Binding Proteins
59.
Peng Y, Wang HY, Molberg KH:
Cutaneous colocalized invasive poorly differentiated carcinoma and chronic lymphocytic leukemia/small lymphocytic lymphoma of the head and neck region: a case report and review of the literature.
Arch Otolaryngol Head Neck Surg
; 2009 Jun;135(6):606-10
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Cutaneous colocalized invasive poorly
differentiated
carcinoma and chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
of the head and neck region: a case report and review of the literature.
[MeSH-major]
Carcinoma, Squamous
Cell
/ secondary. Head and Neck Neoplasms / pathology. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ pathology. Skin Neoplasms / secondary
[MeSH-minor]
Antibodies, Monoclonal. DNA-Binding Proteins / metabolism. Dermis / pathology. Flow Cytometry. Humans. Immunohistochemistry. Immunophenotyping. Keratin-7 / metabolism.
Lymph
Node Excision. Lymphatic Metastasis. Male. Middle Aged.
Neoplasm
Invasiveness
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
MedlinePlus Health Information.
consumer health - Head and Neck Cancer
.
MedlinePlus Health Information.
consumer health - Skin Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19528411.001).
[ISSN]
1538-361X
[Journal-full-title]
Archives of otolaryngology--head & neck surgery
[ISO-abbreviation]
Arch. Otolaryngol. Head Neck Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / DNA-Binding Proteins; 0 / Keratin-7; 0 / TTF1 protein, human
[Number-of-references]
14
60.
Lin J, Yan GT, Gao XN, Liao J, Wang LH, Hao XH:
[Distribution of leptin expression and its effect on the recovery of sepsis-induced internal disorders].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 2008 May;39(3):360-3, 417
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Distribution of
leptin
expression and its effect on the recovery of sepsis-induced internal disorders].
OBJECTIVE: To explore the distribution of
leptin
expression and the effect of sepsis on
leptin
protein and mRNA
levels
.
The mRNA expressions of
leptin
in those samples were determined by RT-PCR.
Radioimmunoassay was applied to measure
serum leptin
concentrations in each group at 12 h after injury, while RT-PCR was also used to detect
Leptin
mRNA expressions in hypothalamus, fat and lung after injury.
RESULTS:
Leptin
mRNA expressions were confirmed in all the above nine vital organs, with the highest in kidney but the lowest in testis.
The
serum leptin level
showed no significant difference between sham operation group and other four groups.
Compared with sham operation group, the
Leptin
mRNA
level
in CLP group decreased significantly in hypothalamus, fat and lung, while that in the other three groups showed different changes.
The effect of intralipid on
Leptin
mRNA expression was found to be a dual-direction pattern, with central stimulation but peripheral inhibition.
CONCLUSION:
Leptin
is widely expressed in multiple vital organs, and it may be a protective factor to promote recovery of sepsis-induced internal disorders.
[MeSH-major]
Gene Expression Profiling.
Leptin
/ physiology. Sepsis / physiopathology
MedlinePlus Health Information.
consumer health - Sepsis
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18575315.001).
[ISSN]
1672-173X
[Journal-full-title]
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
[ISO-abbreviation]
Sichuan Da Xue Xue Bao Yi Xue Ban
[Language]
chi
[Publication-type]
English Abstract; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
China
[Chemical-registry-number]
0 / Leptin; 0 / RNA, Messenger
61.
Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, Keating MJ:
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
J Clin Oncol
; 2009 Feb 20;27(6):904-10
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Other malignancies in chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
.
PURPOSE: Other malignancies have been reported to occur with increased frequency in chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
(CLL/
SLL
).
The aim of this study was to determine the frequency, outcomes, and factors associated with other cancers in patients with CLL/
SLL
.
PATIENTS AND METHODS: We reviewed the records of consecutive patients with previously untreated CLL/
SLL
seen at The University of Texas M. D.
Overall, 625 cancers were observed in 551 patients, including skin (30%), prostate (13%), breast (9%), melanoma (8%),
lymphoma
(8%), gastrointestinal (9%), lung (6%), and other cancers (17%).
In Cox analysis, independent factors predicting development of new cancers were older age, male sex, and elevated
levels
of beta2-microglobulin, lactate dehydrogenase, and creatinine.
In patients who were treated for CLL/
SLL
, the treatment regimen did not affect the risk of subsequent cancer (P = .49).
CONCLUSION: Patients with CLL/
SLL
have more than twice the risk of developing a second cancer and an increased frequency of certain cancer types.
[MeSH-major]
Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ epidemiology. Neoplasms, Second Primary / epidemiology
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Natl Cancer Inst. 1978 Aug;61(2):337-40
[
277720.001
]
[Cites]
J Clin Oncol. 1999 Apr;17(4):1244
[
10561185.001
]
[Cites]
J Natl Cancer Inst. 1992 Sep 16;84(18):1422-7
[
1512794.001
]
[Cites]
Blood. 1993 Jun 1;81(11):2878-84
[
8499626.001
]
[Cites]
Leuk Res. 2005 Oct;29(10):1103-4
[
16111529.001
]
[Cites]
J Natl Cancer Inst. 1996 Mar 6;88(5):270-8
[
8614005.001
]
[Cites]
Ann Hematol. 2004 Jun;83(6):356-63
[
15024607.001
]
[Cites]
JAMA. 1975 Apr 21;232(3):267-9
[
47401.001
]
[Cites]
J Clin Oncol. 2007 Oct 10;25(29):4648-56
[
17925562.001
]
[Cites]
Cancer. 2004 Jun 15;100(12):2583-91
[
15197800.001
]
[Cites]
J Clin Oncol. 2005 Jun 20;23(18):4079-88
[
15767648.001
]
[Cites]
J Clin Oncol. 1999 Aug;17(8):2454-60
[
10561309.001
]
[Cites]
Blood. 1996 Jun 15;87(12):4990-7
[
8652811.001
]
[Cites]
J Clin Oncol. 1991 Jan;9(1):44-9
[
1702145.001
]
[Cites]
J Clin Oncol. 2001 Mar 1;19(5):1414-20
[
11230486.001
]
[Cites]
Blood. 2004 Nov 15;104(10):3064-71
[
15284112.001
]
[Cites]
Semin Oncol. 2000 Dec;27(6 Suppl 12):37-41
[
11225999.001
]
[Cites]
J Natl Cancer Inst. 2006 Jan 4;98(1):15-25
[
16391368.001
]
[Cites]
Blood. 1993 Sep 15;82(6):1695-700
[
8400226.001
]
(PMID = 19114699.001).
[ISSN]
1527-7755
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Other-IDs]
NLM/ PMC4979239
62.
Kartal O, Inal V, Baysan O, Sağlam K:
[Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Anadolu Kardiyol Derg
; 2008 Oct;8(5):342-6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Relationship between
serum leptin levels
and left ventricular hypertrophy in obese hypertensive patients].
[Transliterated title]
Sişman hipertansif hastalarda
leptin
düzeyleri ve sol ventrikül hipertrofisi ile ilişkisi.
OBJECTIVE: Previous studies showed relation between elevated
serum leptin levels
(
SLL
) and hypertension.
The aim of this study was to evaluate relationship between
SLL
and left ventricular hypertrophy (LVH) and body mass index (BMI) in obese hypertensive patients.
Hypertensive patients were classified as;
level
-I or
level
-II according to JNC-VII
classification
and as normal weighted (18-24.99 kg/m2), over weighted (25-26.99 kg/m2) and obese (27 kg/m2 and above) according to BMI's.
All the patients were evaluated by echocardiography and blood samples were withdrawn for determination
SLL
.
Logistic regression analysis was applied for the evaluation of relationship between
SLL
and clinical variables.
RESULTS: Mean
levels
of arterial blood pressure (ABP) of total 80 patients (36 males and 44 females) was 155+/-1.1/95.1+/-0.7 mmHg and the mean age was 48.9+/-1.3 years.
Patients with
level
I hypertension (n=32) had mean ABP of 149.7+/-0.5/90.9+/-0.6 mmHg and with
level
-II hypertension (n=48)--mean ABP 168.5+/-1.6/102.9+/-0.9 mmHg.
There were no differences in LVH incidence between hypertension
level
groups and BMI groups (p>0.05).
Serum leptin levels
were similar in patients with
level
I and
level
II hypertension (33.5+/-2.9 ng/ml and 37.3+/-3.6 ng/ml, respectively, p>0.05).
However,
leptin levels
were higher in obese patients as compared with normal and over weighted patients (40.9+/-3.2 ng/ml versus 28.5+/-3.6 ng/ml and 32.8+/-4.9 ng/ml, p<0.01).
Patients with LVH had significantly higher
levels
of
leptin as
compared with patients without LVH (51.40+/-5.1 ng/ml versus 28.30+/-4.20 ng/ml, p<0.05).
Logistic regression analysis demonstrated that
SLL
independently of blood pressure and BMI is related with LVH (OR--1.7, %95 CI--1.2-1.9, p<0.05).
CONCLUSION: Our study showed that elevated
serum leptin levels
are significantly related with LVH independently of body mass index and
level
of blood pressure.
Thus, elevated
SLLs
, independently of hypertension
level
and BMI
classification
, coexist with LVH.
Sympathetic activation or direct cardiac receptor activation or proliferative effects of
leptin
may be responsible for this coexistence.
[MeSH-major]
Hypertension / blood. Hypertrophy, Left Ventricular / blood. Hypertrophy, Left Ventricular / pathology.
Leptin
/ blood. Obesity / blood
MedlinePlus Health Information.
consumer health - High Blood Pressure
.
MedlinePlus Health Information.
consumer health - Obesity
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Anadolu Kardiyol Derg. 2008 Oct;8(5):347-9
[
18849225.001
]
(PMID = 18849224.001).
[ISSN]
1308-0032
[Journal-full-title]
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
[ISO-abbreviation]
Anadolu Kardiyol Derg
[Language]
tur
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Turkey
[Chemical-registry-number]
0 / Leptin
63.
Goy A, Younes A, McLaughlin P, Pro B, Romaguera JE, Hagemeister F, Fayad L, Dang NH, Samaniego F, Wang M, Broglio K, Samuels B, Gilles F, Sarris AH, Hart S, Trehu E, Schenkein D, Cabanillas F, Rodriguez AM:
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
J Clin Oncol
; 2005 Feb 1;23(4):667-75
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-
cell
non-Hodgkin's
lymphoma
.
PURPOSE: Evaluate efficacy and toxicity of bortezomib in patients with relapsed or refractory B-
cell
non-Hodgkin's
lymphoma
.
PATIENTS AND METHODS: Patients were stratified, based on preclinical data, into arm A (mantle-
cell lymphoma
) or arm B (other B-
cell
lymphomas
) without limitation in number of prior therapies.
RESULTS: Sixty patients with a median number of prior therapies of 3.5 (range, one to 12 therapies) were enrolled; 33 patients were in arm A and 27 were in arm B, including 12
diffuse
large B-
cell
lymphomas
, five follicular
lymphomas
(FL), three transformed FLs, four
small lymphocytic
lymphomas
(
SLL
), two Waldenstrom's macroglobulinemias (WM), and one marginal zone
lymphoma
.
In arm B, four of 21 assessable patients responded (one
SLL
patient had a CR, one FL patient had a CR unconfirmed, one
diffuse
large B-
cell lymphoma
patient had a PR, and one WM patient had a PR) for an ORR of 19% (95% CI, 5% to 42%).
CONCLUSION: Bortezomib showed promising activity in relapsed mantle-
cell lymphoma
and encouraging results in other B-
cell
lymphomas
.
[MeSH-major]
Antineoplastic Agents / therapeutic use. Boronic Acids / therapeutic use.
Lymphoma
, B-
Cell
/ drug therapy. Protease Inhibitors / therapeutic use. Pyrazines / therapeutic use
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
COS Scholar Universe.
author profiles
.
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
Hazardous Substances Data Bank.
BORTEZOMIB
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
J Clin Oncol. 2005 Feb 1;23(4):657-8
[
15613690.001
]
(PMID = 15613697.001).
[ISSN]
0732-183X
[Journal-full-title]
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
[ISO-abbreviation]
J. Clin. Oncol.
[Language]
eng
[Publication-type]
Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Antineoplastic Agents; 0 / Boronic Acids; 0 / Protease Inhibitors; 0 / Pyrazines; 69G8BD63PP / Bortezomib
64.
Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Takeda S:
Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy.
Fertil Steril
; 2008 May;89(5):1247-53
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
INTERVENTION(S): Video tape recording was performed during the second-look laparoscopy (
SLL
) to evaluate the postoperative uterine wound adhesions and adhesions around the uterine adnexa.
MAIN OUTCOME MEASURE(S): Evaluation of adhesions at the uterine wound and of
de
novo adhesions of the uterine adnexa by
SLL
.
RESULT(S): The
SLL
revealed uterine surgical wound adhesions in 141 patients (37.9%) and
de
novo adhesions of the uterine adnexa in 33 patients (8.9%).
The results of analysis to determine the factors influencing the development of postoperative adhesions revealed that the diameter of the largest myoma, number of myomas, and
type
of adhesion-preventing agent used (except for fibrin sheath, which had no effect) influenced the incidence of postoperative adhesions at the surgical wound, but only the diameter of the largest myoma influenced the incidence of
de
novo adhesions of the uterine adnexa.
MedlinePlus Health Information.
consumer health - After Surgery
.
MedlinePlus Health Information.
consumer health - Ovarian Disorders
.
MedlinePlus Health Information.
consumer health - Uterine Cancer
.
MedlinePlus Health Information.
consumer health - Uterine Fibroids
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18155700.001).
[ISSN]
1556-5653
[Journal-full-title]
Fertility and sterility
[ISO-abbreviation]
Fertil. Steril.
[Language]
eng
[Publication-type]
Clinical Trial; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Cellulose, Oxidized; 0 / Fibrin Tissue Adhesive; 0 / INTERCEED
65.
Xia D, Song Y, Li C, Zhang F, Wei M:
The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.
Front Med China
; 2007 Oct;1(4):352-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The change of
serum leptin
and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.
The aim of this paper was to investigate the change of
serum leptin
and its relationship with platelet membrane glycoprotein Ib (GP Ib) in patients with coronary heart disease (CHD).
Serum leptin
was detected by enzyme linked immunosorbent assay.
After correcting the differences of systolic blood pressure, body mass index (BMI), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), fasting glucose, PPBS, fasting insulin and quantitative insulin sensitive index,
serum leptin level
in the CHD group was significantly higher than that in the control group (P < 0.05).
Single factor correlative analysis revealed that
serum leptin
in CHD patients was negatively correlated with the average fluorescence intensity of platelet membrane GP Ib (P < 0.05).
Multifactorial stepwise regression analysis showed that
serum leptin
in CHD patients was independently negatively correlated with the average fluorescence intensity of platelet membrane GP Ib (P < 0.05).
Logistic analysis demonstrated that
serum leptin
was independently correlated with the risk of CHD (P < 0.05).
The increase of
serum leptin
could affect blood platelet activation.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Curr Opin Pharmacol. 2005 Apr;5(2):160-4
[
15780825.001
]
[Cites]
Trends Cardiovasc Med. 2004 Jan;14(1):18-22
[
14720470.001
]
[Cites]
J Clin Endocrinol Metab. 2004 Aug;89(8):3872-8
[
15292320.001
]
[Cites]
J Cell Biol. 2001 Aug 6;154(3):485-90
[
11489912.001
]
[Cites]
J Biol Chem. 2001 Jul 6;276(27):25096-100
[
11342529.001
]
[Cites]
FASEB J. 1999 Jul;13(10):1231-8
[
10385613.001
]
[Cites]
Med Hypotheses. 2006;67(1):82-6
[
16500036.001
]
[Cites]
Kobe J Med Sci. 2001 Jun;47(3):141-50
[
11729375.001
]
[Cites]
Int J Obes Relat Metab Disord. 2003 Jan;27(1):13-8
[
12532148.001
]
[Cites]
Eur Heart J. 2006 Oct;27(19):2294-9
[
16543250.001
]
[Cites]
Diabetes. 1999 Sep;48(9):1787-93
[
10480609.001
]
[Cites]
Circulation. 2001 Dec 18;104(25):3052-6
[
11748099.001
]
[Cites]
Nature. 1998 Feb 5;391(6667):591-4
[
9468137.001
]
[Cites]
Arterioscler Thromb Vasc Biol. 1998 Jun;18(6):928-33
[
9633933.001
]
[Cites]
Atherosclerosis. 2007 Apr;191(2):418-26
[
16712853.001
]
[Cites]
Blood. 1991 Feb 15;77(4):770-9
[
1704263.001
]
[Cites]
Diabetes Care. 1998 May;21(5):782-6
[
9589240.001
]
[Cites]
Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E695-702
[
15886225.001
]
[Cites]
Neurosci Lett. 2000 Oct 27;293(2):107-10
[
11027845.001
]
[Cites]
Diabetes. 2003 Aug;52(8):2121-8
[
12882931.001
]
[Cites]
Coron Artery Dis. 2003 Feb;14(1):65-79
[
12629328.001
]
[Cites]
J Thromb Haemost. 2005 May;3(5):1042-9
[
15869602.001
]
[Cites]
J Clin Invest. 1997 Jul 15;100(2):270-8
[
9218503.001
]
[Cites]
Clin Exp Immunol. 2006 Mar;143(3):452-7
[
16487244.001
]
[Cites]
Int J Obes Relat Metab Disord. 2001 Oct;25(10):1471-3
[
11673768.001
]
[Cites]
Coron Artery Dis. 2003 Aug;14(5):357-63
[
12878900.001
]
[Cites]
Diabet Med. 2005 Mar;22(3):278-85
[
15717875.001
]
[Cites]
Angiology. 2006 May-Jun;57(3):267-72
[
16703186.001
]
(PMID = 24573923.001).
[ISSN]
1673-7342
[Journal-full-title]
Frontiers of medicine in China
[ISO-abbreviation]
Front Med China
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
China
66.
Shen XH, Tang QY, Huang J, Cai W:
Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity.
Exp Biol Med (Maywood)
; 2010 Jan;235(1):47-51
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The aim of this study was to determine the effect of the antioxidant vitamin E (VE) on adiponectin and
leptin
expression in obese rats.
Blood and adipose tissues were then immediately collected; mRNA and protein
levels
of
leptin
and adiponectin were measured by realtime reverse transcription-polymerase chain reaction and Western blotting.
Biomarkers of oxidative stress, including
serum levels
of 8-epi-prostaglandin-F(2)alpha (8-epi-PGF(2)alpha) and glutathione peroxidase activity, were also examined.
Adiponectin and
leptin levels
were lower in the DIO group than in the control group.
VE intervention increased the expression of both
leptin
and adiponectin (P values < 0.05).
Association analysis showed that
serum leptin levels
correlated positively with body fat mass (r = 0.601, P < 0.05).
Both
serum leptin
and adiponectin
levels
were associated with the presence of
serum
8-epi-PGF2 alpha (
leptin
, r = 0.513, P < 0.05; adiponectin, r = -0.422, P < 0.05).
Administration of VE decreases
leptin
and adiponectin expression in obese rats.
[MeSH-major]
Adiponectin / blood. Adiponectin / genetics. Antioxidants / pharmacology.
Leptin
/ blood.
Leptin
/ genetics. Obesity / blood. Obesity / genetics. Vitamin E / pharmacology
MedlinePlus Health Information.
consumer health - Antioxidants
.
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Vitamin E
.
Gene Ontology.
gene/protein/disease-specific - Gene Ontology annotations from this paper
.
Hazardous Substances Data Bank.
PROSTAGLANDIN F2ALPHA
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20404018.001).
[ISSN]
1535-3699
[Journal-full-title]
Experimental biology and medicine (Maywood, N.J.)
[ISO-abbreviation]
Exp. Biol. Med. (Maywood)
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Adiponectin; 0 / Antioxidants; 0 / Biomarkers; 0 / DNA Primers; 0 / Dietary Fats; 0 / Leptin; 0 / RNA, Messenger; 1406-18-4 / Vitamin E; 27415-26-5 / 8-epi-prostaglandin F2alpha; B7IN85G1HY / Dinoprost; EC 1.11.1.9 / Glutathione Peroxidase
67.
Lassiter TL, Ryde IT, Levin ED, Seidler FJ, Slotkin TA:
Neonatal exposure to parathion alters lipid metabolism in adulthood: Interactions with dietary fat intake and implications for neurodevelopmental deficits.
Brain Res Bull
; 2010 Jan 15;81(1):85-91
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We assessed
serum leptin
and adiponectin, tumor necrosis factor-alpha (TNFalpha) in adipose tissues, and thiobarbituric acid reactive species (TBARS) in peripheral tissues and brain regions.
Neonatal parathion exposure uncoupled
serum leptin levels
from their dependence on body weight, suppressed adiponectin and elevated TNFalpha in white adipose tissue.
Our results are consistent with impaired fat utilization and prediabetes,
as well
as exposing a potential relationship between effects on fat metabolism and on synaptic function in the brain.
MedlinePlus Health Information.
consumer health - Dietary Fats
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
PARATHION
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Environ Health Perspect. 2008 Nov;116(11):1456-62
[
19057696.001
]
[Cites]
Neurotoxicol Teratol. 2009 Nov-Dec;31(6):390-9
[
19616088.001
]
[Cites]
J Physiol Pharmacol. 2000 Dec;51(4 Pt 2):883-96
[
11220496.001
]
[Cites]
Diabetes. 2001 May;50(5):1126-33
[
11334417.001
]
[Cites]
Environ Health Perspect. 2002 Dec;110(12):A787-92
[
12460819.001
]
[Cites]
Neurochem Int. 2003 Aug;43(3):243-9
[
12689604.001
]
[Cites]
Environ Health Perspect. 2004 Feb;112(2):170-8
[
14754571.001
]
[Cites]
Metabolism. 2004 May;53(5):589-93
[
15131762.001
]
[Cites]
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Apr;137(4):343-7
[
15228952.001
]
[Cites]
Chem Res Toxicol. 2004 Aug;17(8):983-98
[
15310231.001
]
[Cites]
Arch Environ Contam Toxicol. 1980;9(3):349-82
[
7396557.001
]
[Cites]
Comp Biochem Physiol B. 1983;76(2):335-9
[
6641163.001
]
[Cites]
Biochim Biophys Acta. 1990 Sep 18;1046(2):159-66
[
2223854.001
]
[Cites]
Free Radic Res Commun. 1991;12-13 Pt 1:147-52
[
2071030.001
]
[Cites]
J Neurochem. 1995 Jun;64(6):2755-64
[
7760056.001
]
[Cites]
Toxicol Appl Pharmacol. 1995 Sep;134(1):53-62
[
7545834.001
]
[Cites]
Environ Health Perspect. 2009 Jun;117(6):916-22
[
19590683.001
]
[Cites]
Environ Health Perspect. 2009 Feb;117(2):159-66
[
19270782.001
]
[Cites]
J Expo Anal Environ Epidemiol. 2005 Jul;15(4):297-309
[
15367928.001
]
[Cites]
Neurotoxicology. 2005 Aug;26(4):573-87
[
16112323.001
]
[Cites]
Environ Health Perspect. 2005 Oct;113(10):1291-4
[
16203236.001
]
[Cites]
Environ Health Perspect. 2006 May;114(5):691-6
[
16675422.001
]
[Cites]
Environ Health Perspect. 2006 May;114(5):746-51
[
16675431.001
]
[Cites]
Int J Occup Environ Health. 2006 Apr-Jun;12(2):134-41
[
16722193.001
]
[Cites]
Diabetes. 2006 Jun;55(6):1537-45
[
16731815.001
]
[Cites]
Obesity (Silver Spring). 2006 Aug;14 Suppl 5:242S-249S
[
17021375.001
]
[Cites]
Environ Health Perspect. 2006 Oct;114(10):1542-6
[
17035140.001
]
[Cites]
Ann N Y Acad Sci. 2006 Nov;1084:89-117
[
17151295.001
]
[Cites]
Diabetes Care. 2007 Mar;30(3):529-34
[
17327316.001
]
[Cites]
Environ Health Perspect. 2007 May;115(5):792-8
[
17520070.001
]
[Cites]
J Med Toxicol. 2007 Sep;3(3):89-93
[
18072142.001
]
[Cites]
Brain Res Bull. 2008 Jan 31;75(1):166-72
[
18158111.001
]
[Cites]
Neurotoxicol Teratol. 2008 Mar-Apr;30(2):125-30
[
18166376.001
]
[Cites]
Int J Androl. 2008 Apr;31(2):201-8
[
18315718.001
]
[Cites]
Environ Health Perspect. 2008 Oct;116(10):1308-14
[
18941570.001
]
[Cites]
Brain Res Bull. 2008 Dec 16;77(6):404-11
[
18817854.001
]
[Cites]
Mol Cell Biochem. 1996 Oct-Nov;163-164:137-43
[
8974049.001
]
[Cites]
Shock. 1998 Nov;10(5):329-34
[
9840647.001
]
[Cites]
Exp Clin Endocrinol Diabetes. 1999;107(2):119-25
[
10320052.001
]
[Cites]
Lipids. 1999 May;34(5):457-66
[
10380117.001
]
[Cites]
J Toxicol Environ Health B Crit Rev. 1999 Jul-Sep;2(3):211-55
[
10429680.001
]
[Cites]
Diabetes. 2005 Apr;54(4):917-27
[
15793228.001
]
[Cites]
Toxicol Appl Pharmacol. 2005 Aug 1;206(1):17-26
[
15963341.001
]
[Cites]
Toxicol Appl Pharmacol. 2005 Aug 7;206(2):246-54
[
15967215.001
]
[Cites]
Neurotoxicol Teratol. 2009 Jan-Feb;31(1):11-7
[
18773955.001
]
[Cites]
Environ Health Perspect. 2000 Jun;108(6):515-20
[
10856024.001
]
(PMID = 19615431.001).
[ISSN]
1873-2747
[Journal-full-title]
Brain research bulletin
[ISO-abbreviation]
Brain Res. Bull.
[Language]
ENG
[Grant]
United States / NIEHS NIH HHS / ES / ES010356-090001; United States / NIEHS NIH HHS / ES / P42 ES010356; United States / NIEHS NIH HHS / ES / ES10356; United States / NIEHS NIH HHS / ES / P42 ES010356-090001
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Adiponectin; 0 / Cholinesterase Inhibitors; 0 / Dietary Fats; 0 / Leptin; 0 / Thiobarbituric Acid Reactive Substances; 0 / Tumor Necrosis Factor-alpha; 61G466064D / Parathion
[Other-IDs]
NLM/ NIHMS132377; NLM/ PMC2795103
68.
Konishi N, Otaka M, Odashima M, Jin M, Wada I, Komatsu K, Sato T, Kato S, Matsuhashi T, Watanabe S:
Systemic stress increases serum leptin level.
J Gastroenterol Hepatol
; 2006 Jul;21(7):1099-102
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Systemic stress increases
serum leptin level
.
BACKGROUND AND AIM:
Leptin
, the product of the obese (ob) gene, is a circulating peptide mainly synthesized by adipocytes.
Leptin
inhibits food intake and decreases body weight.
A recent report has suggested that the gastric mucosa is also the source of
leptin
, and that the stomach
leptin
also contributes to the regulation of the
serum leptin level
.
The aim of the present study was to investigate the effect of water-immersion stress on
serum
, stomach and adipose tissue
leptin levels
to understand the relationship between stress and eating behavior.
The
leptin level
in the
serum
, gastric mucosa and adipose tissue was measured using ELISA system before and after the initiation of water-immersion stress.
RESULTS: The
serum leptin level
was significantly increased by water-immersion stress.
However, the gastric
leptin level
significantly decreased 6 and 9 h after the stress.
The adipose tissue
leptin level
significantly increased 3 h after the stress.
CONCLUSIONS: The results suggest that changes in
serum leptin levels
could be associated with stimulation of
leptin
secretion from the gastric mucosa and
leptin
production in the adipose tissue by systemic stress and that
leptin
might be regulated by stress-related events.
[MeSH-major]
Leptin
/ blood. Stress, Physiological / metabolism
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16824059.001).
[ISSN]
0815-9319
[Journal-full-title]
Journal of gastroenterology and hepatology
[ISO-abbreviation]
J. Gastroenterol. Hepatol.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Australia
[Chemical-registry-number]
0 / Biomarkers; 0 / Leptin
69.
Yin CC, Lin KI, Ketterling RP, Knudson RA, Medeiros LJ, Barron LL, Huh YO, Luthra R, Keating MJ, Abruzzo LV:
Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes.
Am J Clin Pathol
; 2009 May;131(5):663-70
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Chronic
lymphocytic
leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical
morphologic
features and unmutated IgVH genes.
The t(2;14)(p16;q32) has been reported previously in only 12 cases of chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
(CLL/
SLL
).
We describe 6 new cases of CLL/
SLL
with t(2;14)(p16;q32).
All showed atypical
lymphocyte morphologic
features with plasmacytoid differentiation and irregular nuclei; 3 had increased prolymphocytes.
Karyotyping identified t(2;14)(p16;q32) as the sole
abnormality
in 1, primary
abnormality
in 2, and part of a complex karyotype in 3.
We conclude that CLL/
SLL
with t(2;14) (p16;q32) and BCL11A/IgH rearrangement is characterized by atypical
morphologic
features and unmutated IgV(H) genes.
[MeSH-major]
Carrier Proteins / genetics. Chromosomes, Human, Pair 14. Chromosomes, Human, Pair 2. Genes, Immunoglobulin Heavy Chain. Immunoglobulin Heavy Chains / genetics. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ genetics. Nuclear Proteins / genetics. Translocation, Genetic
[MeSH-minor]
Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / metabolism. Bone Marrow / pathology. DNA Mutational Analysis. DNA,
Neoplasm
/ analysis. Female. Flow Cytometry. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Karyotyping. Male. Middle Aged. ZAP-70 Protein-Tyrosine Kinase / metabolism
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19369625.001).
[ISSN]
1943-7722
[Journal-full-title]
American journal of clinical pathology
[ISO-abbreviation]
Am. J. Clin. Pathol.
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / P30 CA016672
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / BCL11A protein, human; 0 / Biomarkers, Tumor; 0 / Carrier Proteins; 0 / DNA, Neoplasm; 0 / Immunoglobulin Heavy Chains; 0 / Nuclear Proteins; EC 2.7.10.2 / ZAP-70 Protein-Tyrosine Kinase; EC 2.7.10.2 / ZAP70 protein, human
70.
Aguilar-Chavez EA, Gamez-Nava JI, Lopez-Olivo MA, Galvan-Melendres S, Corona-Sanchez EG, Loaiza-Cardenas CA, Celis A, Cardona-Muñoz EG, Gonzalez-Lopez L:
Circulating leptin and bone mineral density in rheumatoid arthritis.
J Rheumatol
; 2009 Mar;36(3):512-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Circulating
leptin
and bone mineral density in rheumatoid arthritis.
OBJECTIVE: To evaluate the association between circulating
leptin
and bone mineral density (BMD) in patients with rheumatoid arthritis (RA).
Serum leptin
concentrations were measured by ELISA.
Spearman's correlation coefficients (rho) were determined between BMD and
leptin
and other variables.
RESULTS: Patients'
serum leptin levels
varied widely (range 2-128 ng/ml).
Higher
levels
of
leptin
correlated significantly with BMD in the lumbar spine (rho = 0.17, p = 0.04) and total hip (rho = 0.21, p = 0.01).
After adjustment for confounders,
leptin
was no longer associated with BMD.
CONCLUSION: No relevant association was found between circulating
leptin levels
and BMD in patients with RA in this cross-sectional study.
Followup studies are needed to evaluate whether abnormal
leptin levels
confer a risk for fractures due to osteoporosis.
[MeSH-major]
Arthritis, Rheumatoid / blood. Bone Density.
Leptin
/ blood
Genetic Alliance.
consumer health - Arthritis
.
Genetic Alliance.
consumer health - Rheumatoid arthritis
.
MedlinePlus Health Information.
consumer health - Bone Density
.
MedlinePlus Health Information.
consumer health - Rheumatoid Arthritis
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19208597.001).
[ISSN]
0315-162X
[Journal-full-title]
The Journal of rheumatology
[ISO-abbreviation]
J. Rheumatol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Canada
[Chemical-registry-number]
0 / Leptin
71.
Kumakiri J, Kikuchi I, Kitade M, Kumakiri Y, Kuroda K, Matsuoka S, Tokita S, Takeda S:
Evaluation of factors contributing to uterine scar formation after laparoscopic myomectomy.
Acta Obstet Gynecol Scand
; 2010 Aug;89(8):1078-83
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
POPULATION: A total of 692 patients who underwent second-look laparoscopy (
SLL
) after LM.
METHOD: Video-tape recording during
SLL
to evaluate the conditions of uterine suture wound healing, with univariate and logistic regression analysis.
RESULTS:
SLL
revealed that 628 patients (90.8%) had a normal uterus and 64 patients (9.2%) had a scarred uterus.
MedlinePlus Health Information.
consumer health - Scars
.
MedlinePlus Health Information.
consumer health - Uterine Cancer
.
MedlinePlus Health Information.
consumer health - Uterine Fibroids
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20636246.001).
[ISSN]
1600-0412
[Journal-full-title]
Acta obstetricia et gynecologica Scandinavica
[ISO-abbreviation]
Acta Obstet Gynecol Scand
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
72.
Khaled S, Gotlieb V, Schuster IP, Saif MW:
Multiple lymphomatous polyposis associated with small lymphocytic lymphoma: a unique presentation.
J Gastrointestin Liver Dis
; 2008 Dec;17(4):461-3
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Multiple lymphomatous polyposis associated with
small lymphocytic lymphoma
: a unique presentation.
Multiple lymphomatous polyposis (MLP) is a rare extra-nodal manifestation of
lymphoma
.
In most cases, MLP is associated with mantle
cell lymphoma
(MCL).
We report a 66-year-old male diagnosed with
small lymphocytic lymphoma
(
SLL
)/chronic
lymphocytic lymphoma
(CLL), who showed evidence of rectal bleeding.
A CT-scan of the abdomen and pelvis showed an enlarged spleen, multiple paraaortic and mesenteric
lymph
nodes, and some diverticular pouching along the antimesenteric border of the pelvic colon.
A colonoscopy revealed the presence of multiple polypoid lesions, biopsies of which showed
diffuse
lymphoid infiltrate without any identifiable follicles.
Immunohistochemical analysis combined with a Fluorescence In-Situ Hybridization (FISH) study excluded the
diagnosis
of MCL.
A bone marrow aspiration biopsy demonstrated
diffuse
infiltration of the bone marrow with low grade
lymphocytes
that expressed CD 20, CD5 and CD23, with negative BCL-1, t (11;.
A diagnosis
of B-
cell
CLL with kappa light chain restriction was made.
Multiple lymphomatous polyposis is considered to be a digestive counterpart to MCL and can therefore be considered
as a
presentation of MCL.
The patient's bone marrow revealed a B-
cell lymphoma
of CLL/
SLL
phenotype, which to our knowledge has not been linked to MLP in previously reported cases.
[MeSH-major]
Colonic Polyps /
diagnosis
. Colorectal Neoplasms /
diagnosis
. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/
diagnosis
.
Lymphoma
, Mantle-
Cell
/
diagnosis
[MeSH-minor]
Aged. B-
Lymphocytes
/ metabolism. Biomarkers, Tumor / metabolism. Bone Marrow / pathology.
Diagnosis
, Differential. Humans. Male
MedlinePlus Health Information.
consumer health - Colonic Polyps
.
MedlinePlus Health Information.
consumer health - Colorectal Cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19104711.001).
[ISSN]
1841-8724
[Journal-full-title]
Journal of gastrointestinal and liver diseases : JGLD
[ISO-abbreviation]
J Gastrointestin Liver Dis
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Romania
[Chemical-registry-number]
0 / Biomarkers, Tumor
73.
Lin J, Yan GT, Hao XH, Wang LH, Zhang K, Xue H:
Effect of intestinal ischemia-reperfusion injury on protein levels of leptin and orexin-A in peripheral blood and central secretory tissues.
World J Gastroenterol
; 2005 Feb 21;11(7):1000-4
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Effect of intestinal ischemia-reperfusion injury on protein
levels
of
leptin
and orexin-A in peripheral blood and central secretory tissues.
AIM: To explore the effect of intestinal ischemia-reperfusion injury on protein
levels
of
leptin
and orexin-A in peripheral blood and their central secretory tissues and to find out the role
leptin
and orexin-A play in acute inflammatory responses.
Two highly-sensitive radioimmunoassays for
leptin
and orexin-A were established and used to check the change of their concentrations in peripheral blood and central secretory tissues before and after intestinal I/R injury.
RESULTS: Compared with the
serum leptin level
before injury, it decreased significantly in I60'R30' group and increased significantly in I60'R360' group; compared to sham-operation group after injury,
serum leptin level
increased significantly in I60'R360' group; compared to sham-operation group after injury, adipose
leptin levels
decreased significantly in I60'R30' and I60'R90' groups, while increased significantly in I60'R360' group.
There was no significant difference between the expression
levels
of orexin-A before and after I/R injury.
CONCLUSION:
Leptin
has a time-dependent response and orexin-A has a delayed response to acute inflammatory stimuli such as intestinal I/R injury and they may participate in metabolic disorders in injury as inflammatory cytokines.
[MeSH-major]
Adipose Tissue / metabolism. Hypothalamus / metabolism. Intestines / pathology. Intracellular Signaling Peptides and Proteins / blood.
Leptin
/ blood. Neuropeptides / blood. Reperfusion Injury / pathology
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15742403.001).
[ISSN]
1007-9327
[Journal-full-title]
World journal of gastroenterology
[ISO-abbreviation]
World J. Gastroenterol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
China
[Chemical-registry-number]
0 / Antibodies; 0 / Intracellular Signaling Peptides and Proteins; 0 / Leptin; 0 / Neuropeptides; 0 / Orexins
[Other-IDs]
NLM/ PMC4250760
74.
Rico L, Del Rio M, Bravo A, Ramirez A, Jorcano JL, Page MA, Larcher F:
Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance.
Endocrinology
; 2005 Oct;146(10):4167-76
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Targeted overexpression of
leptin
to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early
leptin
resistance.
The epidermis has a great potential
as a
bioreactor to produce proteins with systemic action.
Thus, the long-term effects of
leptin
on skin physiology have not been studied, and the metabolic consequences of sustained keratinocyte-derived
leptin
overexpression are unknown.
Herein we describe that very high
serum leptin levels
can be achieved from a cutaneous source in transgenic mice in which
leptin
cDNA overexpression was driven by the keratin K5 gene regulatory sequences.
Histopathological analysis including the study of skin differentiation and proliferation markers in these transgenic mice revealed that keratinocyte-derived
leptin
overexpression appears not to have any impact on cutaneous homeostasis.
Although young K5-
leptin
transgenic mice showed remarkable thinness and high glucose metabolism as shown in other
leptin
transgenic mouse models, a marked
leptin
insensitivity become apparent as early as 3-4 months of age as demonstrated by increased weight gain and insulin resistance development.
Other signs of
leptin
/insulin resistance included increased bone mass, organomegaly, and wound healing impairment.
In addition, to provide evidence for the lack of untoward effects of
leptin
on epidermis, this transgenic mouse helps us to establish the safe ranges of keratinocyte-derived
leptin
overexpression and may be useful
as a
model to study
leptin
resistance.
[MeSH-major]
Keratinocytes / physiology.
Leptin
/ genetics. Skin / cytology
[MeSH-minor]
Adipose Tissue / cytology. Animals. Animals, Newborn. Body Weight.
Cell
Differentiation. Drug Resistance / genetics. Energy Intake. Epidermis / cytology. Epidermis / physiology. Keratin-15. Keratin-5. Keratins / genetics. Mice. Mice, Inbred C57BL. Mice, Inbred DBA. Mice, Transgenic. Wound Healing
Faculty of 1000.
commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine.
(subscription/membership/fee required).
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Endocrinology. 2005 Oct;146(10):4165-6
[
16166228.001
]
(PMID = 15994350.001).
[ISSN]
0013-7227
[Journal-full-title]
Endocrinology
[ISO-abbreviation]
Endocrinology
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Keratin-15; 0 / Keratin-5; 0 / Krt1-15 protein, mouse; 0 / Leptin; 68238-35-7 / Keratins
75.
Panichi V, Manca-Rizza G, Paoletti S, Taccola D, Consani C, Filippi C, Mantuano E, Sidoti A, Grazi G, Antonelli A, Angelini D, Petrone I, Mura C, Tolaini P, Saloi F, Ghezzi PM, Barsotti G, Palla R:
Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
Nephrol Dial Transplant
; 2006 Mar;21(3):756-62
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
CRP
levels
were measured by a highly sensitive nephelometric assay (Dade, Behring) with a sensitivity of 0.1 microg/ml.
Serum leptin
was determined with a ELISA method (Biosource, USA).
No significant variation in
serum leptin levels
were observed during the study.
CRP and IL-6 were highly correlated (r = 0.54; P < 0.001) as was
serum
albumin and prealbumin (r = 0.39; P < 0.001).
Serum
albumin was negatively correlated with CRP (r = -0.26; P < 0.01) and IL-6 (r = -0.19; P < 0.05);
serum
prealbumin was correlated with IL-6 (r = 0.37; P < 0.001) and with CRP (r = 0.24; P < 0.01).
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16303780.001).
[ISSN]
0931-0509
[Journal-full-title]
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
[ISO-abbreviation]
Nephrol. Dial. Transplant.
[Language]
eng
[Publication-type]
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Hemodialysis Solutions; 0 / Interleukin-6; 130068-27-8 / Interleukin-10; 9007-41-4 / C-Reactive Protein
76.
Oumeish OY, Oumeish I, Tarawneh M, Salman T, Sharaiha A:
Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's lymphoma developing into chronic lymphocytic leukemia: the first case reported in the literature and review of the literature.
Int J Dermatol
; 2006 Mar;45(3):306-10
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's
lymphoma
developing into chronic
lymphocytic
leukemia: the first case reported in the literature and review of the literature.
A 56-year-old married female presented in May 1998 with a 5-month history of xanthelasma of the eyelids, followed 4 months later by two enlarged
lymph
nodes of the left side of the neck and three of the left axilla.
In July 1998, computed tomography (CT) scans of the chest and abdomen with contrast medium showed pretracheal, bilateral axillary, right retrochural, paracaval, aortocaval, and para-aortic
lymph
node enlargement.
These findings were suggestive of
lymphoma
.
One cervical and two left axillary
lymph
nodes were excised.
They revealed total replacement of the nodular architecture by
a diffuse
proliferation of mature lymphoid cells having
small
nuclei and a crumbled chromatin pattern, and very rare mitosis.
It was concluded from the
lymph
node biopsies that these changes were typical of non-Hodgkin's
lymphoma
,
diffuse
and
small cell
type
, of low-grade malignancy.
The bone marrow picture was consistent with
diffuse
,
well
-
differentiated
non-Hodgkin's
lymphoma
, developing into chronic
lymphocytic
leukemia (CLL).
Endoscopy showed antral-
type
gastric mucosa exhibiting mild chronic gastritis.
Skin biopsy from a fresh lesion on the back showed
a diffuse
inflammatory
cell
infiltrate with collections of histiocytic cells.
The blood picture also showed monoclonal IgG paraprotein (3170 mg/dL) of the kappa light chain
type
.
The patient was treated by the oncologist for her
lymphoma
, and was given Cytoxan, prednisolone, endoxan, Leukeran, and melphalan.
She also responded to Leukeran at a dose of 5 mg daily for 5 days every month for 6 months, and showed regression in the size of the
lymph
nodes.
[MeSH-major]
Granuloma / pathology. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ etiology.
Lymphoma
, Non-Hodgkin / complications. Necrobiotic Disorders / pathology. Paraproteinemias / etiology. Xanthomatosis / pathology
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
Genetic Alliance.
consumer health - Xanthogranuloma
.
Hazardous Substances Data Bank.
MELPHALAN
.
Hazardous Substances Data Bank.
CHLORAMBUCIL
.
Hazardous Substances Data Bank.
CYCLOPHOSPHAMIDE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16533236.001).
[ISSN]
0011-9059
[Journal-full-title]
International journal of dermatology
[ISO-abbreviation]
Int. J. Dermatol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antineoplastic Agents, Alkylating; 0 / Glucocorticoids; 18D0SL7309 / Chlorambucil; 8N3DW7272P / Cyclophosphamide; Q41OR9510P / Melphalan
77.
Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO:
Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
Eur J Endocrinol
; 2005 Oct;153(4):545-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Effects of GH replacement therapy in adults on
serum levels
of
leptin
and ghrelin: the role of lipolysis.
OBJECTIVE: The regulation and function of systemic ghrelin
levels
appear to be associated with food intake and energy balance rather than GH.
Since GH, in turn, acutely induces lipolysis and insulin resistance in skeletal muscle, we aimed to study the isolated and combined effects of GH, free fatty acids (FFAs) and insulin sensitivity on circulating ghrelin
levels
in human subjects.
)) were studied on four occasions in a 2 x 2 factorial design with and without GH substitution and with and without administration of acipimox, which lowers FFA
levels
by inhibition of the hormone-sensitive lipase, in the basal state and during a hyperinsulinemic euglycemic clamp.
RESULTS:
Serum
FFA
levels
decreased with acipimox administration irrespective of GH status.
Fasting ghrelin
levels
decreased insignificantly during GH administration alone, but were reduced by 33% during co-administration of GH and acipimox (Aci) (in ng/l): 860 +/- 120 (-GH - Aci), 711 +/- 130 (-GH + Aci), 806 +/- 130 (+GH - Aci), 574 +/- 129 (+GH + Aci), P < 0.01.
GH and acipimox induced a reciprocal 25% increase in
serum leptin levels
(microg/l): 11.2 +/- 4.4 (-GH - Aci), 11.7 +/- 4.4 (-GH + Aci), 11.5 +/- 4.4 (+GH - Aci), 13.9 +/- 4.2 (+GH + Aci), P = 0.005.
CONCLUSION: Our data suggest that antilipolysis via suppression of the hormone-sensitive lipase in combination with GH administration is associated with significant and reciprocal changes in ghrelin and
leptin
.
MedlinePlus Health Information.
consumer health - Hormone Replacement Therapy
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[ErratumIn]
Eur J Endocrinol. 2005 Nov;153(5):721
(PMID = 16189176.001).
[ISSN]
0804-4643
[Journal-full-title]
European journal of endocrinology
[ISO-abbreviation]
Eur. J. Endocrinol.
[Language]
ENG
[Publication-type]
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Drug Combinations; 0 / Fatty Acids, Nonesterified; 0 / Ghrelin; 0 / Hypolipidemic Agents; 0 / Leptin; 0 / Peptide Hormones; 0 / Pyrazines; 12629-01-5 / Human Growth Hormone; 9002-72-6 / Growth Hormone; EC 3.1.1.13 / Sterol Esterase; K9AY9IR2SD / acipimox
78.
Leonard WR, Sorensen MV, Mosher MJ, Spitsyn V, Comuzzie AG:
Reduced fat oxidation and obesity risks among the Buryat of Southern Siberia.
Am J Hum Biol
; 2009 Sep-Oct;21(5):664-70
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Shorter Buryat women (height-for-age Z-scores < or = -1) have significantly lower fasting fat oxidation
levels
compared to their taller counterparts.
Shorter women are also significantly heavier and fatter, and have higher
serum
lipid
levels
.
Among all Buryat women, reduced fat oxidation is significantly correlated with percent body fatness,
serum
triglyceride
levels
, and
serum leptin levels
, after controlling for relevant covariates.
Additionally, Buryat women with high dietary fat intakes and low fat oxidation are significantly fatter and have higher lipid and
leptin levels
than those with low fat intakes and high fat oxidation.
[MeSH-minor]
Adolescent. Adult. Basal Metabolism. Body Weights and Measures. Cultural Evolution. Dietary Fats / metabolism. Female. Humans.
Leptin
/ blood. Lipids / blood. Male. Middle Aged. Nutrition Disorders / ethnology. Oxidation-Reduction. Sex Factors. Siberia / epidemiology. Young Adult
Genetic Alliance.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19322885.001).
[ISSN]
1520-6300
[Journal-full-title]
American journal of human biology : the official journal of the Human Biology Council
[ISO-abbreviation]
Am. J. Hum. Biol.
[Language]
eng
[Grant]
United States / NCRR NIH HHS / RR / 1 C06 RR017515
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Dietary Fats; 0 / Leptin; 0 / Lipids
79.
O'Malley DP, Vance GH, Orazi A:
Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfall.
Arch Pathol Lab Med
; 2005 Jan;129(1):92-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfall.
Chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
(CLL/
SLL
) and mantle
cell lymphoma
usually are distinctly different in regard to clinical presentation, morphology, immunophenotype, and molecular/genetic findings.
Cyclin D1 immunohistochemical staining is usually envisioned
as a
definitive method for resolving this differential
diagnosis
, with positivity supporting
a diagnosis
of mantle
cell lymphoma
.
We report a case involving a 58-year-old man with
a diagnosis
of CLL/
SLL
for several years.
A lymph
node excision was performed after increased adenopathy was noted in the cervical region.
The excised
lymph
node showed typical
morphologic
findings of CLL/
SLL
, including the presence of characteristic proliferation centers.
Fluorescence in situ hybridization and conventional cytogenetics demonstrated trisomy 12 and an absence of t(11;14) in
lymph
node tissue.
Focal cyclin D1 expression by immunohistochemistry in nodal CLL/
SLL
is quite unusual and is discussed
as a
potential diagnostic pitfall.
[MeSH-major]
Chromosomes, Human, Pair 12 / genetics. Cyclin D1 / biosynthesis. Leukemia,
Lymphocytic
, Chronic, B-
Cell
/
diagnosis
.
Lymphoma
, Mantle-
Cell
/
diagnosis
. Trisomy /
diagnosis
[MeSH-minor]
Diagnosis
, Differential. Humans. Immunophenotyping / methods. Male. Middle Aged
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15628916.001).
[ISSN]
1543-2165
[Journal-full-title]
Archives of pathology & laboratory medicine
[ISO-abbreviation]
Arch. Pathol. Lab. Med.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
136601-57-5 / Cyclin D1
80.
Wang LJ, Zhou L, Yuan B, Wang L:
[Regulative effect of leptin on gastric motility: experiment with conscious rats].
Zhonghua Yi Xue Za Zhi
; 2006 Aug 29;86(32):2266-70
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Regulative effect of
leptin
on gastric motility: experiment with conscious rats].
OBJECTIVE: To observe the role of
leptin
on the regulation of inter-digestive migrating motor complex (MMC) and gastric motility of postprandial period,
as well
as the
serum leptin level
and its relationship with motilin during different fast and postprandial periods.
Blood samples were collected during the phases I, II, III, and IV, 3 minutes after feeding and then every 5 minutes to test the
serum leptin
and motilin. (2)
Leptin
group.
After the recording of the first MMC,
leptin
was perfused during the second MMC to observe its effect on the stomach motility. (3) Anti-
leptin serum
group.
During the second MMC, 5 minutes before feeding and 60 minutes after feeding, anti-
leptin serum
was perfused to observe its effect on the postprandial stomach motility. (4)
Leptin
+ atropine group.
During the first MMC perfusion of atropine was followed by perfusion of
leptin
. and (5)
leptin
+ cholecystokinin (CCK)-A receptor blocker group.
Perfusion of CCK-A receptor blocker was followed by perfusion of
leptin
.
Serum leptin
and motilin
levels
were measured by radioimmunoassay.
When the stomach was empty, the mean concentration of
serum leptin
was (5.6 +/- 1.0) microg/L, (11.4 +/- 2.1) microg/L, and (2.1 +/- 0.7) microg/L during the phase I, II and III respectively, being the highest in the phase II, significantly higher than those in the phase I and III (both P < 0.01).
During digestive period, the
serum
concentration of
leptin
began to increase 3 minutes after the meal and reached its peak of (28.1 +/- 4.4) microg/L 10 minutes after the meal.
The
serum
concentration of
leptin
remained on a high
level
till 30 minutes later (compared with that in the inter-digestive period, P < 0.01).
On the contrary, the
serum
concentration of motilin was the highest in the phase III of MMC and the lowest in the digestive period.
Intravenous infusion of
leptin
(2.5 microg x kg(-1) x 10 min) turned the inter-digestive pattern of gastric motility to digestive period pattern with corpus distension and contraction of antrum and pylorus.
The effects of
leptin
on gastric motility were blocked by anti-
leptin serum
, atropine, and CCK-A receptor blocker loxiglumide.
CONCLUSION:
Leptin
is a hormone to promote the inter-digestive MMC phase II and postprandial digestive motility activities of stomach, the concentration fluctuation of which will cause satiety related delay of gastric emptying.
The effect of
leptin
on gastric motility is mediated by cholinergic nerve and CCK-A receptors.
[MeSH-major]
Gastrointestinal Motility / physiology.
Leptin
/ blood. Motilin / blood
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17064572.001).
[ISSN]
0376-2491
[Journal-full-title]
Zhonghua yi xue za zhi
[ISO-abbreviation]
Zhonghua Yi Xue Za Zhi
[Language]
chi
[Publication-type]
English Abstract; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
China
[Chemical-registry-number]
0 / Leptin; 52906-92-0 / Motilin
81.
Lin TS, Naumovski L, Lecane PS, Lucas MS, Moran ME, Cheney C, Lucas DM, Phan SC, Miller RA, Byrd JC:
Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.
Leuk Lymphoma
; 2009 Dec;50(12):1977-82
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Effects of motexafin gadolinium in a phase II trial in refractory chronic
lymphocytic
leukemia.
Chronic
lymphocytic
leukemia (CLL) cells are susceptible to oxidative stress.
A phase II trial administered MGd 5 mg/kg/day IV for 5 days every 3 weeks until disease progression to patients with previously treated CLL and
small lymphocytic lymphoma
.
[MeSH-major]
Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ drug therapy. Metalloporphyrins / therapeutic use
[MeSH-minor]
Aged. Aged, 80 and over. Antineoplastic Agents / adverse effects. Antineoplastic Agents / pharmacokinetics. Antineoplastic Agents / therapeutic use. Chromosome Deletion. Chromosomes, Human, Pair 11 / genetics. Chromosomes, Human, Pair 17 / genetics. Drug Administration Schedule. Drug Resistance,
Neoplasm
. Female. Flow Cytometry. Humans. Immunoblotting. In Situ Hybridization, Fluorescence. Male. Middle Aged. Phosphorylation / drug effects. Proto-Oncogene Proteins c-akt / metabolism. Treatment Outcome
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19860624.001).
[ISSN]
1029-2403
[Journal-full-title]
Leukemia & lymphoma
[ISO-abbreviation]
Leuk. Lymphoma
[Language]
eng
[Publication-type]
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Antineoplastic Agents; 0 / Metalloporphyrins; 6433A42F4F / motexafin gadolinium; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt
82.
Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE:
Update on risk-stratified management for chronic lymphocytic leukemia.
Leuk Lymphoma
; 2006 Sep;47(9):1738-46
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Update on risk-stratified management for chronic
lymphocytic
leukemia.
Major recent advances in understanding the biology of chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
(CLL) have improved clinical evaluation and influenced treatment decisions.
CLL can be diagnosed early and accurately, and biological measurements can be used to predict a prognosis at
diagnosis
.
However, recent developments suggest that allogeneic stem
cell
transplant could have a larger role in a selected group of these patients.
Potential new treatment modalities include targeted molecules that interrupt key components of CLL
cell
survival pathways, and active and passive immunotherapy.
[MeSH-major]
Leukemia,
Lymphocytic
, Chronic, B-
Cell
/ therapy. Risk Management
[MeSH-minor]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Hematopoietic Stem
Cell
Transplantation. Humans
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17064983.001).
[ISSN]
1042-8194
[Journal-full-title]
Leukemia & lymphoma
[ISO-abbreviation]
Leuk. Lymphoma
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / CA 97274
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Review
[Publication-country]
England
[Number-of-references]
73
83.
Shoemaker RC, House DE:
A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings.
Neurotoxicol Teratol
; 2005 Jan-Feb;27(1):29-46
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Serum leptin levels
were abnormally high and alpha melanocyte stimulating hormone (MSH)
levels
were abnormally low.
Leptin
and MSH
levels
showed statistically significant improvement.
MedlinePlus Health Information.
consumer health - Indoor Air Pollution
.
Hazardous Substances Data Bank.
CHOLESTYRAMINE RESIN
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15681119.001).
[ISSN]
0892-0362
[Journal-full-title]
Neurotoxicology and teratology
[ISO-abbreviation]
Neurotoxicol Teratol
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Anion Exchange Resins; 0 / Anti-Infective Agents; 0 / Bacterial Toxins; 0 / Mycotoxins; 11041-12-6 / Cholestyramine Resin
84.
Ustundag B, Gungor S, Aygün AD, Turgut M, Yilmaz E:
Oxidative status and serum leptin levels in obese prepubertal children.
Cell Biochem Funct
; 2007 Sep-Oct;25(5):479-83
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Oxidative status and
serum leptin levels
in obese prepubertal children.
The aim of this study was to evaluate the oxidative and antioxidant status and any correlation with
leptin
in obese prepubertal children.
Mean plasma
leptin
concentration was significantly higher in the obese children.
Homocysteine and malondialdehyde (MDA)
levels
were also significantly higher in the obese group.
In conclusion, in prepubertal obese children oxidative stress was increased and MDA and homocysteine
levels
were
well
correlated with
serum leptin level
and BMI.
[MeSH-major]
Leptin
/ blood. Obesity / blood. Puberty / blood
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity in Children
.
MedlinePlus Health Information.
consumer health - Puberty
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16874844.001).
[ISSN]
0263-6484
[Journal-full-title]
Cell biochemistry and function
[ISO-abbreviation]
Cell Biochem. Funct.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
0 / Leptin
85.
Yakut A, Dinleyici EC, Idem S, Yarar C, Dogruel N, Colak O:
Serum leptin levels in children with cerebral palsy: relationship with growth and nutritional status.
Neuro Endocrinol Lett
; 2006 Aug;27(4):507-12
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum leptin levels
in children with cerebral palsy: relationship with growth and nutritional status.
Several studies indicated that
leptin
which is produced by adipocytes, might regulate energy intake and expenditure.
The aim of this study is to determine
serum leptin levels
in children with CP and to investigate the relationship between nutritional status and anthropometric measurements.
Serum leptin
, growth hormone, C-peptide and cortisol
levels
were studied.
Group DSF had lower
leptin
concentrations compared to Group non-DSF and controls (p<0.001, p<0.001).
On the other hand non DSF group had higher
leptin levels
than controls (p<0.05).
There was a positive and significant correlation between
leptin
and anthropometric measurements, especially TST in children with CP.
Serum leptin levels
were also lower in non-ambulatory children than ambulatory children with CP (p<0.05).
Serum leptin levels
were lower in CP, especially in DSF group.
We concluded that
leptin
which regulates energy intake might have a role of nutritional disorders in cerebral palsy.
[MeSH-major]
Cerebral Palsy / metabolism. Child Nutrition Disorders / metabolism. Growth Disorders / metabolism.
Leptin
/ blood. Nutritional Status
Genetic Alliance.
consumer health - Cerebral Palsy
.
MedlinePlus Health Information.
consumer health - Cerebral Palsy
.
MedlinePlus Health Information.
consumer health - Child Nutrition
.
MedlinePlus Health Information.
consumer health - Growth Disorders
.
Hazardous Substances Data Bank.
HYDROCORTISONE
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16891993.001).
[ISSN]
0172-780X
[Journal-full-title]
Neuro endocrinology letters
[ISO-abbreviation]
Neuro Endocrinol. Lett.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Sweden
[Chemical-registry-number]
0 / C-Peptide; 0 / Leptin; 12629-01-5 / Human Growth Hormone; WI4X0X7BPJ / Hydrocortisone
86.
Karaosmanoglu D, Karcaaltincaba M, Oguz B, Akata D, Ozmen M, Akhan O:
CT findings of lymphoma with peritoneal, omental and mesenteric involvement: peritoneal lymphomatosis.
Eur J Radiol
; 2009 Aug;71(2):313-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
CT findings of
lymphoma
with peritoneal, omental and mesenteric involvement: peritoneal lymphomatosis.
PURPOSE: We aimed to describe computed tomography (CT) findings in patients with peritoneal, omental and mesenteric
lymphoma
involvement.
MATERIALS AND METHODS: We searched our archive retrospectively to find out patients with peritoneal, omental and mesenteric
lymphoma
involvement.
We found 16 patients with non-Hodgkin
lymphoma
meeting these criteria.
RESULTS: There were 14 males and 2 females with peritoneal and/or mesenteric and omental
lymphoma
involvement.
Subgroups of non-Hodgkin
lymphoma
were
diffuse
large B-
cell lymphoma
(n=11),
small cell lymphocytic lymphoma
(n=2),
small
cleaved
cell lymphoma
(n=1), T-
cell lymphoma
(n=1) and Burkitt's
lymphoma
(n=1).
CONCLUSION: Peritoneal involvement can be seen in many subtypes of
lymphoma
and most frequently in
diffuse
large B-
cell lymphoma
.
Peritoneal lymphomatosis can mimic peritoneal carcinomatosis and should be included in the differential
diagnosis
list in patients with ascites, hepatosplenic lesions and unidentified cause of peritoneal thickening on CT in a male patient.
[MeSH-major]
Lymphoma
/ radiography. Mesentery / radiography. Omentum / radiography. Peritoneal Neoplasms / radiography. Tomography, X-Ray Computed / methods
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - Lymphoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18513906.001).
[ISSN]
1872-7727
[Journal-full-title]
European journal of radiology
[ISO-abbreviation]
Eur J Radiol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Ireland
87.
Li CW, Jiang DL, Qiao J, Sun JM, Huang JP, Chen HP, Zhu H:
[Changes of leptin resistance, blood lipids and inflammatory response before and after the exercise therapy in children with obesity].
Zhongguo Dang Dai Er Ke Za Zhi
; 2010 Jan;12(1):40-2
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Changes of
leptin
resistance, blood lipids and inflammatory response before and after the exercise therapy in children with obesity].
OBJECTIVE: Some research has shown that C-reactive protein (CRP),
leptin
, soluble
leptin
receptor (sLR) and blood lipids are involved in the development of obesity.
This study aimed to investigate the changes of
leptin
resistance, blood lipids and inflammatory response before and after the exercise therapy in children with obesity.
The
levels
of
serum leptin
, sLR, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hs-CRP) were measured before and after the exercise therapy.
RESULTS: Compared with the control group,
serum levels
of
leptin
, TG, TC, LDL-C and hs-CRP and the body mass index (BMI) in the obese group increased (p<0.01), while the
serum level
of sLR decreased significantly (p<0.05).
The
levels
of hs-CRP,
leptin
, TC, TG, LDL-C and BMI in the obese group were significantly reduced after the exercise therapy (p<0.05).
In the obese group, the
serum leptin level
was positively correlated with the
levels
of blood lipids and hs-CRP (p<0.05);
serum levels
of
leptin
and hs-CRP were negatively correlated with the sLR
level
(p<0.05); the hs-CRP
level
was positively correlated with the
levels
of blood lipids (p<0.01).
CONCLUSIONS:
Leptin
resistance and the changes of blood lipids and inflammatory response are found in children with obesity.
[MeSH-major]
C-Reactive Protein / analysis. Exercise Therapy.
Leptin
/ blood. Lipids / blood. Obesity / therapy
[MeSH-minor]
Body Mass Index. Child. Female. Humans. Male. Receptors,
Leptin
/ blood
Genetic Alliance.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity
.
MedlinePlus Health Information.
consumer health - Obesity in Children
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20113633.001).
[ISSN]
1008-8830
[Journal-full-title]
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
[ISO-abbreviation]
Zhongguo Dang Dai Er Ke Za Zhi
[Language]
chi
[Publication-type]
English Abstract; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Leptin; 0 / Lipids; 0 / Receptors, Leptin; 9007-41-4 / C-Reactive Protein
88.
Lei X, Peng X, Wu N, Hu M, Sun Z:
[Serum adiponectin, leptin level, and bone mineral density in postmenopausal women].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 2009 Jun;34(6):559-62
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[
Serum
adiponectin,
leptin level
, and bone mineral density in postmenopausal women].
OBJECTIVE: To determine whether
serum
adipocytokines and
leptin level
are associated with bone mineral density (BMD) in postmenopausal women.
METHODS:
Serum
adiponectin and
leptin level
were measured by ELISA in 336 postmenopausal women.
RESULTS:
Serum
adiponectin
levels
were negatively related to BMD at the whole body, the lumbar spine, the hip, and the forearm (r = -0.181, r = -0.208, r = -0.228, r = -0.203, and P < 0.05, respectively).
Serum leptin levels
were positively related to BMD was at the hip and the forearm (r = 0.162, r = 0.210, and P < 0.05, respectively).
[MeSH-major]
Adiponectin / blood. Bone Density / physiology.
Leptin
/ blood. Postmenopause / blood
MedlinePlus Health Information.
consumer health - Bone Density
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19587442.001).
[ISSN]
1672-7347
[Journal-full-title]
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
[ISO-abbreviation]
Zhong Nan Da Xue Xue Bao Yi Xue Ban
[Language]
chi
[Publication-type]
English Abstract; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Adiponectin; 0 / Leptin
89.
Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M:
Serum leptin levels in rheumatoid arthritis and relationship with disease activity.
South Med J
; 2006 Oct;99(10):1078-83
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum leptin levels
in rheumatoid arthritis and relationship with disease activity.
OBJECTIVES: This study was performed to evaluate
serum leptin levels
in rheumatoid arthritis (RA) patients and investigate the correlation with
serum
tumor necrosis factor alpha (TNF-alpha)
levels
and clinical and laboratory parameters of disease activity.
Immunoradiometric assay was used for measuring
serum leptin levels
(ng/mL).
Serum
TNF-alpha
levels
(pg/mL) were measured by sandwich enzyme-linked immunosorbent assay method in 41 of 50 RA patients and in 24 control subjects.
Serum leptin levels
were higher in RA (P = 0.000).
In RA patients, there were no correlations between
serum leptin levels
and disease duration, swollen and tender joint counts, DAS28, CRP, ESR,
serum
TNF-alpha
levels
, oral glucocorticoid and methotrexate usage (P > 0.05).
There was no statistically significant
serum leptin level
difference between patients with high disease activity and mild and low disease activity (P = 0.892).
Serum leptin levels
positively correlated with BMI in both patient and control groups (P < 0.05).
In both groups, mean
serum leptin levels
were higher in women than men.
CONCLUSIONS: Even though
serum leptin levels
were found to be significantly higher in RA patients than in control subjects in this study, there was no correlation between
serum leptin levels
and TNF-alpha
levels
, clinical and laboratory parameters of disease activity.
However
serum leptin levels
positively correlated with BMI in both patient and control groups.
In RA, circulating
leptin levels
do not seem to reflect disease activity.
[MeSH-major]
Arthritis, Rheumatoid / blood.
Leptin
/ blood
Genetic Alliance.
consumer health - Arthritis
.
Genetic Alliance.
consumer health - Rheumatoid arthritis
.
MedlinePlus Health Information.
consumer health - Rheumatoid Arthritis
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17100028.001).
[ISSN]
0038-4348
[Journal-full-title]
Southern medical journal
[ISO-abbreviation]
South. Med. J.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin; 0 / Tumor Necrosis Factor-alpha
90.
Antoniades L, Eftychiou C, Petrou PM, Bagatzounis A, Minas M:
Primary cardiac lymphoma: case report and brief review of the literature.
Echocardiography
; 2009 Feb;26(2):214-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary cardiac
lymphoma
: case report and brief review of the literature.
Primary cardiac
lymphoma
is defined
as a
non-Hodgkin's
lymphoma
mainly located in the heart and/or the pericardium.
Diagnosis
is usually late and prognosis is poor.
We report a case of a patient with a large primary cardiac
lymphoma
who presented with chest pain and negative T-waves in electrocardiogram.
Tissue biopsy showed a high-grade B-
cell
diffuse
lymphocytic lymphoma
.
[MeSH-major]
Heart Neoplasms /
diagnosis
. Heart Neoplasms / therapy.
Lymphoma
, Large B-
Cell
,
Diffuse
/
diagnosis
.
Lymphoma
, Large B-
Cell
,
Diffuse
/ therapy
[MeSH-minor]
Aged. Chest Pain / etiology.
Diagnosis
, Differential. Echocardiography. Electrocardiography. Follow-Up Studies. Heart Atria / ultrasonography. Heart Ventricles / ultrasonography. Humans. Male. Rare Diseases. Remission Induction / methods
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19138175.001).
[ISSN]
1540-8175
[Journal-full-title]
Echocardiography (Mount Kisco, N.Y.)
[ISO-abbreviation]
Echocardiography
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
15
91.
Carver JD, Calverley D, Shen P:
Chronic lymphocytic leukemia/small lymphocytic lymphoma presenting in urinary bladder without peripheral blood lymphocytosis: case report and literature review.
Leuk Lymphoma
; 2006 Jun;47(6):1163-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Chronic
lymphocytic
leukemia/
small lymphocytic lymphoma
presenting in urinary bladder without peripheral blood lymphocytosis: case report and literature review.
[MeSH-major]
Leukemia,
Lymphocytic
, Chronic, B-
Cell
/
diagnosis
. Urinary Bladder Neoplasms /
diagnosis
[MeSH-minor]
Aged, 80 and over.
Cell
Proliferation. Epithelial Cells / metabolism. Humans. Immunohistochemistry.
Lymphocytes
/ metabolism. Male. Treatment Outcome
Genetic Alliance.
consumer health - Chronic Lymphocytic Leukemia
.
MedlinePlus Health Information.
consumer health - Bladder Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16840214.001).
[ISSN]
1042-8194
[Journal-full-title]
Leukemia & lymphoma
[ISO-abbreviation]
Leuk. Lymphoma
[Language]
eng
[Publication-type]
Case Reports; Letter
[Publication-country]
England
92.
Turner CA, Rubin CM, Royle GT, Flynn M, Theaker JM:
Screen detected sclerosing lymphocytic lobulitis and amyloid of the breast in the same patient--a possible causal link.
Breast
; 2006 Apr;15(2):281-3
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Screen detected sclerosing
lymphocytic
lobulitis and amyloid of the breast in the same patient--a possible causal link.
Sclerosing
lymphocytic
lobulitis (
SLL
) and amyloidosis of the breast are both rare.
Wire-guided excision biopsy showed features typical of
SLL
but also localised amyloid deposits within the specimen.
Amyloidosis and
SLL
may have similar immunological causes.
[MeSH-major]
Amyloidosis /
diagnosis
. Breast / pathology. Breast Diseases /
diagnosis
[MeSH-minor]
Biopsy, Needle.
Diagnosis
, Differential. Female. Humans. Mammography. Middle Aged. Sclerosis / complications. Sclerosis /
diagnosis
. Sclerosis / pathology. Sclerosis / radiography
MedlinePlus Health Information.
consumer health - Amyloidosis
.
MedlinePlus Health Information.
consumer health - Breast Diseases
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15982886.001).
[ISSN]
0960-9776
[Journal-full-title]
Breast (Edinburgh, Scotland)
[ISO-abbreviation]
Breast
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Scotland
93.
Deemer SE, King GA, Dorgo S, Vella CA, Tomaka JW, Thompson DL:
Relationship of leptin, resting metabolic rate, and body composition in premenopausal hispanic and non-Hispanic White women.
Endocr Res
; 2010;35(3):95-105
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Relationship of
leptin
, resting metabolic rate, and body composition in premenopausal hispanic and non-Hispanic White women.
OBJECTIVE: The purpose was to evaluate the relationships between fasting
serum leptin
, resting metabolic rate (RMR), and body composition in premenopausal Hispanic and non-Hispanic White (White) women.
Serum leptin levels
were determined by EIA.
Leptin
was not a significant predictor of RMR.
CONCLUSION: Further research needs to be done to examine the role of
leptin
on metabolism, especially in ethnic groups predisposed to development of obesity and related disorders.
MedlinePlus Health Information.
consumer health - Bone Density
.
MedlinePlus Health Information.
consumer health - Hispanic American Health
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20712423.001).
[ISSN]
1532-4206
[Journal-full-title]
Endocrine research
[ISO-abbreviation]
Endocr. Res.
[Language]
ENG
[Grant]
United States / NCRR NIH HHS / RR / G12 RR008124; United States / NIMHD NIH HHS / MD / P20 MD000548; United States / NCRR NIH HHS / RR / 5G12RR008124; United States / NIMHD NIH HHS / MD / P 20 MD000548
[Publication-type]
Comparative Study; Journal Article; Research Support, N.I.H., Extramural
[Publication-country]
England
[Chemical-registry-number]
0 / Adiponectin; 0 / Leptin
[Other-IDs]
NLM/ NIHMS732174; NLM/ PMC4635679
94.
Kim HJ, Kim SK, Shim WS, Lee JH, Hur KY, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS:
Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 2008 Jul;81(1):42-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Rosiglitazone improves insulin sensitivity with increased
serum leptin levels
in patients with
type
2 diabetes mellitus.
Leptin
is highly correlated with adiposity, while the activation of PPARgamma is known to inhibit Lep gene expression and
leptin
release.
This study was performed to evaluate the relationship between changes in circulating
leptin levels
, insulin sensitivity and regional adiposity after RSG treatment.
Two hundred fifty-one
type
2 diabetic patients (176 men and 75 women) who had been treated with sulfonylurea and/or metformin received 4 mg of RSG daily, in addition to the previous medications.
Before and after RSG treatment (average duration 5.6+/-0.9 months), indices of insulin resistance, metabolic parameters, and
serum leptin
and adiponectin
levels
were measured.
After RSG treatment, HOMA-IR index decreased significantly (2.82+/-1.94 vs. 2.01+/-1.58), while BMI and SFT(max) increased, and
leptin
(4.72+/-3.77 vs. 5.69+/-4.30 ng/ml) and adiponectin
levels
(7.54+/-10.20 vs. 12.89+/-10.13 microg/ml) increased.
The increase in
serum leptin
correlated with an increase in SFT(max) (r=0.511, p<0.001) and with a reduction in HOMA-IR (r=-0.368, p<0.001).
The correlation of Delta
leptin
with Delta HOMA-IR and with Delta SFT(max) was higher in females and among insulin-resistant subjects.
In conclusion, RSG improves the insulin sensitivity with increased
serum leptin levels
in patients with
type
2 diabetes mellitus, which is related to an increase in subcutaneous adiposity.
[MeSH-major]
Diabetes Mellitus,
Type
2 / blood. Diabetes Mellitus,
Type
2 / drug therapy. Hypoglycemic Agents / therapeutic use.
Leptin
/ blood. Thiazolidinediones / therapeutic use
Genetic Alliance.
consumer health - Diabetes
.
Genetic Alliance.
consumer health - Diabetes, Type 2
.
Genetic Alliance.
consumer health - Diabetes mellitus type 2
.
MedlinePlus Health Information.
consumer health - Diabetes Medicines
.
MedlinePlus Health Information.
consumer health - Diabetes Type 2
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
ROSIGLITAZONE
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18394743.001).
[ISSN]
1872-8227
[Journal-full-title]
Diabetes research and clinical practice
[ISO-abbreviation]
Diabetes Res. Clin. Pract.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Ireland
[Chemical-registry-number]
0 / Blood Glucose; 0 / Hemoglobin A, Glycosylated; 0 / Hypoglycemic Agents; 0 / Insulin; 0 / Leptin; 0 / Thiazolidinediones; 05V02F2KDG / rosiglitazone
95.
Venkatraman L, Catherwood M, Benson G, Drake M:
Hodgkin transformation of small lymphocytic lymphoma: gene usage, mutational status and clonal relationship.
Histopathology
; 2007 Dec;51(6):866-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Hodgkin transformation of
small lymphocytic lymphoma
: gene usage, mutational status and clonal relationship.
[MeSH-major]
Mixed Tumor,
Malignant
/ pathology. Salivary Gland Neoplasms / pathology. Tracheal Neoplasms / pathology
[MeSH-minor]
Adenoma, Pleomorphic / pathology. Adenoma, Pleomorphic / surgery. Aged. Carcinoma, Adenoid Cystic / pathology.
Diagnosis
, Differential. Humans. Male. Pulmonary Disease, Chronic Obstructive / pathology. Smoking
Genetic Alliance.
consumer health - Hodgkin lymphoma
.
MedlinePlus Health Information.
consumer health - Salivary Gland Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18042076.001).
[ISSN]
0309-0167
[Journal-full-title]
Histopathology
[ISO-abbreviation]
Histopathology
[Language]
eng
[Publication-type]
Case Reports; Letter
[Publication-country]
England
96.
Lam MF, Leung JC, Lo WK, Tam S, Chong MC, Lui SL, Tse KC, Chan TM, Lai KN:
Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
Nephrol Dial Transplant
; 2007 May;22(5):1445-50
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BACKGROUND: The
serum leptin level
is elevated in patients undergoing peritoneal dialysis (PD) and associated with a loss of lean body mass.
Blood samples were obtained as baseline (D0) before the onset of peritonitis, and once peritonitis developed,
leptin
, adiponectin (ADPN) and other inflammatory markers were collected, on day 1 (D1), day 7 (D7) and day 42 (D42) of peritonitis.
The
serum leptin levels
increased significantly from baseline to day 1 and 7, but fell back to the premorbid state at day 42.
In contrast, the ADPN
level
decreased from a baseline value of 15.60+/-10.4 microg/ml to 13.01+/-8.1 microg/ml on day 1 (P=0.01) but rose to 14.39+/-8.9 microg/ml on day 7 (P=0.28) and 13.87+/-7.9 microg/ml on day 42 (P=0.21).
CONCLUSIONS: Our study confirmed an increase in
serum leptin
during acute peritonitis and a prolonged course of systemic inflammation after apparent clinical remission of peritonitis.
[MeSH-major]
Inflammation / etiology. Kidney Failure, Chronic / mortality.
Leptin
/ blood. Peritoneal Dialysis. Peritonitis / blood. Peritonitis / complications. Protein-Energy Malnutrition / etiology
MedlinePlus Health Information.
consumer health - Kidney Failure
.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17277343.001).
[ISSN]
0931-0509
[Journal-full-title]
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
[ISO-abbreviation]
Nephrol. Dial. Transplant.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Adiponectin; 0 / Interleukin-6; 0 / Leptin; 0 / Tumor Necrosis Factor-alpha; 9007-41-4 / C-Reactive Protein
97.
Zukauskaite S, Seibokaite A, Lasas L, Lasiene D, Urbonaite B, Kiesylyte J:
Serum hormone levels and anthropometric characteristics in girls with hyperandrogenism.
Medicina (Kaunas)
; 2005;41(4):305-12
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum
hormone
levels
and anthropometric characteristics in girls with hyperandrogenism.
RESULTS:
Serum
testosterone and dehydroepiandrosterone sulphate
levels
were significantly higher in all patients than in controls.
Free androgen index and
leptin levels
were significantly higher, and sex-hormone-binding globulin lower in hirsute adolescents vs. controls.
Serum
dehydroepiandrosterone sulphate negatively correlated with birth weight standard deviation scores in the group of girls with premature adrenarche (r=-0.57, p<0.001).
By linear regression, 76% in variation of
serum leptin levels
could be explained by subscapular skinfold thickness standard deviation scores, and by
serum
sex-hormone-binding globulin, insulin, and dehydroepiandrosterone sulphate
levels
in all participants.
CONCLUSIONS: Inverse correlation of dehydroepiandrosterone sulphate
levels
and weight at birth indicates relationship between premature adrenarche in girls and fetal growth.
Higher
leptin levels
in adolescents with hyperandrogenism than in healthy girls show possible involvement of
leptin
in pathogenesis of hyperandrogenism.
[MeSH-minor]
Adolescent. Age Factors. Birth Weight. Body Height. Body Mass Index. Body Weight. Child. Child, Preschool. Female. Hirsutism /
diagnosis
. Humans. Insulin / blood.
Leptin
/ blood. Linear Models. Menarche. Polycystic Ovary Syndrome /
diagnosis
. Puberty, Precocious. Risk Factors
Genetic Alliance.
consumer health - Hyperandrogenism
.
Hazardous Substances Data Bank.
TESTOSTERONE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15864003.001).
[ISSN]
1648-9144
[Journal-full-title]
Medicina (Kaunas, Lithuania)
[ISO-abbreviation]
Medicina (Kaunas)
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
Lithuania
[Chemical-registry-number]
0 / Insulin; 0 / Leptin; 3XMK78S47O / Testosterone; 57B09Q7FJR / Dehydroepiandrosterone Sulfate
98.
Remmers F, Fodor M, Delemarre-van de Waal HA:
Neonatal food restriction permanently alters rat body dimensions and energy intake.
Physiol Behav
; 2008 Sep 3;95(1-2):208-15
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Neonatal food restriction (FR) in rats, by means of increased litter size, has been used
as a
model for developmental programming by several investigators.
Serum leptin levels
were determined in four subsets of different ages.
FR acutely reduced growth in all body dimensions and
serum leptin levels
.
These results suggest that neonatal food restriction programmed both male and female Wistar rats to remain
small
and lean in adult life, with a lower food intake.
Low neonatal
leptin levels
may play a mechanistic role in this process.
[MeSH-minor]
Age Factors. Analysis of Variance. Animals. Body Mass Index. Body Weight / physiology. Eating / physiology. Female.
Leptin
/ blood. Male. Nutritional Status. Pregnancy. Radioimmunoassay / methods. Random Allocation. Rats. Rats, Wistar. Sex Factors
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18588905.001).
[ISSN]
0031-9384
[Journal-full-title]
Physiology & behavior
[ISO-abbreviation]
Physiol. Behav.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Leptin